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ABSTRACT 
System Biology proposes to study biological components, as well as the interactions between them, to 
understand and predict systems’ behaviour through the use of mathematical models. 
Under this scope, Genome-Scale Metabolic Models (GSMMs) can be regarded as mathematical 
representations of the intrinsic metabolic capabilities of a given organism, encoded in its genome, and can 
be used in a variety of applications like predicting the phenotypical behaviour of a given organism in 
different environmental and genetic perturbations. The reconstruction of these models comprehends four 
fundamental stages, namely Genome Annotation, Assembling of a Metabolic Network from the Genome, 
the Conversion of the Network to a Stoichiometric Model and finally the Validation of the Metabolic Model. 
Although this procedure is currently relatively standardized in some stages, a significant amount of work 
still needs to be done by the community before the reconstruction process becomes semi-automated and 
reproducible. The present work aims at contributing to this field through the development of several tools 
for aiding the reconstruction process, while simultaneously applying some of those tools to an industrially 
relevant organism, the yeast Kluyveromyces lactis. 
The genome annotation stage is critical, as an inadequate annotation may delay, or even impair, the 
development of the model. The genome metabolic annotation consists on identifying and attributing 
functions to metabolic genes, i.e., genes encoding enzymes and transport proteins. While the identification 
of enzyme encoding genes can be performed by assigning Enzyme Commission numbers to the proteins 
encoded in the genes, the transport proteins encoding genes annotation is not straightforward. 
In this work, an automatic system to detect and classify all potential transport proteins from a given 
genome and integrate the related reactions into GSMMs is proposed, based on the identification and 
classification of genes that encode transmembrane proteins. The integration of the data provided by this 
methodology with highly curated models allowed the identification of new transport reactions. 
This tool was included in the merlin tool, a user-friendly Java application developed under the scope of this 
thesis that performs the reconstruction of GSMMs for any organism that has its genome sequenced. It 
performs several steps of the reconstruction process, including the functional genomic annotation of the 
whole genome. merlin 2.0 also performs the compartmentalisation of the model, predicting the organelle 
localisation of the proteins encoded in the genome, and thus the localisation of the metabolites involved in 
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the reactions induced by such proteins. Finally, merlin 2.0 expedites the transition from genome-scale 
data to SBML (the standard Systems Biology Markup Language) metabolic models, allowing the user to 
have a preliminary view of the biochemical network. 
The yeast Kluyveromyces lactis has long been considered a model organism for studies in genetics and 
physiology, mainly due to its ability to metabolize lactose and to express recombinant proteins. Although 
the genome of Kluyveromyces lactis has been publicly available for some years, until now no complete 
metabolic functional annotation has been performed to the proteins encoded in the Kluyveromyces lactis 
genome and consequently no GSMM has been made available. 
In this work, a new metabolic genome-wide functional re-annotation of the proteins encoded in the 
Kluyveromyces lactis genome was performed, resulting in the annotation of 1759 genes with metabolic 
functions, and the development of a methodology supported by merlin. The new annotation includes 
novelties, such as the assignment of transporter superfamily numbers to genes identified as transporter 
proteins. The methodology developed throughout this work can be used to re-annotate any yeast or, with a 
little tweak of the reference organism, the proteins encoded in any sequenced genome. The new 
annotation provided by this study served as the basis for the reconstruction of a compartmentalized, 
genome-scale metabolic model for Kluyveromyces lactis. 
The partially compartmentalised (4 compartments) genome-scale metabolic model of Kluyveromyces 
lactis, the iOD962 metabolic model, comprises 962 genes, 2038 reactions and 1561 metabolites. 
Previous chemostat experiments were used to adjust both growth and non-growth associated energy 
requirements, and the model proved accurate when predicting the biomass, oxygen and carbon dioxide 
yields. Also, the in silico knockouts predicted accurately the in vivo phenotypes, when compared to 
published experiments. This model allowed determining a minimal medium for cultivating Kluyveromyces 
lactis and will surely bring new insights on the milk yeast metabolism, identifying engineering targets for 
the improvement of the yields of products of interest by performing in silico simulations. 
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RESUMO 
A Biologia de Sistemas propõe-se estudar os componentes biológicos e as interações entre eles, para 
compreender e prever o comportamento dos sistemas através do uso de modelos matemáticos.  
Nesse âmbito, os Modelos Metabólicos à Escala Genómica (MMEGs) podem ser considerados 
representações matemáticas das capacidades metabólicas intrínsecas de um dado organismo, 
codificadas no seu genoma, e podem ser usados numa grande variedade de aplicações tais como a 
previsão do comportamento fenotípico de um determinado organismo face a diferentes perturbações 
ambientais e genéticas. O processo de reconstrução destes modelos compreende quatro fases 
fundamentais: anotação do genoma, desenvolvimento da rede metabólica, conversão da rede num 
modelo estequiométrico e, finalmente, a validação do modelo metabólico. Apesar de algumas destas 
fases estarem já relativamente normalizadas, existe ainda uma lacuna significativa na comunidade no que 
se refere à (semi-) automação e reprodutibilidade deste processo. O presente trabalho apresenta-se como 
uma contribuição para esta área, através do desenvolvimento de várias ferramentas de apoio à 
construção de modelos metabólicos e, simultaneamente da sua aplicação ao organismo Kluyveromyces 
lactis, uma levedura de elevado interesse industrial. 
A fase de anotação do genoma é uma fase crítica, pois uma anotação inadequada pode atrasar, ou 
mesmo comprometer o desenvolvimento de um modelo metabólico. A anotação metabólica do genoma 
consiste na identificação e atribuição de funções aos genes metabólicos, ou seja, genes que codificam 
enzimas e proteínas de transporte. Enquanto que a identificação de enzimas codificadas nos genes pode 
ser realizada através da atribuição de números da Comissão para as Enzimas, a anotação de genes que 
codificam as proteínas de transporte é um processo mais complexo. 
Neste trabalho é proposto um sistema automático para a deteção e classificação de proteínas de 
transporte. Este sistema é baseado na identificação e classificação dos genes que codificam proteínas 
transmembranares. A integração dos dados fornecidos por esta metodologia com modelos metabólicos 
curados permitiu a identificação de novas reações de transporte em organismos bem estudados. 
Esta ferramenta está incluída na ferramenta bioinformática merlin desenvolvida no âmbito desta tese, que 
é uma aplicação Java de fácil utilização, direcionada para a reconstrução de modelos metabólicos à 
escala genómica. Esta aplicação executa várias etapas do processo de reconstrução, incluindo a anotação 
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funcional do genoma. O merlin 2.0 também efetua a compartimentação do modelo, prevendo a 
localização das proteínas codificadas no genoma, e consequentemente dos metabolitos envolvidos nas 
reações induzidas por essas proteínas. Finalmente, merlin 2.0 acelera a transição de dados do genoma 
para modelos metabólicos no formato SBML (Systems Biology Markup Language), possibilitando uma 
visão preliminar da rede bioquímica. 
A levedura Kluyveromyces lactis tem sido considerada um organismo modelo para estudos de genética e 
fisiologia, principalmente devido à sua capacidade de metabolizar a lactose e pela sua capacidade de 
expressar proteínas recombinantes. Apesar de o genoma da Kluyveromyces lactis ter sido disponibilizado 
publicamente há alguns anos, até agora não foi efetuada uma anotação funcional completa para 
identificar as proteínas codificadas no genoma da Kluyveromyces lactis. Consequentemente, não existe 
ainda nenhum MMEG para esta levedura. 
Neste trabalho foi efetuada uma re-anotação funcional das proteínas codificadas no genoma da 
Kluyveromyces lactis, resultando na anotação de 1759 genes com funções metabólicas, e no 
desenvolvimento de uma metodologia apoiada na aplicação merlin. A nova anotação do genoma inclui 
novidades, tais como a atribuição de números de superfamílias de transportadores a genes que codificam 
proteínas de transporte. A metodologia desenvolvida ao longo deste trabalho pode ser usada para re-
anotar qualquer levedura ou, com um ajuste do organismo de referência, as proteínas codificadas em 
qualquer genoma sequenciado. A nova anotação fornecida por este estudo serviu de base para a 
reconstrução de um modelo metabólico à escala genómica da Kluyveromyces lactis. 
Este modelo metabólico, parcialmente compartimentado (4 compartimentos), designado iOD962, inclui 
962 genes, 2038 reações e 1561 metabolitos. Foram utilizadas experiências em quimiostato publicadas 
anteriormente para ajustar os requisitos energéticos associados à manutenção celular, e o modelo 
mostrou precisão na previsão dos rendimentos de biomassa, de dióxido de carbono e de oxigénio. Além 
disso, as simulações in silico previram com precisão os fenótipos in vivo, quando comparadas com as 
experiências publicadas. Este modelo permitiu determinar um meio mínimo para o cultivo de 
Kluyveromyces lactis e certamente trará novas perspectivas sobre o metabolismo desta levedura, 
identificando alvos de engenharia metabólica para a melhoria dos rendimentos dos produtos de interesse 
através da realização de simulações in silico. 
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1.1 OBJECTIVES OF THE THESIS 
The yeast Kluyveromyces lactis has long been considered a model organism for studies in 
genetics and physiology, mainly due to its ability to metabolize lactose and to express 
recombinant proteins. Although the genome of K. lactis has been publicly available for some 
years, a complete functional genome-scale metabolic model has not been reconstructed yet. 
Therefore, the main purpose of this thesis is the reconstruction of a working metabolic model of 
K. lactis from the information contained in its genome. The validation of the model was 
performed by comparing model simulation results to published experiments. The achievement of 
the main goal of this thesis relies on the accomplishment of the following objectives: 
• Development of bioinformatics techniques for the semi-automated genome annotation for 
the identification of both enzymatic activities and transporter proteins 
• Development and implementation of novel tools for the assembly of a genome-scale 
metabolic model from the genome annotation results  
• Design and implementation of approaches for the use of existing physiological data for 
aiding model construction and validation 
The availability of a reliable and validated genome-scale model for K. lactis will allow, in the near 
future, its use by the scientific and industrial communities for several applications, with a special 
emphasis on: 
• In silico simulation of the phenotypic behaviour of the microorganism under different 
environmental and genetic conditions. 
• In silico design of metabolic engineering strategies that can enhance the performance of 
the wild-type strain aiming the overproduction of industrially relevant compounds. 
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was used in the development of the K. lactis genome-scale metabolic model. The work presented 
in this chapter was submitted for peer review in an article with the following title: Genome-wide 
Semi-automated Annotation of Transporter Systems2. 
This tool was included in the second version of the application developed for MEtabolic models 
Reconstruction using genome-scaLe INformation, merlin 2.0. The first version of merlin was 
presented in 11th International Symposium on Computer Applications in Biotechnology (CAB 
2010)3. In Chapter 4, the second generation of merlin featuring several new features and 
improvements is presented. The work presented in this chapter was submitted for peer review in 
an article with the following title: Reconstructing genome-scale metabolic models with merlin 
2.04. 
This application was developed for semi-automatically performing several steps of the 
reconstruction process. The first step of this routine is the metabolic (re-)annotation of the 
genome. This task was performed using merlin for the organism studied in this work, and 
resulted in the publication of the Genome-wide metabolic (re-) annotation of Kluyveromyces lactis, 
in BMC genomics5, which is available in Chapter 5. 
This re-annotation was used as basis for the development of the metabolic model, which is 
available in Chapter 6. In such chapter, the methodologies for the development and validation of 
the model are described. The work presented in this chapter was submitted for peer review in an 
article with the following title: Reconstruction of the genome-scale metabolic model of 
Kluyveromyces lactis6. 
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1.3 OUTPUTS OF THIS THESIS 
The scientific outputs of this thesis are listed in references 1-6. Moreover, several conferences 
were used as means of learning new methods and of assessing the acceptance of the scientific 
community to the new technologies developed throughout this work. The works presented in 
these events are enumerated bellow: 
ORAL PRESENTATIONS 
• Dias, O.; Gombert, A. K.; Rocha, I.; Ferreira, E.C. iOD962 - the first genome-scale 
metabolic model of Kluyveromyces lactis. Bioinformatics Open Days 2013. Braga, 
Portugal. March 14-15, 2013. 
• Dias, O.; Rocha, M.; Ferreira, E.C.; Rocha, I. Merlin: Metabolic models reconstruction 
using genome-scale information. CAB 2010 - Proceedings of the 11th International 
Symposium on Computer Applications in Biotechnology (Julio R. Banga, Philippe 
Bogaerts, Jan Van Impe, Denis Dochain, Ilse Smets, Eds.), Leuven, Belgium, July 7-9, 
120-125, 2010. 
POSTER PRESENTATIONS 
• Dias, O.; Rocha, Miguel; Rocha, I.; Ferreira, E.C. Metabolic reconstruction of less 
characterized microorganisms: a new methodology for reaction identification from 
genome sequencing data. Jornadas de Bioinformática JB'2009 - Challenges in 
Bioinformatics: proceedings (), 57-, 2009.  
• Dias, O.; Rocha, I. Genome-scale metabolic models reconstruction of less characterized 
organisms with Merlin. Metabolic Engineering VIII, Jeju Island, Korea, June 13-17, 2010. 
• Dias, O.; Ferreira, E.C.; Rocha, I. Towards genome-wide semi-automated transporter 
system annotations. ICSB 2011 - Abstract Book of the 12th International Conference on 
Systems Biology, Heidelberg/Mannheim, Germany, August 28 - September 1, (PS 432), 
230-231, 2011. 
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The work presented in this chapter corresponds to the following book chapter: 
Oscar Dias and Isabel Rocha. 
Systems Biology in Fungi. 
Molecular Biology of Food and Water Borne Mycotoxigenic and Mycotic Fungi, 
(2013). 
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2.1 ABSTRACT 
The leading purpose of this chapter is to present and discuss the current 
status of Fungi metabolic Systems Biology. System Biology proposes to 
study biological components, as well as the interactions between them, to 
understand and predict biological behaviour. System Biology is not a 
novelty, though its existence has been in recent years highlighted by 
several technologies, which brought it to the post-genomic era. For 
instance, the assembly of genomes and the prediction of genes and their 
functions became a widespread common procedure. Meanwhile other 
“omics” analyses have been developed and Genome-Scale Metabolic 
Models started to be reconstructed to help understanding and predicting 
the behaviour of biological systems. 
These models can be regarded as mathematical representations of the 
intrinsic metabolic capabilities of a given organism, encoded in its 
genome. The reconstruction process comprehends four fundamental 
stages, namely Genome Annotation, Assembling of a Metabolic Network 
from the Genome, the Conversion of the Network to a Stoichiometric 
Model and finally the Validation of the Metabolic Model. These models can 
be used in a variety of applications like predicting the phenotypical 
behaviour of a given organism in different environmental and genetic 
perturbations or designing minimal media. Genome-Scale Metabolic 
models of Fungi have been proven useful by various successful case 
studies in accomplishing several goals, such as identifying new target 
genes to enhance the biosynthesis of by-products or gene deletion studies, 
as it is shown throughout this chapter, together with a detailed description 
of the methodologies to construct fungi metabolic models. 
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2.2 MOTIVATION 
Systems Biology analyses both the components and the interactions of organisms to understand 
their organization and to predict behaviour1,2. Currently, systems biology has a variety of 
applications using industrial organisms, and in medical problems. This holistic approach involves 
a combination of modelling and omics analyses and was naturally more rapidly and easily 
applied to prokaryotic organisms. Nevertheless, fungal systems biology started as a discipline 
quite soon, especially driven by the accumulated knowledge in the yeast Saccharomyces 
cerevisiae that is, simultaneously, a eukaryotic model organism and a widely used industrial 
organism3–5. 
Within systems biology, integrated studies of metabolism (“Metabolic Systems Biology”) emerge 
for two main reasons: availability of data and importance of applications. Indeed, accumulated 
knowledge on metabolism is vast and allows creating reliable models that allows simulation of 
microorganism behaviour in a variety of conditions. Also, metabolism is directly related to 
valuable end products and a variety of diseases have a metabolic origin6,7. Knowledge on 
metabolism of a given organism is easily applied to other organisms, using simple Bioinformatics 
tools such as Basic Local Alignment Tool (BLAST)8, while the same is not true for other functions 
such as transcription regulation and signalling. Therefore, it is easy to understand why a variety 
of metabolic models are available for organisms ranging from simple bacteria to filamentous 
fungi or even Homo sapiens 9, while only a few regulatory or signalling models have been 
constructed10,11, and notably none for eukaryotes at a genome-scale.  
The general purpose of this chapter is detailing the state of the art of systems biology in fungi. 
Besides S. cerevisiae, several other fungi are being studied within metabolic systems biology 
which are important for industrial or pharmaceutical purposes. Several applications of those 
models are also described throughout this chapter besides detailing the state of the art 
methodologies to build a genome-scale metabolic model for fungal species. 
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2.3 METABOLIC SYSTEMS BIOLOGY 
The first association between “Systems” and “Biology” was performed in 1915, by Walter 
Cannon, describing the human body as a control system12. In, 1950 Ludwig von Bertalanffy 
introduced the General System Theory13, and he was probably the first to declare that “… 
organismic conceptions have evolved in all branches of modern biology which assert the 
necessity of investigating not only parts but also relations of organization resulting from a 
dynamic interaction and manifesting themselves by the difference in behaviour of parts in 
isolation and in the whole organism”. Thus, the principle of analysing the components, and the 
interactions between them, to understand and predict biological behaviour is well established. 
The novelty arises from the availability of large scale data-sets5, which enables more complex 
analysis. 
The introduction of whole-genome high-throughput sequencing techniques, which promoted the 
completion of several whole-genome sequencing projects in the last decade, the advent of the 
Internet and the development spree of various bioinformatics tools, motivated a paradigm shift in 
biology, bringing this field to the post-genomic era14. 
Unlike traditional components biology, which sees cells as a set of individual components 
involved in biological processes, the study of biological systems, Systems Biology, similarly to the 
study of any other type of system, involves quantifying the components in parallel and analysing 
the interactions between them2,5,13,15,16, through the use of mathematical models. Thus, it is 
foreseeable that research will focus in the so called “emergent properties”, which arise from the 
whole instead of the individual parts, and represent real biological properties16. 
Leroy Hood provides a visual aid for this definition, declaring that cell systems can be seen as 
cars17. He proposes that, understanding how a car works may be regarded as the formulation of 
a simple model. The determination of the car components would be performed by high-
throughput technologies. Then, removing a part of the car (i.e. perturbation) would allow 
comparing its behaviour to normal cars. The integration of all this information would allow 
building a model of the car, and the model could be refined with integration of new data. 
14 SYSTEMS BIOLOGY IN FUNGI 
 
Although the major challenge of Systems Biology is to be able to represent the whole-cell 
behaviour in a computer model, a good model is not just able to mimic cell comportment, but 
rather predict such behaviour18. Thus, these models should be able to foretell the phenotypical 
behaviour of a cell, an organism, or an individual. 
In the pre-genomic era, strain development for industrial applications was carried out by random 
mutagenesis, followed by screening and selection of phenotypes of interest or by performing 
targeted modifications in genes known to be associated with the product of interest. This last 
reductionist approach, sustained by components biology, requires that biological events are 
related to only a few genes, or proteins5 and is often unsuccessful, because the identification of 
functional properties for specific cell components is insufficient to understand the biological 
systems as a whole19. Random mutagenesis, on the other hand, although successful, does not 
allow understanding the cellular mechanisms leading to the end result20. 
The models provided by systems biology approaches, together with an already high, yet growing, 
number of bioinformatics tools, allow identifying high probability genetic targets for increasing 
yields, titers, productivities and robustness in industrial biotechnology processes20–23. Thus, these 
systems level models allow accelerating the development of biological processes, reducing the 
commitment of resources and commercialization time20. 
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The output of the high-throughput sequencing technologies is a set of short sequence reads that 
needs to be assembled. This process is called de novo Genome Assembly. The new sequencing 
technologies allow decoding microbial genomes at moderate costs employing only a small 
number of experiments27–30. However, the trade-off for these improvements is usually a much 
smaller read length31, which increases significantly the difficulty of the sequence reassembly 
process. The complexity of the sequence increases by a factor of 4 for each base added to the 
read and the likelihood of detecting redundancy in a pool of sequences decreases drastically32. 
Thus, new sequencing approaches able to generate longer read lengths and improve data quality 
are welcome by those working on de novo genome assembly33. Even so, the cost for sequencing 
genomes has been decreasing every year, generating hundreds of gigabases of data, per 
genome. Therefore, new algorithms, even more efficient, are needed to analyse and assemble a 
genome de novo 34. 
The next step in genome annotation is to find all genes in a given genomic sequence. This stage 
is called the genome structural annotation and consists of the identification of all protein 
encoding genes, different types of RNA and other DNA within the genome. This process is usually 
performed using bioinformatics resources, as experimental verification can be costly and time 
consuming14,35,36. In prokaryotes (and certain minor eukaryotes) it is fairly simple to pinpoint the 
frontiers of protein encoding open reading frames (ORFs). Essentially, it is a question of 
identifying long ORFs within these genomes, by running a tool that identifies the ORFs longer 
than a given threshold within all 6 frames14. The accuracy of the tools, which predict ORFs in 
these organisms, is very high (over 90%)35. In eukaryotes, the bigger genomes, large number of 
introns and the alternative splicing pose a superior challenge for predicting the ORFs35,36. 
Moreover, gene finding is different in prokaryotic and eukaryotic genomes, since about 90% of the 
bacterial genome is coding sequences whereas higher eukaryotes have less than 10% of coding 
sequences37. Several tools for gene prediction can be found at 
www.geneprediction.org/software.html. Most of these use probabilistic methods, such as Hidden 
Markov Models (HMM), to identify coding sequences within the ORFs (e.g. GLIMMER37, 
GenMark38 and EuGène39). Alternatively, some tools use methods other than HMM (e.g. 
Gismo40). Despite the availability of several software tools that perform ORF predictions, a clear 
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winner has yet to emerge35. Thus, several programs should be used to check predictions and, 
when possible, the results confirmed by experimentations. Similarly, there are some software 
tools to predict non-coding genes, which encode RNA instead of a functional protein-product. 
More information in RNA gene prediction can be found in a review by Meyer41. 
After knowing where to find the protein encoding genes the question to ask is, what are the 
functions of those genes? This stage of the genome annotation is named Genome Functional 
Annotation, and it consists of assigning putative functions to each protein encoding gene. These 
functions are often identified by similarity to formerly characterized sequences kept in 
databases42. A classic genome functional annotation pipeline will start by performing similarity 
searches against databases of nucleotide or protein sequences, using an algorithm of the BLAST8 
family or HMMER43. The analysis of the homologous genes allows identifying the protein each 
ORF is most likely to encode, assigning each gene with specific functions. Whilst performing the 
annotation, the product of a given gene may be unknown, and dubbed as a hypothetical protein. 
Nevertheless, the assignment of a specific function to a given gene should be performed carefully 
because such function may not be the correct one, leading to a misclassification44. Finally, the 
genes can be grouped according to specific characteristics of interest. For example, if one is 
interested in building a hybrid metabolic-regulatory model, each gene within the genome will be 
classified either as a regulatory gene, a metabolic gene or other type of gene. 
2.4.1 OTHER OMICS 
The genome is a static entity that does not change significantly with time. In order to identify and 
characterize other cellular components, which provide context for utilization and regulate the 
expression levels of the genes, other “omics” technologies were developed. Unlike genomics, the 
other “omics” are susceptible to environmental and genetic perturbations5. Most of these 
technologies, namely transcriptomics, proteomics and metabolomics, provide “snapshots” of the 
physiological state of system. 
The transcriptome can be determined using Next-Generation Sequencing methods (RNA-Seq) or 
microarray technology (DNA oligonucleotide and cDNA arrays). Both measure the mRNA 
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expression levels, for a given condition, of virtually every ORF in the genome. These tools may 
also be useful for annotating genes5. 
The proteome characterizes all proteins in the cell. It provides information on enzymes, transport 
proteins, regulatory proteins, signalling proteins and others. Although proteins are encoded in the 
genome, no direct linear correlation has been found between the transcriptome and the 
proteome45,46, i.e., between the quantity of mRNA molecules and the corresponding proteins. 
Traditionally, proteins are separated using two-dimensional gel electrophoresis (2DGE), followed 
by identification by mass spectrometry (MS). Recently, liquid chromatography (LC) combined with 
MS proved to be a more efficient method47,48. Protein microarrays are also being increasingly 
used for proteins identification and functional annotation5. Since protein amplification methods 
do not exist, as they do for DNA, the main problem in the development of this technology is the 
availability of sufficient amounts of proteins. Thus, for detailed functional and structural analysis, 
proteins have to be recombinantly produced and purified. 
The metabolome represents the availability of metabolites in the system49. Metabolomics 
techniques were developed on the premise that cells control concentrations of intracellular 
metabolites very rigidly5. Metabolite profiling is very important in systems biology, as the 
connectivity of the networks is determined by the availability of metabolites. Although the number 
of metabolites is significantly lower than the number of proteins or genes, the full metabolic 
profile cannot be determined with the technology currently available. The analysis of the 
metabolome is typically determined by MS and nuclear magnetic resonance (NMR). Yet, the 
combination of GC and LC with MS is probably one of the best techniques for metabolite 
profiling. 
Though representing the physiological state of the cell, the fluxome cannot be quantified directly, 
in contrast to the “snapshot” of the system in a given moment provided by the concentrations 
measured with other omics50. Fluxes can be measured using stable isotope tracers, such as 
substrates labelled with C-13 markers51,52that can be analysed by NMR or MS5. In either case, 
some or all metabolic fluxes are inferred from those isotopes combined with measurements on 
the extracellular fluxes and biomass and with a metabolic model50. 
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Alternatively, metabolic fluxes can be estimated by performing flux balance analysis (FBA) on 
stoichiometric metabolic models. FBA is a mathematical approach, which applies linear 
programming, for analysing the flow of metabolites through a metabolic network, maximizing or 
minimizing an objective function. Usually, it is assumed that cells are under selective pressure 
and biomass precursor fluxes are favoured53–55. 
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2.5 GENOME-SCALE METABOLIC MODELS 
Metabolic reconstructions existed before genomic data were available where literature and 
biochemical characterization of enzymes were the main sources of information for these 
networks. Nowadays, the whole genome sequences and the availability of well-studied 
biochemical reactions in several biological databases26,56, allow generating metabolic networks at 
the genome-scale, even for organisms less characterized in the literature57. Genome-Scale 
Metabolic Networks (GSMNs) can be defined as the set of biological reactions retrieved from the 
enzymes encoded in the target organism’s genome. A metabolic reconstruction process implies 
knowing, for each reaction in the network, which are the substrates and products, its 
stoichiometry, the reversibility of the reaction and its location57. GSMNs characterize biochemical 
reactions, which produce compounds that are consumed by other reactions, and relations 
between the reactions. Although GSMNs allow determining some physiological and biochemical 
properties of the cells, only Genome-Scale Metabolic Models (GSMMs) can be used for predicting 
the capabilities of the metabolic system. These models may include reaction kinetics and 
regulatory information; though, such information is currently only available for a few well studied 
organisms56. Thus, the information contained in these models only includes details on the 
biomass composition and energetic needs, apart from the network data. These models are 
currently used to predict, in silico, the response to perturbations of microorganisms, and for 
identifying candidate drug targets56. 
The same process may, in theory, be applied for reconstructing eukaryotic and prokaryotic 
metabolic models58. Nevertheless, Eukaryotic models are more demanding due to their larger 
knowledge base and genomes, and the various compartments within the cells. The GSMMs 
reconstruction process is currently a widespread procedure, as several authors published 
guidelines and protocols for the reconstruction of these models56,58. Moreover, tools like merlin 
2.044,59, model SEED60, MicrobesFlux61, or Pathway tools62, developed specifically for model 
reconstruction, are becoming increasingly available. These tools are usually developed for 
assisting in the automation of some steps of the reconstruction of the model, although manual 
curation is always required. 
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Other tools, such as CellDesigner63 or Cytoscape64, amongst others, allow visualizing networks 
within the models. Almost all tools developed for reconstructing, simulating or visualizing 
metabolic models accept or export the models in the Systems Biology Markup Language 
(SBML)65 format. This language was initially developed for representing dynamic models, yet it 
can also be used for stoichiometric models. 
The reconstruction of GSMMs is supported by information available in several online databases. 
These provide information about genome sequences and annotation and/or the functional 
capabilities of the proteins. Some of the most important data sources for developing GSMMs are 
listed in Table 2.1. 
Table 2.1. Main online data sources used for the reconstruction of genome-scale metabolic 
models. 
Database 
Web address 
Reference 
Description Data types Curated 
BioCyc 
www.biocyc.org 
Caspi et al. 66 
BioCyc is a collection of Pathway/Genome Databases 
(PGDBs). Each PGDB in the BioCyc collection describes the 
genome and metabolic pathways of a single organism. 
These PGDBs contain additional features, including 
transport systems and gap fillers. Also, the BioCyc Web site 
contains tools for the visualization and analysis of the 
PGDBs. 
genomic, 
metabolic • 
BKM 
bkm-react.tu-bs.de 
Lang et al. 67 
BRENDA-KEGG-MetaCyc-reactions online. BKM-react is an 
integrated and non-redundant database containing known 
enzyme-catalysed and spontaneous biological reactions 
collected from BRENDA, KEGG, and MetaCyc by aligning 
substrates and products. 
metabolic  
BRENDA 
www.brenda-enzymes.org 
Schomburg et al. 68 
BRaunschweig ENzyme Database (BRENDA) is the main 
collection of enzyme functional data available to the 
scientific community. Contains functional and molecular 
information of enzymes, based on primary literature. 
metabolic • 
Expasy 
www.expasy.org 
Artimo et al. 69 
Expert Protein Analysis System (ExPASy) is the Swiss 
Institute of Bioinformatics Resource Portal in different 
areas of life sciences including systems biology. 
Furthermore, ExPASy is one of the main bioinformatics 
resources for proteomics in the world. 
genomic, 
proteomic, 
metabolic 
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GOLD 
www.genomesonline.org 
Pagani et al. 70 
Genomes Online Database (GOLD) is a resource for 
comprehensive access to information regarding genome 
and metagenome sequencing projects. 
genomic 
 
KEGG 
www.kegg.jp 
Kanehisa et al. 71 
Kyoto Encyclopedia of Genes and Genomes (KEGG) is an 
online public repository that is, currently, the most 
extensive combined collection of information on genes, 
metabolites, reactions and pathways. 
genomic, 
metabolic  
MetaCyc 
www.metacyc.org 
Caspi et al. 66 
MetaCyc is a database of non-redundant metabolic 
pathways. MetaCyc is curated from the scientific literature 
and contains pathways involved in primary and secondary 
metabolism, as well as associated compounds, enzymes, 
and genes. 
metabolic • 
NCBI 
ncbi.nlm.nih.gov 
Sayers et al. 72 
The National Center for Biotechnology Information (NCBI) 
is a repository of several databases that provides analysis, 
visualization and retrieval resources for biomedical, 
genomic and other biological data made available through 
the NCBI web site. 
genomic 
 
SABIO-RK 
sabio.villa-bosch.de 
Wittig et al. 73 
SABIO-RK is a curated database that contains information 
about biochemical reactions, their kinetic rate equations 
with parameters and experimental conditions. 
metabolic • 
SGD 
www.yeastgenome.org 
Cherry et al. 74 
The Saccharomyces Genome Database (SGD) provides 
comprehensive integrated biological information for the 
budding yeast Saccharomyces cerevisiae. 
genomic • 
TCDB 
www.tcdb.org 
Saier et al. 75 
Transporter Classification Database (TCDB) comprehends 
a classification system for membrane transporter proteins 
known as the Transporter Classification system. 
genomic, 
metabolic 
• 
UniProt 
www.uniprot.org 
Apweiler et al. 76 
Universal Protein Resource Knowledgebase (UniProtKB) is 
the central hub for the collection of accurate, rich and 
consistent functional information on proteins. It consists of 
two sections: a section containing manually-annotated 
records with information extracted from literature and 
computational analysis (referred to as "UniProtKB/Swiss-
Prot"), and a section with computationally analysed records 
waiting full manual annotation ("UniProtKB/TrEMBL"). 
genomic, 
metabolic 
• 
Most of these databases will be continuously referenced throughout this thesis. 
There are already several works that describe the reconstruction process56–58,77. In these, a 
concise description of the methodology for the reconstruction of genome-scale metabolic models 
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for unicellular eukaryotes is presented. The reconstruction process comprehends four 
fundamental stages, namely Genome Annotation, Assembling of a Metabolic Network from the 
Genome, the Conversion of the Network to a Stoichiometric Model, and the Validation of the 
Metabolic Model. 
As depicted in Figure 2.2 the reconstruction of a GSMM is an iterative process in which the 
information retrieved from several data sources is compiled and used for assembling a draft of 
the GSMN. After obtaining the initial metabolic reconstruction from the genome annotation, the 
draft network is debugged and, the network is converted to a GSMM by adding an equation that 
represents the biomass formation and other constraints. The biomass equation does not belong 
to the GSMN, since this reaction is not derived from the genome and is not a reaction that 
naturally occurs in the cell. It is a reaction that represents the cell and, inclusively, all metabolites 
within this reaction are expressed in different units from the metabolites in the network 
(millimoles per gram of biomass). Thus, the flow through this reaction must be expressed in 
grams of biomass per time unit (i.e., the growth rate of a microorganism), contrasting with fluxes 
through the other reactions (expressed in millimoles per time unit)56. 
The resulting model is validated by comparing experimental data to simulations performed with 
the GSMM. If the model does not comply, data sources can be used to revise the reactions set 
and improve the model. If it does comply, the model can be used in several applications such as 
gene deletion studies, or designing minimal media. A brief description of each of the stages, 
inferred from two reviews56,58 of the reconstruction process, is provided next. 
2.5.1 GENOME ANNOTATION 
Every genome-scale reconstruction begins with the annotated genome of the target organism. 
The genome annotation stage is critical for developing high-quality GSMMs, because the 
annotation is assumed to be correct and it is performed only once throughout the whole 
reconstruction process. The genome annotation process assigns genes with functions, providing 
unique identifiers, such as the Enzyme Commission (EC)78 and Transporter Classification (TC)79 
numbers, to the reconstruction. During the reconstruction process, subunits of protein complexes 
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Since the quality of the curated genome annotation is critical for the reliability of the 
reconstructed model, the re-annotation of previously annotated genomes may be required. Thus, 
some re- annotations, with the purpose of developing GSMMs, have been performed80–82.  
Performing the genome (re-) annotation involves seeking specific data, namely gene or ORF 
names, product names and, if available, EC numbers. Only the so-called metabolic genes, are 
mandatory for the development of GSMMs, which are the genes encoding enzymes and transport 
systems. Other genes involved in regulatory control or signalling are not included in GSMMs, but 
may be useful for later integration of the model with these networks. 
merlin 2.0 44,59 is a Java application developed by the present authors for assisting in the 
reconstruction of GSMMs of organisms with sequenced genomes. It performs several steps of the 
reconstruction process in a semi-automatic manner, including the functional genomic 
annotations of the whole genome. merlin 2.0 44,59 utilizes two of the most used tools, BLAST and 
HMMER, for performing the (re-) annotation of genomes. The similarity searches results are then 
evaluated and an automatic annotation of the genome is presented. This tool assigns annotations 
to each gene of the target organism, using an internal scorer that weights both the frequency of 
functions and the taxonomy of every homologue of each gene of the target genome. Some 
parameters should be inputted for the computation of the annotation to be assigned to each 
gene. For fungi, the α (alpha) value should be set to 0.2. This parameter leverages the weight of 
each score (frequency and taxonomy), according to the following equation. 
ܵܿ݋ݎ݁ = 	ߙ	 × ܵܿ݋ݎ ௙݁௥௘௤௨௘௡௖௬ + ሺ1 − ߙሻ ܵܿ݋ݎ݁௧௔௫௢௡௢௠௬ 2.1
Usually, genes with annotation scores above 0.5 can be regarded as being always correct and a 
confidence level of 1 (highest) should be assigned to those annotations. On the other hand, gene 
annotation scores bellow 0.2 should be ignored. Gene assignments with intermediate scores 
should be manually curated, and this can be performed taking advantage of the user-friendly 
graphical user interface (GUI). A concise pipeline for the manual curation of the metabolic 
annotations for fungal genomes is presented in Figure 2.3. It is based on the fact that the most 
widely characterized fungus species is S. cerevisiae and, if no information is available for the 
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the star within the button is golden, the UniProt record is reviewed. However, if the star is 
silvered then the record exists but is not reviewed. If the surrounding colour is green, the EC 
numbers’ annotations in both UniProt and merlin 2.0 are in accordance and the gene can be 
annotated with that function with a high confidence level (1 for reviewed UniProt records and 2 
for unreviewed), after confirming the enzyme function in BRENDA. On the other hand, if the 
background of the star is red, it either means that the annotations are distinct or that the UniProt 
record is not annotated. In the former case, the annotations of both merlin and UniProt should be 
analysed and reviewed records, as well as entries associated to complete EC numbers, should be 
favoured. The gene should be annotated with the function suggested by this analysis, with a 
confidence level of 3, after confirmation in BRENDA. In the latter case, an S. cerevisiae 
homologue should be sought within merlin 2.0’s similarity search results of the target gene. If a 
baker’s yeast homologue exists, then its function should be determined by analysing the 
corresponding UniProt and SGD records, with preference to the organism-specific database. This 
function should be proposed to annotate the target gene, with a confidence level of 3, after 
confirmation in BRENDA. If a homologue to S. cerevisiae cannot be found, within merlin 2.0 
similarity records for the target gene, then a BLAST (or HMMER) alignment should be performed 
against NCBI’s yeast database. Again, if available, the target gene should be annotated with the 
S. cerevisiae function, with a confidence level of 4, after confirmation of the function. In the 
absence of an S. cerevisiae homologue, the gene should be aligned to UniProt’s Swiss-Prot 
database, so that reviewed homologues of other species, with preference to other Fungi, can be 
used to annotate the gene. The first homologue record, if it has metabolic functions, should be 
selected to annotate the target gene, with a confidence level of 5, after confirming the function in 
BRENDA. 
BRENDA, as a primary source on enzymatic information, is used to confirm the annotations to be 
assigned to each gene, eliminating errors originated by one of the following reasons: the EC 
number may have been transferred to another EC code, it may have been deleted, or there may 
be a mismatch between the EC number and the enzymatic function caused by errors in the 
annotation of the homologue gene. This procedure intends to limit the propagation of annotation 
errors. A previous work by the authors80 used a similar schema to annotate the Kluyveromyces 
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lactis genome. At the end of this stage, the metabolic annotation of the genome must be 
retrieved, so that the enzymatic reactions associated to the target organism’s metabolism can be 
collected. 
assembling the metabolic network 
The second stage of the reconstruction of metabolic models involves identifying and collecting 
biochemical reactions to form a network. This stage encompasses several steps. The first step is 
building the backbone of the network using reactions catalysed by enzymes and transport 
systems encoded in the annotated genome. 
2.5.1.1 GENES, PROTEINS AND REACTIONS 
The association between annotated genes, proteins and reactions (the GPR associations) is 
usually performed by searching biological databases (Table 2.1) with the protein names, EC 
numbers or other identifiers (e.g. KEGG reaction number) to which the reaction was associated77. 
The Nomenclature Committee of the International Union of Biochemistry and Molecular Biology 
(NC-IUBMB) provides a hierarchical nomenclature for classifying enzymes, the so called EC 
numbers. This system is a code that contains four elements, separated by three dots (#.#.#.#). 
The left most number represents one of the six main divisions to which the enzymes may belong 
to, namely oxidoreductases, transferases, hydrolases, lyases, isomerases and ligases. Each 
element to the right of the main class refines the classification of the enzyme. A complete EC 
number where all elements of the EC code are available represents a single enzymatic activity for 
which the catalysed reaction(s) is usually known.  
Likewise, TC numbers represent proteins that promote the relocation of metabolites. This system 
is analogous to the EC system, except that it incorporates functional and phylogenetic 
information. The TC code contains five elements, separated by four dots (#.*.#.#.#). The left 
most number represents one of the seven main divisions to which the transporters may belong 
to, namely Channels/Pores, Electrochemical Potential-driven, Primary Active, Group 
Translocators, Transmembrane Electron Carriers, Accessory Factors Involved in Transport and 
Incompletely Characterized Transport Systems. The second element is a letter and the remainder 
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elements are numbers. Similarly, each element to the right of the main class restricts the 
classification of the transporter. The TCDB can be accessed for retrieving the metabolites and 
type of transport supported by a given carrier protein. These transport reactions should also be 
added to the draft network. 
Therefore, the initial draft of the network can be reconstructed by associating enzymes and 
transporters, through the use of EC and TC numbers, with substrates and products using 
databases such as TCDB, BRENDA and KEGG. These data should, preferably, be automatically 
retrieved using tools developed for that purpose, e.g. merlin 2.0. Also, it should be noticed that 
proteins involved in DNA methylation and RNA modification, although commonly associated to EC 
numbers, are not usually incorporated into the model. 
2.5.1.2 SPONTANEOUS REACTIONS 
The second step of this stage is the addition of non-enzymatic and spontaneous reactions to the 
network. These reactions can be found in published literature or in a few online data sources, 
such as KEGG. Information available in the latter can be retrieved automatically using tools which 
support such operation, e.g. merlin 2.0. 
2.5.1.3 STOICHIOMETRY 
After collecting the set of reactions, their stoichiometry should be revised. Information on this 
step may be found in databases such as BKM-react, BRENDA and MetaCyc. 
2.5.1.4 LOCALISATION 
The next step is the compartmentation of the reactions. The localization of enzymes inside 
compartments or outside the cell is important for the development of GSMMs, because it 
determines the organelles in which the enzymes operate. In prokaryotes, the compartments are 
typically limited to cytosol, periplasmic space and the extracellular space. In Fungi, and other 
eukaryotes, the reactions can occur in various compartments, including Golgi apparatus, 
lysosome, mitochondrion, endoplasmic reticulum or glyoxysome. For higher eukaryotes it may be 
further necessary to differentiate between tissues. The first GSMM reconstruction of S. 
cerevisiae83 accounted for three compartments, the second84 eight and the consensus85 fifteen. 
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The existence of several S. cerevisiae GSMMs also demonstrates the dynamism of GSMMs, 
which are in continuous improvement. 
It is important to distinguish similar reactions with the same metabolites and stoichiometry, but 
being held in different compartments, as distinct reactions. Likewise, it is critical to annotate one 
metabolite in different compartments as distinct metabolites. That is, the metabolite should be 
replicated in each compartment and its name, as well as its identifier, should reflect each 
localization. For example, if glucose is present in the exterior of the cell and in cytosol, then two 
glucose species should be created and their names could be glucoseext and glucosecyt. 
Several bioinformatics tools were developed for predicting the localization of enzymes from the 
amino acids sequence of the proteins and physiological data of the organism. The most 
commonly used applications for this are tools from the PSort family86,87 and TargetP88. Also, 
information about the localization of enzymes and reactions can be found in the literature and 
online databases such as UniProt. Nevertheless, when in doubt, reactions and metabolites are 
usually assigned to the cytosol. The compartmentalized draft GSMN serves as an input for the 
next step. 
2.5.1.5 MANUAL CURATION 
Unfortunately, automatic methods, although very useful, are fallible77. An automatic draft 
reconstruction will be incomplete because it will have missing reactions and it may contain 
reactions irrelevant to the GSMM57. To obtain a metabolic network that reflects each organism's 
specificities revision of all reactions added to the network is mandatory. Thus, the last step of the 
GSMN reconstruction is the thorough revision of the literature, including publications and 
textbooks, organism-specific databases and consultation of expert researchers, for the validation 
of the reactions set, the so-called manual curation of the GSMN. This step may involve verifying 
the data sources used for building the network; hence, the decisions taken throughout the 
reconstruction process should be traceable. Unlike the automated generation of the draft GSMN, 
the manual curation can be slow, and tedious. Manual curation should deal with issues such as 
(a) the inconsistencies of the proteins and functions identifiers, (b) the addition of new organism-
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specific reactions unavailable in the queried data sources and (c) assess the assignment of 
reactions to ambiguous identifiers77, such as partial EC numbers (e.g. assignment of several 
reactions to EC number 3.6.1.-). 
The presence of each reaction of the model in the target organism metabolism should be 
confirmed in this step. Dubious reactions for which no evidence has been found in literature 
should be discarded56. For instance, various enzymes may potentially promote several reactions; 
however, reactions specific to the target organism should only be included in the GSMN. 
Accordingly, the charged formula of each metabolite should be determined, as the metabolites 
inside the cells may be protonated or deprotonated. For instance, the pH of organelles may alter 
the protonation state of the metabolites. 
The reversibility of the reactions may be assessed (a) by biochemical studies of enzymes of the 
target or closely related organisms or (b) determined from the estimation of the standard Gibbs 
free energy of formation (ΔfG’0) and of reaction (ΔrG’0) as demonstrated in previous studies89,90. 
Reconstructions can also be accelerated91 and curated using comparative genomics, by 
paralleling the draft network with curated models from closely related organisms. A different 
approach, which can be combined with the previous, is comparing the draft network to known 
biological pathways, and searching for gaps. A gap in a metabolic model refers to a reaction in a 
pathway uncoupled to a gene77. The lack of a reaction in a biological pathway would lead to 
accumulation of compounds produced by energetically favoured reactions. Simultaneously, the 
downstream of the pathway would be halted because the substrate produced by the absent 
enzyme would be missing. Thus, gap-filling analysis should be performed so that missed 
reactions can be added. One of the major biological databases used for studying gaps in 
networks is KEGG Pathways, which is a collection of manually drawn pathway maps representing 
molecular interaction and reaction networks. 
Some enzymes may use several cofactors to convert substrates. However, substrates specificity 
and the directionality of the reaction may vary between organisms57. If it is known that the 
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organism of interest only uses one of the cofactors in a reaction, such information should be 
taken into account when performing the manual curation. 
Finally, a debugged GSMN is obtained, which is converted into a mathematical computational 
GSMM in the next stage. 
 
2.5.2 CONVERTING THE METABOLIC NETWORK TO A 
STOICHIOMETRIC MODEL 
The third stage involves the conversion of the reactions set into a metabolic model, 
encompassing the conversion of the network into a stoichiometric matrix and the addition of 
constraints to the model. Before converting the network to a GSMM, the biomass formation 
equation should be included in the reactions set. The biomass equation represents the 
macromolecular composition of the cell, and the building blocks used to generate those 
molecules. To perform simulations it is necessary to include a reaction that denotes a drain of 
biomolecules (e.g. amino acids, nucleotides) into the biomass. The biomass formation reaction 
can be represented by the following equation: 
෍ܿ௞ܺ௞ → ܾ݅݋݉ܽݏݏ
௉
௄ୀଵ
 2.2
where ck represents the coefficient of the metabolite Xk. The flux associated with this reaction 
represents the growth rate of an organism56. This equation should include growth–associated 
energy requirements in terms of ATP molecules per mass (grams) of biomass synthesized. 
Alternatively, if the biomass formation reaction cannot be determined, the biomass equation of a 
related organism is typically used. Previous studies92 suggest that this alternative approach does 
not introduce significant errors in the model. Nevertheless, some studies to confirm this 
statement should be performed, as in some cases biomass composition can be significantly 
altered, such as in deletion mutants56. 
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When the metabolic network is complemented with the biomass equation and the non-growth 
ATP requirements reactions (represented simply by a drain of ATP into ADP and inorganic 
phosphate) the set of reactions can be represented in the form of a stoichiometric matrix. The 
classic principles of chemical engineering can be used to construct the matrix that represents the 
dynamic behaviour of the metabolites concentration, by performing dynamic mass balances with 
ordinary differential equations, according to the following notation: 
݀ ௜ܺ
݀ݐ = 	෍݆ܵ݅ × ݒ௝ + 	ߤܺ,						݅ = 1,…ܯ
ே
௝ୀ଴
 2.3
Equation 2.3 represents the rate of change of the concentration of metabolite i with time t. Xi is 
then the concentrations of metabolite i, vj is the rate of reaction j (i.e. its metabolic flux) and Sij is 
the stoichiometric coefficient of metabolite i in reaction j. The growth rate of the system is 
represented by μX. 
The development of models that predict all concentration profiles as functions of time would 
imply determining stoichiometry and kinetic rates of all biochemical reactions, at specific 
conditions, in the model. However, at the present time it is virtually impossible to collect kinetic 
expressions and parameters at the genome-scale, hindering the development of dynamic models. 
Thus, a steady state approximation is applied, where it is assumed that metabolite 
concentrations remain constant throughout time. It is reasonable to assume that the values of 
the fluxes are several times greater than the specific growth rate. Thus, the rates of consumption 
become equal to the rates of production of the metabolites and equation 2.3 is converted, in the 
matrix format, to: 
ܵ. ݒ = 0 2.4
In this notation v is the flux vector and S is the stoichiometric matrix, where columns represent 
reactions and rows the metabolites. Worthy of note is the fact that, in equation 2.4, v also 
includes exchange fluxes.  
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Most metabolic networks are underdetermined systems, as the number of fluxes is much greater 
than the number of mass balance constraints. Therefore, an infinite number of solutions (flux 
distributions) may satisfy the mass balance constraints, the so called null space of S2,56. It is 
therefore not possible to have detailed information on the cell behaviour and compute a single 
solution16. Yet, it is possible to establish constraints that limit such behaviour. The imposition of 
these constraints (e.g. determining irreversibility of reactions, non-growth ATP requirements, 
measuring of exchange flux values) can reduce the null space of S to a set of feasible solutions, 
the flux cone of solutions. 
The main constraints that should be added to the mathematical model are related to the 
reversibility of the reactions. Usually, a reversible reaction is constrained between minus infinity 
and plus infinity, irreversible reactions should be constrained in the minimum (or the maximum 
depending on the directionality of the reaction) flux to zero.  
Similarly, transport fluxes for most nutrients should be constrained between 0 and a maximum. It 
is mandatory that the limiting substrate maximum uptake rate is constrained to a specific uptake 
rate. The constraining of oxygen may be significant for simulating chemostate cultivations of 
Crabtree-positive yeasts, as these yeasts exhibit fermentative metabolism in aerobic conditions at 
high glucose concentrations and high growth rates. Metabolites unavailable in the medium 
should be constrained to zero, and metabolites that may be excreted should be left 
unconstrained in the outward direction. 
As an example of the conversion of a GSMN to a GSMM, consider the pseudo metabolic system 
composed of metabolites A-G as well as compartments 1 and 2 (Figure 2.4). 
Several of the steps described thus far are illustrated in Figure 2.4. The network is described in 
section (1), where metabolite A represents the limiting substrate available to the system. The flux 
for this metabolite is constrained to the maximum uptake rate, a, while metabolites B and F are 
freely uptake into the system. Metabolites E and G exit the system as metabolic products through 
unconstrained fluxes. Section (2) provides the set of reactions, where the directionality and 
stoichiometry are shown. In section (3) both the internal and exchange fluxes are bounded in a 
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reversibility of the reactions is indicated by the arrows, where double arrows represent reversible reactions and a 
forward arrow is used to characterize irreversible reactions. In section (2) the stoichiometry of the network is 
represented. Section (3) shows the constraints around the flux values (where a represents the maximum uptake rate 
for the consumption of the limiting substrate A) and the steady-state mass balances are described in panel (4). A flux 
value may be negative for reversible reactions with unconstrained fluxes (e.g. v6). Section (5) shows the 
stoichiometric matrix in which the mass balances are represented. 
2.5.3 VALIDATION OF THE METABOLIC MODEL 
Once the mathematical representation of the model is created, it can be used to predict the 
behaviour of the target organism and compare it to experimental data. Thus, increasing the 
knowledge on the physiology, biochemistry and genetics of the target organism, will improve the 
predictive capabilities of the model58. Nevertheless, if experimental data on the target organism is 
scarce or not available, data on phylogenetic neighbours can be of great help58. 
Usually, the first consistency check performed with the metabolic model is computing growth 
rates under specific conditions and compare those rates to published characterization studies. 
These studies typically provide phenotypic data (including growth, secretion and uptake rates) 
and sometimes they are performed using defined growth media57. 
FBA is currently the most used methodology to compute a solution from the flux cone of a 
GSMM. The linear programing of FBA, which can be resolved using one of several available 
solvers, corresponds to the maximization or minimization of a linear combination of metabolic 
fluxes, subject to the constraints imposed by the metabolic model and by upper and lower 
bounds on the fluxes. Usually the growth rate is the flux to be maximized, as various studies 
demonstrated that organisms tend to maximize the specific growth rate, when exposed to 
limitations in the carbon source20,56. Therefore, FBA with maximization of biomass formation can 
be regarded as a simulation method. However, this approach can also be used in simulations 
with different objective functions such as maximization / minimization of ATP production or to 
evaluate maximum production capabilities by maximizing a specific target compound96. 
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One of the first analysis that can be performed for model validation is using high-throughput 
growth phenotyping data, obtained for instance from Biolog Inc.97, to assess the simulation 
results. These techniques allow testing several carbon, nitrogen and other nutrients sources 
simultaneously. Thus, the model can be tested for growth in several limiting substrates and the 
results compared to the high-throughput data. If the GSMM predictions are not in accordance 
with the experimental results, the model should be examined and potentially missing reactions 
included, as well as incorrect reactions removed. 
Another assessment typically performed for the validation of GSMMs is the analysis of strategic 
fluxes, e.g. specific growth rates, by-products formation or the corresponding yields, for different 
growth conditions described in the literature. These fluxes or yields can be calculated by 
imposing the reported environmental conditions as model constraints and can be 
straightforwardly compared to the published data. Besides serving as model validation, this 
information can also be used to calibrate the model for example by fine-tuning the ATP (growth 
and non-growth associated) parameters previously described. The study of active pathways under 
specific growth conditions (e.g. aerobic or anaerobic growth) can be performed for model 
validation. The non-zero fluxes should be analysed and if inconsistencies between the model and 
experimental data arise, the model should be reviewed and corrected56. Another approach for 
validating GSMMs is assessing simulation results to experiments performed with deletion 
mutants. This approach can provide valuable insights into the predictive capabilities of the model 
and a good training set may be of great value for model debugging. The prediction of the 
phenotypical behaviour of the microorganism when a deletion is simulated in the GSMM, should 
replicate the experimental data. If it does not, the genome annotation should be revised and 
corrected. 
Independent of the methodology used to validate the model, the fact is that if the model does not 
comply with the expectations, further debugging must be performed. The model must be 
thoroughly analysed, so that the error(s) within it is (are) found. The data sources should be 
consulted subsequently and the reactions set and stoichiometric matrix corrected. When the 
model predictions are not in conformation with the experimental data, the process should be 
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repeated from the second stage onwards. In some specific infrequent cases, the genome 
annotation may also have to be reviewed, especially if the (re-) annotation of the genome was not 
performed. Finally, the validation of the model may have to revisit some of the decisions taken in 
the manual curation step, where wrong conclusions may have been inferred. 
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2.6 APPLICATIONS 
In this section, a brief overview of some of the most promising developments in this field will be 
performed. The rapid increase of fungi genome sequences availability affords the execution of 
comparative analysis within these organisms, and it provides insights into the genomic diversity 
that can unravel industrially relevant resources. Moreover, yeasts, particularly S. cerevisiae, have 
traditionally been regarded has model organisms for researching cellular physiology or 
biotechnological cell factories.  
Table 2.2 shows the currently available fungi GSMMs reconstructions. A total of eight fungal 
species have GSMMS available and, to our knowledge, two other are being finalized. 
Nevertheless, Table 2.2 exhibits 17 models, as some organisms, namely S. cerevisiae and Pichia 
pastoris, have more than one model based on the same and different strains, respectively. Still, 
all models in the table are composed by a different number of genes, metabolites and reactions. 
The oldest model was reconstructed in 2003, for S. cerevisiae, and a decade later the 
reconstruction of the Ashbya gossipy and Kluyveromyces lactis models is being concluded within 
our research group. After successfully validating the reconstruction of a GSMM, the model can be 
used to perform various tasks, including the prediction of phenotypical behaviour of the target 
organism in different environmental and genetic perturbations, the analysis of the robustness of 
the network when changing the flux levels of essential gene products98, or performing in silico 
metabolic engineering. 
The following examples demonstrate successful case studies where fungal metabolic models 
were used to accomplish several goals. In 2003 Famili et al. 99 computed the consequences of 
gene knockouts on growth phenotypes using the first GSMMs of S. cerevisiae. They observed that 
the results were consistent with experimental observations, proving that a constraint based 
approach could be used to predict phenotypes. Meanwhile, several works have used GSMMs to 
predict such phenotypes. 
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Table 2.2. Currently available and on-going fungal reconstructions. 
Organism Genome Type ID Genes Metabolites Reactions Locations Reference 
Ashbya gossipy 
ATCC 10895 
4726 f iDG1137 1137 1285 1758 3 
Gomes et al. 
(unpublished) 
Aspergilus nidulans 9451 f iHD666 666 732 794 4 
David et 
al.100 
Aspergilus niger 
CBS 513.88 
14165 f iMA871 871 1045 1190 3 
Andersen et 
al.101 
Aspergilus oryzae 
RIB40 
12074 f - 1314 1073 1053 3 
Vongsangnak 
et al.102 
Candida glabrata 
CCTCC M202019 
6885 b/f iNX804 804 1025 1287 6 Xu et al.103 
Kluyveromyces 
lactis CBS 2359 
5448 b iOD962 962 1567 2038 5 Dias et al.  
Pichia pastoris 
DSMZ 70382 
5450 b 
PpaMBEL1
254 
540 1147 1254 8 
Sohn et 
al.104 
Pichia pastoris 
GS115 
5313 b 
iPP668 668 1177 1361 8 
Chung et al. 
105 
iLC915 915 899 1423 7 Caspeta et 
al.106 
 
Pichia stipitis CBS 
6054 
5841 b iSS884 884 992 1332 4 
Saccharomyces 
cerevisiae Sc288 
6183 b 
iFF708 708 584 1175 3 
Förster et al. 
83 
iND750 750 646 1149 8 
Duarte et 
al.84 
iLL672 672 636 1038 3 
Kuepfer et 
al.107 
iIN800 800 1013 1446 3 
Nookaew et 
al.108 
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iMH805/7
75 
832 1168 1857 15 
Herrgård et 
al.85 
iMM904 904 713 1412 8 Mo et al.109 
Schizosaccharomyc
es pombe Sz-0205 
4940 F 
SpoMBEL1
693 
605 1744 1693 8 
Sohn et 
al.110 
Type of Fungi: b – budding; f - filamentous 
The iFF708 S. cerevisiae GSMM was used by Bro et al.111 to predict the best strategy for 
decreasing glycerol yield, while increasing ethanol yield, from glucose under anaerobic 
conditions. Four approaches were tested in silico, including the deletion and the insertion of 
several genes. The best strategy involved the heterologous expression of a D-glyceraldehyde-3-
phosphate:NADP+ oxidoreductase (EC 1.2.1.9), which catalyses the irreversible oxidation of 
glyceraldehyde-3-phosphate and NADP+ into 3-phosphoglycerate and NADPH during glycolysis. 
They were able to predict, in silico, the complete elimination of glycerol formation coupled with 
an increase of 10% in the ethanol yield. The implementation of this strategy, in vivo, allowed 
engineering a S. cerevisiae strain that decreased the glycerol yield by about 40% on glucose, 
whereas the ethanol yield was increased by 3%, without any effect on the maximum specific 
growth rate. Asadollahi et al.112 used a GSMM to identify new target genes to enhance the 
biosynthesis of sesquiterpenes in S. cerevisiae. The effect of gene deletions on the flux 
distributions was assessed using the minimization of metabolic adjustments113 (MOMA) as the 
objective function. The best target was the deletion of the NADPH-dependent glutamate 
dehydrogenase encoded by GDH1. In vivo, such deletion enhanced the availability of cytosolic 
NADPH, which could then be used by other enzymes such as HMG-CoA reductase. The cubebol 
yield was increased by approximately 85%, although a significant decrease in the maximum 
specific growth rate was also detected. Furthermore, Brochado et al.114 improved vanillin 
productivity in S. cerevisiae for the development of an alternative to the chemical synthesis of this 
flavouring agent. Previous work115 engineered the implementation of a de novo synthetic pathway 
for heterologous vanillin production from glucose in S. cerevisiae. The S. cerevisiae GSMM was 
revised to reflect the alterations performed in this study, which was enhanced with an 
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Arabidopsis thaliana glycosyltransferase. The utilization of bioinformatics tools, i.e. OptGene116, 
selected the deletion of two targets (PDC1 and GDH1) for experimental validation. The verification 
of the targets successfully led to overproducing strains, with vanillin yields increasing between 
1.5 and 5 fold, when compared to the previous work on de novo vanillin biosynthesis in S. 
cerevisiae.  
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2.7 FUTURE APPLICATIONS 
The potentialities of systems biology include the in silico design of novel drug-targets, innovative 
therapies for the treatment of complex diseases and developing cell factories for the production 
of drugs, biofuels and chemicals of interest. Although, as seen in the previous segment, the latter 
two are already well implemented, the others are still in development.  
In fact, it is expected that systems biology will facilitate the drug discovery process, using 
genome-scale models for simulations that may lead to the identification of optimal drug targets. 
The identification of these targets will allow developing more efficient drugs with fewer side 
effects. Plasmodium falciparum is the microorganism responsible for one of the world’s most 
common and deadly diseases, specifically malaria. Yeh et al.117 initiated he Plasmodium genome 
project in 2004 in which the PlasmoCyc network model was developed and used to identify 216 
“chokepoint enzymes”, which are enzymes that catalyse a reaction that either uniquely 
consumes a specific substrate or uniquely produces a specific product. Interestingly, all three 
approved drugs for malaria and 87.5% of proposed drug targets with biological evidence in the 
literature are related to the so called “chokepoint enzymes”. Hence, the identification of those 
chokepoint enzymes may represent one systematic way of identifying potential metabolic drug 
targets. Moreover, Fatumo et al.118, proceeded with this line of work and present a refined list of 
22 new potential candidate targets for P. falciparum, half of which had reasonable evidence to be 
valid targets against microorganisms and cancer. Since some yeasts such as Candida albicans119 
are major human pathogens, drug targets can also be predicted for pathogenic yeasts and 
therefore for human diseases in the same way they were predicted for P. falciparum. 
Moreover, the genome sequences of fungi, especially yeasts, and humans revealed a high degree 
of conservation, which emphasizes the value of yeasts as a tool for drug discovery119. thirty 
percent of the human genes involved in diseases, had functional homologues in yeasts3,120 and 
yeasts are also currently seen as model system for anticancer drug discovery121. 
In the field of metabolic engineering, it is common to engineer fungi as cells factories. A. gossypii 
is a filamentous fungus that had its genome sequenced in 2004 presenting the smallest genome 
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among the eukaryotes with 4726 protein-coding genes. Despite presenting filamentous growth, it 
was reported a 95 % genome similarity level comparing with the budding yeast S. cerevisiae, 
even with the latter having a significantly higher number of genes. A. gossypii arises as an 
interesting target for metabolic engineering, as it benefits from the huge amount of information 
available for S. cerevisiae, which indirectly increases the knowledge regarding this organism, in 
addition to the low-complexity genome and the haploid nucleus, which is suitable for genetic 
manipulation. The on-going reconstruction of a genome-scale metabolic model for A. gossypii, 
which has been intensively used for industrial riboflavin production, may be a critical step on the 
overall improvement of this fungus as an efficient cell factory system.  
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2.8 FINAL REMARKS 
Systems biology may be regarded as an integrative discipline that aims at organizing the data 
provided from biology’s reductionist approach. Large-scale data sets are converted into in silico 
models, allowing replication and prediction of the behaviour of organisms. These data may come 
from several new “omic” technologies, namely genomics, transcriptomics, fluxomics or 
metabolomics. 
A high quality reconstruction is a combination of automatic retrieving of potentially relevant data 
and intensive manual curation57. A good metabolic reconstruction is the first step for 
understanding the genotype – phenotype association of a given organism. However, the 
metabolic reconstruction process is never concluded, since the knowledge on the metabolism of 
every organism is always growing77. The minimal requirement for considering that an operational 
model has been achieved is that the reconstructed metabolic network is consistent with the 
physiology of the organism it aims to model. For instance, it should include all pathways known 
to be present in the target organism, and reactions should be balanced and essential pathways 
complete, if the purpose of the model is performing flux predictions. GSMMs represent a fraction 
(about 30%) of all genes, namely genes encoding enzymes and transport systems. However, the 
absence of mechanistic details (kinetics rate constants) is a shortcoming of these models, since 
it restricts the models simulations to complete mutations (i.e. full gene additions or deletions). 
Metabolic models become truly useful when analysing the solution space of a simulation where 
specific constraints, such as gene deletions and additions or other constraints have been 
imposed5. Moreover, the integration of metabolic models with regulatory (gene regulation) and 
signalling (protein regulation) networks, may improve the prediction capabilities of the models, 
and the coverage of the genome77. Recent developments in systems biology, demonstrate that 
this discipline will assume a crucial role in how biological and biomedical research is performed. 
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3.1 ABSTRACT 
Usually, transport reactions are added to genome-scale metabolic models 
(GSMMs) based on experimental data and literature. A transport reaction 
is added for each metabolite known to be taken in from the medium or 
excreted from the cell. This kind of procedure does not allow performing 
gene-protein-reaction associations, impairing model predictions. Novel 
methods for systematic genome-wide transporter functional annotation 
and their integration into GSMMs are therefore necessary. 
In this work, an automatic system to detect and classify all potential 
transport proteins for a given genome and integrate the related reactions 
into GSMMs is proposed, based on the identification and classification of 
genes that encode transmembrane proteins. The pipeline identifies the 
metabolites transported by each transmembrane protein and its trans-
porter family and the localization of the carriers is also predicted and, 
consequently, their action is confined to a given membrane. 
The integration of the data provided by this methodology with highly cu-
rated models allowed the identification of new transport reactions. This 
tool is included in the new release of merlin 2.0, a software tool previously 
developed by the authors, which expedites the GSMM reconstruction pro-
cesses. 
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3.2 INTRODUCTION 
Genome-scale metabolic models (GSMMs) can be used to simulate in silico the phenotype of 
organisms of interest in selected genetic/environmental conditions. These models are becoming 
increasingly common since the number of fully sequenced organisms, as well as the available 
data generated by high-throughput techniques, has been growing exponentially1. GSMMs have 
been used to address strain optimization tasks within the Metabolic Engineering arena, and also 
to guide biological discovery, analyse global network properties and to study evolution2. Several 
new methods, tools and databases are being developed to create and use GSMMs in strain opti-
mizations tasks3,4. 
GSMMs include diverse information, such as reaction and metabolite sets, Enzyme Commission 
(EC) numbers5 and gene-protein-reaction (GPR) associations. Albeit most GSMMs have few com-
partments, over the years several have been released including broader compartmentalization 
information. Models such as the iMH805/775 (15 compartments)6 and the iMM904 (8 com-
partments)7 for Saccharomyces cerevisiae or the iRS1563 for Zea mays (6 compartments)8 in-
clude reactions occurring in specific cellular organelles, such as the mitochondria, chloroplasts 
(in photosynthetic organisms), lysosomes, cell nucleus or the Golgi apparatus. On the other 
hand, despite not having intracellular organelles, prokaryotic cells can have up to three distinct 
compartments: cytoplasm, periplasm, and the extracellular space. The presence of compart-
ments in GSMMs implies that compounds have to cross cell or organelle-specific membranes so 
that reactions can take place. 
Usually, transport reactions are added to GSMMs mainly based on experimental data and litera-
ture curation. A transport reaction is added for every metabolite known to be taken from the me-
dium or excreted from the cell or transported across intracellular membranes9. This kind of pro-
cedure does not allow performing GPR associations, impairing the quality of model predictions 
(e.g. for gene knockouts). 
The identification of genes encoding transport proteins and the metabolites being transported by 
those carriers is important so that more robust and accurate GSMMs can be reconstructed10 for 
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eukaryotes and prokaryotes, also allowing the elemental and charge balances to be assessed 
more easily9,11. 
Some efforts have been undertaken by Lee et al.12 to infer transport systems based in the ge-
nome annotation. However, to the best of our knowledge, a systematic approach to automatically 
identify, classify and annotate membrane transporters as well as the reactions promoted by these 
proteins is lacking, albeit for example, Feist et al.13 had recently referred that new methods for 
this task are required. Such a framework should also envision the (semi)-automated integration of 
these transporters into GSMMs, within the model reconstruction processes. 
In this work, a tool which detects and classifies potential transport proteins from a given genome, 
based on the identification and classification of genes that encode transmembrane proteins is 
proposed. Furthermore, this tool automatically generates transport reactions for specific metabo-
lites, which are then integrated with GSMMs. The tool developed in this work is currently available 
in merlin 2.0, (www.merlin-sysbio.org) a software tool developed in-house that expedites the 
GSMMs reconstruction process. 
Manually annotated cellular transport systems are described and stored in databases such as the 
Transporter Classification Database (TCDB)14 or the TransportDB15. Since it is the most compre-
hensive, TCDB is used at the core of our tool. It proposes a classification system for transport 
proteins, the transporter classification (TC) numbers, analogous to the EC system, but including 
also phylogenetic information. However, given the purely textual fields available in its records, a 
data integration workflow was developed, using other databases, for extracting information from 
TCDB regarding the identification of the metabolites involved in each TC record. This information 
is central to provide connections to GSMMs. 
The transport of metabolites is usually performed by proteins located on membranes16. Thus, 
proteins with transmembrane domains may be regarded as suitable candidates to potential 
transport systems. There are a few tools available for the prediction of transmembrane protein 
topology from its sequence. The TransMembrane prediction using Hidden Markov Models 
(TMHMM) tool17 has been considered the best for this task18 and was therefore used in this work 
to find genes encoding proteins with transmembrane helices in their sequences, classifying these 
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genes as transporter candidates. After the identification of the transporter candidate genes 
(TCGs), similarity searches are performed, comparing the proteins encoded in such genes with 
the ones available in TCDB. The similarity between sequences is calculated using the dynamic 
programming based algorithm Smith-Waterman (SW)19 for local alignments, guaranteeing opti-
mality and high sensitivity when looking for homologous sequences. This TMHMM/TCDB/SW 
coupled strategy allows identifying and annotating different types of transport proteins located in 
membranes. 
WoLF PSORT20 and PSORTb 3.021 tools were used to assign sub cellular localizations of the iden-
tified transporters. The first was chosen because it has been reported as the best protein subcel-
lular localization prediction tool in the literature22–24, while PSORTb 3.0 is the next generation of 
the PSORTb tools, which continues to be the most widely employed localization prediction soft-
ware for bacteria25. 
After identifying the transporter systems within the target organism's genome, as well as their 
localization in the cell, an algorithm for generating transport reactions is deployed. These reac-
tions are balanced and can be directly integrated into GSMMs. The transport reactions are built 
taking into account the metabolites annotated in the TCDB records, identified as similar to the 
TCGs in the target genome. 
Several organisms were used to validate this approach, namely Kluyveromyces lactis, Ashbya 
gossypii, Saccharomyces cerevisiae, Helicobacter pylori and Escherichia coli. Almost all S. cere-
visiae GSMMs are compartmentalized, having intracellular transport reactions. E. coli is the most 
studied microbe and, despite being a prokaryote, several GSMMs with transport reactions from 
the outside to the periplasm and inside of the cell are available. The other cases represent less 
annotated organisms of interest for which the authors have expertise.  
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3.3 METHODS 
3.3.1 SPECIFICATIONS 
The Transporter Systems annotation tool proposed in this work was developed in Java™ and the 
information retrieved from the different data sources is kept in a MySQL® relational database. 
As depicted in Figure S3.1 of the supplemental material, there are two layers on the relational 
database. The transporter candidates’ layer (dynamic layer) is organism specific, with an in-
stance of these tables for each organism. This layer is connected to the shared layer of the data-
base, the transport reactions layer (static layer), by three connections that allow transporter can-
didate genes to be assigned with a TC family, a range of metabolites to be transported and a 
direction for such transport. 
Five online databases are used by this tool. TCDB (www.tcdb.org) is used as the main data 
source, since TCGs are compared against its sequences. Also, information on the metabolites 
used to construct transport reactions are manually retrieved from TCDB records. Kyoto Encyclo-
pedia of Genes and Genomes (KEGG – www.kegg.jp)26, Chemical Entities of Biological Interest 
database (ChEBI – www.ebi.ac.uk)27 and semantics SBML 2.0 (semanticsbml.org/)28 are used 
for collecting additional data for metabolite identification and characterization. UniProt 
(www.uniprot.org) is used to retrieve the phylogenetic data of each of the TCDB transport sys-
tems that are essential for the assignment of transport reactions to the candidate genes, as it is 
described later. 
3.3.2 DEVELOPMENT OF A DATABASE OF TRANSPORT REACTIONS 
FROM TCDB 
A database of transport reactions, based on information retrieved from TCDB, was compiled 
throughout this work. A concise description of that process is provided next. 
TCDB proposes a classification system for transport proteins, based on TC numbers including 
five components separated by a dot: #.*.#.#.#, where # represent numbers and * a letter. The 
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first number corresponds to the class, while the letter corresponds to the subclass. The numbers 
after the letter indicate, respectively, the family (or superfamily) and the sub-family (or family) of 
the transporter, and the specific transporter system associated to a particular range of carried 
substrates 16. For example, the TC number 2.A.1.1.1 identifies a galactose:proton symport carri-
er of the Sugar Porter Family (2.A.1.1). This record is, currently, associated to a single E. coli’s 
gene (b2943). Unlike enzymes, transporter proteins should not be directly classified with TC 
numbers from homology, as this classification is manually assigned by the TCDB expert curators. 
Enzymes are associated with EC numbers that classify the catalysed reactions and a gene can be 
annotated with several EC numbers. On the other hand, TC numbers are associated with carriers 
that transport a specific substrate or range of substrates on a specific direction (in, out or both) 
using a given mechanism (uniport, symport, etc.), and are normally associated to a single organ-
ism due to the phylogenetic characterization of the TC numbers. Thus, the assessment of TC 
numbers must be prudently controlled. 
TCDB classifies transport proteins in 7 classes. The proteins in the Channels/Pores class 
(1.*.#.#.#) promote facilitated diffusion, through a pore or a channel, without energy require-
ments or carrier mediated mechanisms. Electrochemical Potential-driven transporters (2.*.#.#.#) 
utilize carrier-mediated processes to facilitate uniport (single species transported by facilitated 
diffusion), antiport (two or more species transported in opposite directions) and/or symport (spe-
cies transported together in the same direction). Transport proteins in this class do not use a 
primary source of energy other than the chemiosmotic energy, unlike the Primary Active Trans-
porters (3.*.#.#.#), which use a source of energy (ATP, GTP, NADH, etc.) to transport metabolites 
against the concentration gradient. Group Translocators (class 4.*.#.#.#) involve chemical and 
vectorial reactions, modifying the carriers during transport. Transport Electron Carriers (5.*.#.#.#) 
influence cell or organelle energetics by catalysing electron flow across membranes, while Acces-
sory Factors Involved in Transport (8.*.#.#.#) include proteins that facilitate transport across 
membranes but do not participate directly in transport. Finally, the last class (9.*.#.#.#) compris-
es the Incompletely Characterized Transport Systems that include all the transport proteins of 
unknown classification16. 
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TCDB records often provide direct access to specific information, for user appraisal, namely: 
UniProt accession number, organism, protein name, length, molecular weight, organism species, 
number of transmembrane helices and location / topology / orientation. However, to date, it 
does not contain specific fields for transported metabolites and direction of transport, which have 
to be manually inferred from the textual definition in each record, as well as from equations that 
TCDB provides for several families and superfamilies. 
The following information was compiled and used to populate the internal transport reactions 
database that currently has 3248 records (all records that had homologies with the case studies), 
when available: UniProt accession number, organism, taxonomy, TC number, TC family, trans-
ported metabolite, direction, reversibility, reacting metabolites and equation. These data were 
retrieved using different approaches. 
Data from concerning UniProt accession number, protein name, TC number, TC family and TC 
number description fields were automatically retrieved from the HTML interface using a Java 
routine. 
The taxonomy of the record was directly retrieved from the UniProt database using the accession 
numbers available in the TCDB records and UniProtJAPI29. 
The direction, reversibility, reacting metabolites and generic equation were manually retrieved 
from the TC families or, when not available from the superfamily descriptions. Thus, such pro-
cess was not linear because in the latter case distinct transport system families share the same 
equations, such as: 
ܵ݋݈ݑݐ݁௢௨௧ + ܣܶܲ → ܵ݋݈ݑݐ݁௜௡ + ܣܦܲ + ௜ܲ 
This equation represents the generalized transport reaction for the 3.A.1 ATP-binding Cassette 
uptake system. However, for example, distinct families like the 3.A.1.1: The Carbohydrate Uptake 
Transporter-1 (CUT1) Family and the 3.A.1.3: The Polar Amino Acid Uptake Transporter Family 
will have similar ATP dependent transport systems. 
The difference between transported and reacting metabolites is that the first ones are only in-
volved in reactions across membranes; while reacting metabolites are involved in chemical trans-
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look for a KEGG compound with a name or synonym that is a perfect match to the name manual-
ly gathered from TCDB. If any KEGG entity meets the requirements, then the ChEBI cross-
reference from the KEGG’s record is also retrieved. A valid ChEBI id allows the algorithm to stop 
and the metabolite to be annotated. On the other hand, an invalid ChEBI id or the lack of a 
match to a KEGG compound leads to the search of a match to the ChEBI database, performed by 
using its Java API (www.ebi.ac.uk/webservices/chebi/2.0/webService.jsp#Java). As previously, a 
perfect match to a ChEBI entity name or synonym allows the algorithm to annotate the metabo-
lite entity with a ChEBI id. The algorithm stops if the metabolite was previously annotated with a 
KEGG id or if ChEBI has a valid cross-reference to KEGG. 
If the metabolite is not annotated with both KEGG and ChEBI identifiers after this direct search, 
semantics SBML is used to try to retrieve such ids. The semantics SBML REpresentational State 
Transfer (REST) API “search” method is used to search for MIRIAM annotations30, using the me-
tabolite name, and to get the list of matching annotation groups. The method is configured to 
return only results with a precision of 1. If successful, the results obtained from this method allow 
the algorithm to annotate the metabolite with both KEGG and ChEBI identifiers. In the case none 
of the previous three methods assigns either a KEGG or ChEBI id, the metabolite is left un-
annotated. 
Often, the metabolite retrieved from a TCDB record description is a generic entity (such as sug-
ars, anions, lipids, etc.); thus, all the child elements that are associated to the generic (or parent) 
metabolite in ChEBI by a “is a” or “has role” ontology, are also associated to the transport sys-
tem of the parent metabolite. For example, α-D-glucose (CHEBI:17925) and β-D-glucose 
(CHEBI:15903) are both child elements of D-glucose (CHEBI:4167). Thus, for each child of a 
generic compound classified as substrate of a carrier encoded in the genome, a new transport 
reaction will be included in the GSMM and annotated to the corresponding gene. Still, not all the 
child elements retrieved from ChEBI for a given parent metabolite keep KEGG cross-references. 
Only reactions where all metabolites have KEGG ids will be later integrated in the model, as pre-
viously mentioned. Reactions for metabolites without KEGG ids will be generated, although not 
included in the model. The metabolites’ formulae are retrieved for the validation of the transport 
reactions. A reaction is accepted if the equation is balanced; i.e., if there are the same number of 
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atoms of a given element on the left and right hand sides of the equation. 
All of the previous information is kept in the transport reactions layer of the database, according 
to Figure S3.1 of the supplemental material. This database associates TCDB entries with 
transport reactions, including the transport type and transported metabolites, as well as other 
metabolites involved in the transport process. 
3.3.3 ASSIGNMENT OF TRANSPORT SYSTEMS TO TRANSPORTER CAN-
DIDATE GENES 
The most important feature of this tool is probably the assignment of transport systems (including 
the transport reactions) to genes. For identifying transporters, initially, the TCGs are collected 
from TMHMM (www.cbs.dtu.dk/services/TMHMM) searches over the full genome, so that pro-
teins with transmembrane domains can be found. If a gene has at least one transmembrane 
domain it is considered a TCG. Then, SW alignments are performed over each of the TCGs, 
against the TCDB database, to identify proteins with strong sequence similarities to known 
transport systems. The similarity threshold for considering the homology was of 10% of identity. 
However, as TCDB is a very small database (6601 records as of February 2012) a heuristic 
method was used to lower the similarity threshold, whenever a TCG has at least 5 transmem-
brane helices. In these cases, the evidence for a transporter role is stronger, justifying the special 
case. For each extra transmembrane helix, the similarity threshold was lowered by 0.5% until a 
minimum of half the initial similarity threshold is reached (5% in this case). 
Table S3.1 of the supplemental material shows the result of the alignment of a single Kluyvero-
myces lactis gene (KLLA0A01364g) with TCDB. This TCG has 10 transmembrane helices, thus 
the similarity threshold was set to 7%. If this heuristic was not used, this gene would only have 17 
similar genes in TCDB (instead of 47). Glycerol will be associated with that TCG with a final clas-
sification score (see the details below) of 0.44. However, if the initial similarity threshold of 10% 
was used, glycerol would not be included in the list of transported metabolites because the TCDB 
homologous gene with the highest similarity to that TCG, which transports glycerol, has a similari-
ty of 8.28%. 
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The UniProt accession numbers of the TCDB records found during the similarity alignment are 
cross-referenced with this application’s transport reactions database. This step allows associating 
each TCG with metabolites, transport directions, reversibility and other information, as depicted 
in Table S3.2 of the supplemental material. A routine is then used to select which metabolites 
will be actually assigned to each gene g weighting the number of times each metabolite m is 
found within the homologous gene records (frequency), and the taxonomy of the organisms ap-
pearing in those records. Equation 3.1 describes how this process is performed. The balance 
between the frequency score and the taxonomy score is given by a parameter α, according to 
ݏܿ݋ݎ݁௠௚ = 	ߙ × ݏܿ݋ݎ ௙݁௥௘௤௨௘௡௖௬ + ሺ1 − ߙሻ × ݏܿ݋ݎ݁௧௔௫௢௡௢௠௬ (3.1)
Equation 3.2 shows the frequency score, which calculates the number of occurrences of a me-
tabolite m within all TCDB similar records for that gene. This score is obtained by summing up 
the similarities of each homologous TCDB gene that transports the metabolite m and dividing by 
the sum of the similarities of all homologous genes, no matter what they transport, according to: 
ݏܿ݋ݎ ௙݁௥௘௤௨௘௡௖௬ሺ݉ሻ = 	
∑ ݏ௜ 	× ܸ݉௜ு௜ୀଵ
∑ ݏ௜ு௜ୀଵ
 (3.2)
In this notation, si is the similarity of the gene with record i in TCDB, H is the total number of hits 
for the gene, and 
ܸ݉௜ = 	 ൜1, 	if	metabolite	݉	is	in	the	metabolites	list	of	record	݅0, 																																																																															otherwise 
In the example (Table S3.2 of the supplemental material), the sum in the numerator, considering 
D-glucose as the metabolite, is approximately 2.86, being divided by 5.15. Therefore, the fre-
quency score is about 0.55. 
The taxonomy score is put forward to favour homologies of TCGs with TCDB records of closely 
related organisms. It is calculated as shown in Equation 3.3. In the numerator, the taxonomy 
frequency (sum of the number of common taxa between the organism being studied and the one 
in the TCDB record, over all hits) is multiplied by a penalty factor. This is used to penalize the 
score for metabolites that are associated to a scarce number of similar genes and may be the 
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result of incorrect assignments (β is a penalty parameter set to 0.05). The penalty factor (pm) is 
calculated by subtracting the frequency of the genes that transport a given metabolite from a 
user defined minimal number of hits (set to 2). If this subtraction is positive, it is multiplied by β 
and subtracted to 1, otherwise the penalty is zero. In the denominator, the maximum taxonomy 
(MT) value (number of taxa of the target organism) is multiplied by the frequency of the genes that 
transport the metabolite, according to: 
ݏܿ݋ݎ݁௧௔௫௢௡௢௠௬ሺ݉ሻ = 	
ሺ∑ ݐ௜ 	× ܸ݉௜ு௜ୀଵ ሻ × ሺ1 − ݌௠ × ߚሻ
ܯ் × ∑ ܸ݉௜ு௜ୀଵ
 (3.3)
In this notation ti is the number of common taxa between the organism to which record i belongs 
to and the target organism. The metabolite penalty is given by: 
݌௠ =	
ە
ۖ
۔
ۖ
ۓ 0,																														 ෍ܸ݉௜ ≥ Min୦୧୲ୱ
ு
௜ୀଵ
ܯ݅݊ு௜௧௦ −	෍ܸ݉௜
ு
௜ୀଵ
, 																							otherwise
 
Table S3.1 of the supplemental material shows in bold all the taxa that each TCDB gene has in 
common with Kluyveromyces lactis case study gene (KLLA0B00264g). As shown in Table S3.1 
and Table S3.2, S. cerevisiae has 8 taxa in common with K. lactis. On the other hand, the Homo 
sapiens homologue only has 1 taxon in common and Bacteria have none. The taxonomy fre-
quency sum for the metabolite D-glucose is calculated by adding all the common taxa count for 
the TCDB records (Table S3.2 - highlighted in blue) and the final result is 114. The maximum 
taxonomy frequency is 10 (result obtained by counting all the K. lactis taxa) which will be multi-
plied by 25 records associated to the transport of D-glucose. D-glucose is available more times 
than the minimum required; therefore, there will be no penalty. On the other hand, lactose (Table 
S3.2, highlighted in green) is available just one time and it will have a frequency penalty of 5%. 
The taxonomy score for D-glucose on this gene is 0.456. The final D-glucose score, for α=0.3, is 
0.486. If α was set to 0.4 the score would be of 0.496. Lactose has a score of 0.669 (α =0.3) 
and for α =0.4 the score would be 0.576. 
It is possible that genes being classified by this tool have records in TCDB and, consequently, a 
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similarity score of 1 in the SW alignments. Nevertheless, such genes may also have similarity to 
other genes in the transporters classification database. Thus, all the hits are used to classify the 
metabolites to be transported by those genes. It is assumed that TCDB associates the transport 
of specific metabolites to genes according to published experiments; however, those carriers may 
also be able to transport other metabolites, specifically metabolites carried by similar transport 
systems untested in such experiments. Thus, the approach proposed in this work may identify 
other metabolites that can be carried by transport systems already annotated in TCDB, although 
such data may not yet have been confirmed experimentally. 
The same metabolite can be transported by several types of porters, such as uniport, symport or 
antiport. The algorithm developed for metabolites classification was also used to classify how a 
metabolite is transported. In the previous example, glucose can be transported by symport (Table 
S3.2 of the supplemental material, emphasized in light red) or uniport (light blue). The final score 
for D-glucose transport by symport is 0.428 and the score for uniport is 0.499; thus, uniport will 
be selected. If the scores were equal, both types of transport would have been selected. 
3.3.4 AUTOMATIC ASSEMBLY OF TRANSPORT REACTIONS 
After the metabolites identification and transport type selection, our tool automatically generates 
the transport reactions using a few heuristic rules. For each of the genes identified as a TCG with 
similarities to the TCDB, reactions for the selected metabolites, according to selected types of 
transport, are assembled. If a metabolite is transported by antiport or symport by a carrier en-
coded in a given gene, then co-transported metabolites are used to assemble reactions. For ex-
ample, if symport was selected for the previous example, reactions for all the metabolites that are 
co-transported by symport with D-glucose (in this case, just the H+ proton) would be generated 
and proposed to be integrated in the GSM. This reaction would be 
D − glucoseୣ୶୲୰ + Hୣ୶୲୰ା 	<=> D − glucoseୡ୷୲୭ + Hୡ୷୲୭ା 	 
For uniport the reaction is simply 
D − glucoseୣ୶୲୰ <=> D − glucoseୡ୷୲୭ 
Moreover, the child metabolites of the selected metabolites are also used to generate similar 
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reactions. Thus, for the above example, reactions will be replicated switching D-glucose by its 
child metabolites α-D-glucose and β-D-glucose. Therefore, from D-glucose alone, 3 transport reac-
tions will be generated and associated to this K. lactis gene (KLLA0A01364g), as shown in Table 
S3.2 of the supplemental material. 
This example does not involve any source of energy to drive the active transport of D-glucose. 
However, other types of carriers implicate energy requirements, as is the case of the P-type 
ATPase Superfamily transport proteins that use energy from the ATP hydrolysis to transport a 
metabolite across a membrane. If a gene has similarities with genes of this family, that gene will 
be associated to ATP, ADP and Pi. The reacting metabolites are treated as currency metabolites, 
not being scored. 
Although not in the scope of this work, a system for the assignment of partial TC numbers to 
these genes was developed and is available in the supplemental material. 
The generated transport reactions and final annotation for the gene in the example are displayed 
in Table S3.3 of the supplemental material. As expected, increasing the threshold reduces the 
number of reactions associated with a specific gene. 
3.3.5 PREDICTION OF PROTEINS SUBCELLULAR LOCALIZATION 
PSORTb 3.0 (www.psort.org) is used for determining the localization of proteins in prokaryotic 
organisms. However, unfortunately, this tool does not provide a web API. Still, the compartmen-
talization data may be retrieved in one of two manners. PSORTb 3.0 offers pre-computed genome 
results, for genomes deposited in GenBank. This data can be retrieved from the PSORTdb data-
base at http://db.psort.org/browse. On the other hand, if the genome in question is not available 
in the pre-computed genome results, the target genome sequence files, in the FASTA format, 
should be submitted to the PSORTb 3.0 HTML interface. However, the maximum size allowed for 
submission is 100 Kb; therefore, some files may have to be split. 
WoLF PSORT (http://www.wolfpsort.org) is used to determine the localization in eukaryotic or-
ganisms. Unlike PSORTb 3.0, it was possible to use a simple remote Java API from a Java ar-
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chive (jar) provided by Paul Horton, in a personal communication, where it was also indicated 
that “intracellular organelle membranes, say mitochondrial or E.R., are lumped together with 
soluble proteins in their organelle”. Secondary locations are also considered for protein subcellu-
lar localization. If any compartment(s) has(have) a score that differs less than 10% from the main 
location score, such compartment(s) is(are) also taken into account when generating transport 
reactions. 
As a final point, confirming a TCG as a transport system involves meeting three criteria. The first 
is to have transmembrane domains. The second is to have similarities to TCDB records. The third 
is to have a localization prediction within a membrane: cytoplasmic membrane or outer mem-
brane for prokaryotes and plasma membrane for eukaryotes. However, since intracellular mem-
branes are lumped with the intracellular organelle predictions, it was decided that if a TCG met 
the first two requirements, thus having strong evidences of being a transporter, and WoLF PSORT 
assigned an intracellular organelle to such TCG, it would be considered that the TCG was located 
in the organelle’s membrane, encoding an intracellular transport system. 
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3.4 RESULTS AND DISCUSSION 
The proposed tool was used to identify transport systems encoding genes, and to generate 
transport reactions for several organisms (K. lactis, A. gossypii, S. cerevisiae, H. pylori and E. 
coli). The main results are provided in Table 3.1 and Table 3.2 and Figure 3.2. Table 3.1 repre-
sents the genes that obey to criteria 1 (having transmembrane domains) and 2 (having similari-
ties to TCDB records) while Table 3.2 contains the number of genes that obey to the third criteri-
on. 
Table 3.1. Number of potential transport systems encoding genes in each of the studied 
genomes. 
Organism Nr. of Genes 
TCGs 
from TMHMM from TMHMM and 
w/ TCDB hits
w/ transport reactions 
(A/B) 
K. lactis 5085 967 355 327 / 267 
S. cerevisiae 5882 1144 427 384 / 332 
A. gossypii 4726 860 296 265 / 215 
E. coli 4146 1039 675 536 / 486 
H. pylori 1590 330 176 137 / 77 
Genes having transmembrane domains and similarities to TCDB records. The last column presents values for two 
thresholds (score from Equation 3.1): A – Threshold of 0.2; B – Threshold of 0.4. 
The default threshold of the overall score was empirically set to 0.2; however, values for a 
threshold of 0.4 are also shown. 
Figure 3.2 represents the intersection of these results, i.e. the genes that obey to all the three 
criteria. The default values used for parameters α and β were 0.3 and 0.05, respectively. Table 
3.1 clearly shows that, as expected, increasing the stringency of the conditions that a given gene 
has to meet in order to be annotated as a transport system reduces the number of genes anno-
tated as carriers. 
In all of the studied organisms, 18 to 20% of the genes were identified as TCGs by TMHMM, ex-
cept for E. coli (with 25%). In Fungi 34% to 37% of those TCG’s have similarities with TCDB en-
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tries, whereas H. pylori and E. coli have more than half of the TCG’s with homology to TCDB 
records. 
Table 3.2. Number of genes predicted to encode proteins localised in each of the mem-
branes. 
Organism Plasma Intracellular Cytoplasmic Outer 
K. lactis 546 (37) 66 - - 
S. cerevisiae 653 (63) 86 - - 
A. gossypii 533 (29) 54 - - 
E. coli - - 1087 (12) 85 (3) 
H. pylori - - 312 (2) 50 (3) 
WoLF PSORT was used to determine genes encoding proteins localized in plasma and intracellular membranes in 
Eukaryotes. PSORTb 3.0 was used for the remaining membranes in Bacteria. The numbers in brackets represent the 
number of genes that are assigned to membranes in secondary locations. Those genes are not accounted outside 
the brackets. 
For a threshold of 0.2, Fungi have about 90% of genes that meet the first two criteria associated 
with transport reactions. For Bacteria, only 75% (H. pylori) and 79% (E. coli) of the genes with 
TCDB hits can be associated with transport reactions. For the second threshold (Table 3.1), all 
organisms except H. pylori assign reactions to about 71% to 77% of the genes. 
The number of genes predicted to encode proteins which will be localized in membranes, accord-
ing to WoLF PSORT and PSORTb 3.0, is indicated in Table 3.2. Fungi have a nearly constant ratio 
(11%) of genes predicted to encode proteins localized in the plasma membrane. Bacterial predic-
tions are somewhat different. H. pylori is predicted to have 3% of the genes encoding outer 
membrane proteins and 20% encoding cytoplasmic membrane proteins. E. coli is expected to 
have 2% of genes encoding outer membrane proteins and 25% encoding cytoplasmic membrane 
proteins. 
These predictions confirm the prominent role of the periplasm in prokaryotes, as there are about 
10 times more transporters between the periplasm and the cytoplasm, than between the exterior 
and the periplasm. 
The cross linking of the information from Table 3.1 and Table 3.2 is available in Figure 3.2. More 
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Table 3.3. Distribution of the internal membrane transporters identified in this work. 
Organism E.R. mitochondrial Nuclear Golgi 
K. lactis 3 42 20 1 
S. cerevisiae 15 62 26 4 
A. gossypii 1 46 7 0 
This table displays the number of genes encoding proteins predicted to be localized in an internal membrane. 
The database of Transport Reactions from TCDB, compiled throughout this work, contains infor-
mation for 3248 TCDB records, which were associated to 828 distinct parent metabolites. Those 
metabolites were submitted to the annotation pipeline to retrieve KEGG and ChEBI identifiers. For 
the majority (433) both identifiers were retrieved, while 195 were not assigned with any identifi-
cation, 167 were only assigned with ChEBI identifications and 33 were only assigned with KEGG 
identifications. Moreover, 15271 child metabolites of the 600 metabolites with ChEBI identifica-
tions were also retrieved, of which 3156 metabolites also have KEGG ids. The total number of 
metabolites (manually and automatically) assigned to all the transporter genes with both identifi-
cations is 3589. The 633 (433+33+167) metabolites that had at least one database identifier 
were used to create 2914 reactions associated with the respective proteins in TCDB. 
The numbers of reactions where all metabolites have KEGG identifiers and of all reactions creat-
ed by this methodology are presented in Table 3.4. The consequences of performing a conserva-
tive approach, retrieving all the child metabolites from the ChEBI ontology so that all possible 
substrates of a given transporter could be found, are well demonstrated. The colossal number of 
transport reactions is explained by several facts: i) for each child metabolite of a given ChEBI 
entity, a transport reaction similar to the reaction of the parent metabolite is created; ii) moreo-
ver, each metabolite (and its children) may be transported through several transport systems 
(uniport, symport, etc.), depending on the classification of each gene associated with that metab-
olite; and, iii) the same reactions on different membranes are regarded as different reactions. 
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Table 3.4. Number of reactions generated using different thresholds. 
Organism Reactions with KEGG metabolites (A/B) All reactions (A/B) 
K. lactis 6176 / 4354 94911 / 75288 
S. cerevisiae 7029 / 5215 110708 / 95029 
A. gossypii 5297 / 3964 87664 / 71056 
E. coli 8586 / 6872 116212 / 100791 
H. pylori 7475 / 592 71951 / 4071 
This table shows the number of reactions where all metabolites have KEGG identifiers and all reactions created by 
this methodology. These values are shown for two thresholds: A – Threshold of 0.2; B – Threshold of 0.4. 
Even though only reactions for which every metabolite has KEGG identifiers are used and inte-
grated with the models, the number of transporters is still in the order of the thousands. Still, 
regardless of the number of reactions generated, a filtering process is performed when integrat-
ing this information with the GSMMs. Indeed, only transport reactions where all metabolites are 
already present in the model are added. Moreover, when performing simulations, those reactions 
will only be active if the compartments where that relocation takes place hold the reactants of the 
transport reaction. Worth mentioning is the fact that the duplication of the threshold decreases 
the number of reactions between 25% and 30% for Fungi, although the number of genes that 
encode reactions is reduced in less than 20%. However, for E. coli, the reduction in the number 
of generated transport reactions is less than 20%, while H. pylori’s decrease is more significant 
(around twelve fold). This fact may be explained by the poor homologies that this organism has in 
TCDB. 
According to Table 3.4 and Table S3.3 of the supplemental material, we recommended setting 
the threshold to 0.2, because this value provides acceptable results. The non-restriction of the 
threshold would lead to the generation of transport reactions using all available metabolites for 
each gene, providing incorrect transport reactions for inclusion in the model. Increasing the 
threshold from 0.2 to 0.4 on Table S3.3 of the supplemental material would generate less 15 
reactions and according to Table 3.4 it can be too restrictive for less characterized organisms. 
The results obtained with our approach were compared with recently published models of E. coli 
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and S. cerevisiae, iAF1260 (406 genes encoding transport reactions) and iMM904 (201 genes 
encoding transport reactions), respectively. To gather the genes encoding transport systems in a 
model, the rule was the following: if a given reaction in the model has substrates and products in 
different compartments, the reaction is regarded as of transport and the genes associated with 
that reaction are considered transport system encoding genes. It is not surprising that the pipe-
line described in this work annotates a number of genes with transport functions much larger 
than published models. According to Figure 3.2, E. coli and S. cerevisiae have 625 and 420 
genes encoding transport reactions, respectively. Nevertheless, there are 59 genes for S. cere-
visiae and, surprisingly, 242 for E. coli assigned with transport reactions in the models that are 
not identified in this work. 
Analysing the results further, about 25% of the unidentified yeast carrier genes (15) are not identi-
fied as porters because WoLF PSORT predicted such genes to be expressed in the cytoplasm, 
thus not complying with one of the three criteria of this approach. The remaining 44 genes were 
not annotated as carriers because TMHMM did not predict any transmembrane region. 
For E. coli, PSORTb 3.0 indicated roughly 32% (77) of the unidentified carriers as periplasmic, 
cytoplasmic or in one unknown location. Furthermore, 165 genes classified as carriers by the 
model and assigned to the cytoplasmic membrane or outer membrane by PSORTb 3.0, could not 
be identified as transporters using this approach as 88 of those genes did not have any similarity 
with TCDB and TMHMM did not predict any transmembrane region in the remaining 77 genes. 
On the other hand, this approach proposes 461 new carrier genes for E. coli and 278 for yeast. 
These predictions should be confirmed with wet-lab experiments and its impact verified through 
phenotype simulations using GSMMs. 
The reactions generated by this tool were also integrated in the GSMMs. For that purpose, the 
pipeline used for performing metabolites identification (Figure 3.1) was also used to assign KEGG 
ids to the metabolites in both models. For the yeast model 550 out of 713 metabolites were as-
signed with identifications. For E. coli, 666 within 1038 metabolites were identified. The number 
of annotated metabolites is low because of the particular labels assigned to the metabolites with-
in these models, which is not similar to the names available in the selected databases. 
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ber of reactions that had no gene assigned in the model but were assigned to a gene by this tool. The block list 
displays some properties of the reaction set to which it is connected to. 
A large number of reactions already existing in the model were not matched by this approach, 
due to several reasons. Nearly 200 of such reactions were associated to metabolites without 
KEGG ids, thus such reactions could not be matched. Moreover, 75% of the reactions where the 
metabolites had KEGG ids were associated with reactions in the outer membrane, but as shown 
in Table 3.2, PSORTb 3.0 predicted that only 85 genes in the entire genome are encoding pro-
teins in that location, while for the cytoplasmic membrane the number of genes is 12 folds high-
er. Finally, only 51 reactions for metabolites with KEGG ids in the cytoplasmic membrane with 
gene associations were not matched, including several chemically complex transport reactions 
that could not be directly compared to the generated reactions. 
According to CBS-KNAW Fungal Biodiversity Centre (http://www.cbs.knaw.nl/) and EcoCyc 
(http://ecocyc.org), S. cerevisiae and E. coli are able to grow in a broad number of carbon 
sources. As shown in Table S3.4 of the supplemental material, considering that the presence of a 
transport reaction would allow the organism to grow on a given carbon source, the following re-
sults were generated. Table 3.5 shows that this tool provides reactions for more carbon sources 
where the yeast is known to have growth, than the accounted for in the existing model. 
Table 3.5. Comparison of the predictions of the GSMMS and this tool regarding transport 
reactions for known carbon sources. 
Organism 
S. cerevisiae E. coli 
iMM904 Tool iAF1260 Tool 
R NR R NR R NR R NR
G 10 9 12 7 20 3 6 (20) 17 (3) 
NG 14 22 20 16 8 19 4(18) 23(9) 
This table represents the comparison of the predictions of the GSMMs and our tool, considering that the presence of 
a transport reaction would allow the organism to grow on a given carbon source. In brackets are the results obtained 
for the metabolites transported between the periplasm and the cytoplasm. Legend: G – Growth; NG – No -growth; R 
– reaction; NR - no reaction. 
However, it provides reactions to uptake 20 other carbon sources, although this yeast cannot 
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grow using those metabolites as sole carbon source, while the model has only 14 of such reac-
tions. For E. coli, the tool predictions are, once again, impaired by the number of proteins pre-
dicted to be located in the outer membrane, thus transporting external metabolites. These results 
may possibly be associated to the utilization of a biased training set for assignment of localisa-
tions in the PSort tools. Only 6 carbon source porters are identified by the tool; however, search-
ing for transporters of the same metabolites, but from the periplasm to the inside of the cell, the 
numbers are quite different and the number of carbon sources transported by E. coli increases 
over three fold. 
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3.5 CONCLUSIONS 
In this work, a new methodology to identify transport systems, automatically generating transport 
reactions for every metabolite those carriers can transport, and optionally annotating the carriers 
with surrogate TC family numbers, is proposed. These reactions can be directly integrated with 
GSMMs since all metabolites involved have KEGG and/or ChEBI identifiers. This methodology 
combines several tools to obtain more reliable results, minimizing false positives. 
The results for the integration of the data provided by this methodology with curated models (con-
tinuously curated for over 10 years) are quite acceptable, including the association of transport 
reactions to genes that were previously not annotated, providing gene-reaction associations re-
quired for several simulations, and the identification of new reactions that can be added to the 
existing models. This tool was able to provide uptake transport reactions for metabolites that the 
yeast can use as sole carbon sources, not previously identified in the model. 
Probably the main limitation of the tool also derives from the minimization of false positives, 
which inevitably will impose a significant number of false negatives. Indeed, a wrong prediction in 
one of the methods will exclude the gene of the transport systems encoding genes set. The first 
step (transmembrane domains identification) is a crucial step, because if TMHMM does not pre-
dict at least one transmembrane helix, the gene is excluded. Moreover, TMHMM predicts that 
approximately one third of the genes available in TCDB do not have any transmembrane helix. 
Thus, this methodology has a false negative rate of at least 33%, but greatly decreases the 
chance of false positives. In the future, the authors intend to consider more elaborate methods 
for this first step, taking more information into account and considering the use of machine learn-
ing approaches. 
WoLF PSORT and PSORTb 3.0 also have a prominent role in the transport systems assignment. 
A wrong compartment prediction will also exclude the gene of the carriers set. Again, here there 
seems to be considerable space for future improvements using alternative methods. 
Furthermore, TCDB records are directly extracted from literature; thus, experimental data are 
directly used to infer transporter systems for homologous genes. When studying a genome, the 
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transport protein encoding genes available in TCDB are annotated to that genome. As such, a 
direct comparison between the experimentally validated TCGs and the ones predicted by this tool 
would be too biased. 
Therefore, although using the best tools and databases to perform this task, in the future other 
databases and tools will need to be tested. Moreover, further tests will be performed to try to 
relax some of the strict rules that this methodology uses, so that false negatives can be de-
creased. 
We believe that this fully automated tool can be used as a first step of a semi-automated meth-
odology to identify genome associated transport reactions, which after manual curation can be 
integrated with existing and under development models, offering reliable results. This methodolo-
gy can also provide new insights in such well-studied organisms, proposing new functions to pre-
viously unannotated genes. For example E. coli’s b3597 gene is currently annotated as a putative 
membrane protein. In this work, such gene was annotated as a metabolite exporter. For S. cere-
visiae, the YBR220C gene was annotated as a peptide-Acetyl-Coenzyme A transporter using this 
methodology, and such gene was previously annotated as a protein of unknown function. 
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3.7 SUPPLEMENTAL MATERIAL 
Additional file 3.1 – File with Additional figure in PDF format: 
Figure S3.1 – Relational database schema of the transporters identification and annotation tool. 
 
Additional file 3.2 – File with Additional tables in Excel format: 
Table S3.1 – Result of the SW similarity alignment between a single Kluyveromyces lactis gene 
(KLLA0A01364g) and TCDB. 
Table S3.2 – Transport information retrieved for of each of the TCDB homologue genes. 
Table S3.3 – Reactions generated for three different thresholds (0.0, 0.2 and 0.4). 
Table S3.4 – Comparison of the predictions of the GSMMs and our tool regarding transport reactions for 
known carbon sources (extended version). 
 
Additional file 3.3 – File in PDF format: 
Description of the methodology for assignment of partial TC numbers by the transporters identification 
and annotation tool. 
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4.1 ABSTRACT 
The second version of the MEtabolic models Reconstruction using 
genome-scaLe Information (merlin 2.0) tool is an user-friendly Java 
application that performs the reconstruction of genome-scale metabolic 
models for any organism that has its genome sequenced. It performs 
several steps of the reconstruction process, including the functional 
genomic annotation of the whole genome. Moreover, merlin 2.0 includes 
tools for the identification and annotation of transport proteins encoding 
genes, as well as the generation of transport reactions for those carriers. 
merlin 2.0 also performs the compartmentalisation of the model, 
predicting the organelle localisation of the proteins encoded in the 
genome, and thus the localisation of the metabolites involved in the 
reactions induced by such proteins. 
Finally, merlin 2.0 expedites the transition from genome-scale data to 
SBML metabolic models, allowing the user to have a preliminary view of 
the biochemical network. 
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4.2 INTRODUCTION 
Genome-scale metabolic models (GSMM) are used to predict, in silico, the microorganisms' 
responses to different genetic or environmental stressors1–3. The reconstruction and use of these 
biochemical networks is, nowadays, a common alternative to the more expensive and time-consuming 
wet-lab experiments. Moreover, the output provided by the in silico GSMM simulations permits 
focusing on experiments with promising results. 
A GSMM allows anticipating a given organism's phenotype from its genome sequence. For this, a set 
of biochemical reactions taking place inside a given organism should be assembled4. These reactions 
are catalysed by enzymes encoded in the genome. Also, the crossing of cellular membranes by the 
metabolites involved in such reactions is often promoted by transporter proteins also encoded in the 
genome. 
The collection of these reactions is a laborious and iterative process, which was described in a protocol 
with about 100 steps3 that can be summarized in 6 stages1, according to Figure 4.1. 
In the first stage, Genome Annotation information is retrieved from several databases. Data collected 
in this stage includes Enzyme Commission (EC) numbers5 and Transporter Classification (TC) 
numbers6, as well as the associated genes and gene product names, if available. Other data, such 
as genes associated to signal transduction or expression regulation are excluded from the GSMM. 
Although the genome annotation information can be found in public databases for a wide variety of 
organisms, it should be remarked that often that annotation has been performed a long time ago and 
also the information collected during this process not always complies with the requirements of a 
GSMM. Therefore, often a re-annotation has to be performed as a first step in the reconstruction 
process. Previous works in which the re-annotation of genomes was performed have been published7–
9. 
The next stage is the Identification of the metabolic reactions associated with the organism. Initially, 
only reactions associated to the EC numbers identified are retrieved. Afterwards, reactions catalysed 
by enzymes without EC numbers assigned, namely transport reactions, as well as reactions known 
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The reconstruction of a GSMM could not be complete without the addition of an equation representing 
the biomass formation to the reactions set. This equation should denote a drain of building blocks 
(e.g., amino acids) into the biomass. Growth-associated energy requirements (ATP molecules needed 
per gram of biomass synthesized) are also necessary for inclusion in the biomass equation. 
The addition of Other GSMM Constraints includes checking the reversibility of the reactions, the 
definition of the numeric values for the uptake reaction fluxes and the nongrowth ATP requirements. 
All of these constraints are important and should be sought in online databases and the literature. 
After debugging the reactions set, the GSMM simulation results should be assessed to experimental 
data. This comparison will allow further debugging the reactions set improving the simulation results 
and the GSMM in an iterative loop. 
Using this, or a similar approach, several GSMMs were reconstructed since the publication of the 
Haemophilus influenza GSMM13, which was the first microorganism to see its network reconstructed. 
The complete reconstruction of a GSMM can take from weeks to over a year. Only the tasks of 
developing and refining a draft model can takes several months, according to Thiele and Palsson3. 
However, this process can be greatly accelerated if some steps are automated. The sequence of steps 
described above involve the utilization of a disparate number of bioinformatics tools available to the 
public, usually in different services and that require the definition of several parameters that have to 
be optimized and validated for this specific purpose, together with tools that need to be developed, 
such as data integration tools. Moreover, many of those steps require subsequent manual curation 
and validation and a significant amount of data still needs to be extracted from the literature and 
manually inserted into the model. Finally, it is important for many model developers that the 
reconstruction process is fully managed and controlled by them, a feature only possible with 
standalone applications. 
In summary, in our view, a tool that could greatly accelerate the reconstruction process would need 
to perform the sequence of the bioinformatics-based tasks, including genome (re-)annotation, in an 
optimized way while simultaneously allowing for manual curation in a standalone format.  
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Therefore, to face these overwhelming challenges of the process of reconstructing a GSMM, we have 
developed merlin 2.0. This tool can annotate a genome with both enzymatic and transport functions, 
and build a compartmentalised draft GSMM, with minimum user interaction, in less than a week. It 
also provides a user-friendly interface to perform manual curation of the draft model at any stage. 
Various software tools have been developed and databases have been assembled to help on the 
reconstruction process. Some features within merlin 2.0 can be found in repositories and web 
applications such as, FAME14, MEMOSys15, MicrobesFlux16, the Pathway Tools17, or Model SEED18. 
Nevertheless, none complies with the requirements described above. 
Table 4.1 show the differences between of these applications and merlin 2.0. 
Table 4.1. Comparing software tools developed for aiding the reconstruction of 
genome-scale metabolic models. 
Software FAME MEMOSys MicrobesFlux
Pathways 
Tool 
Model 
SEED 
merlin 2.0
Enzymes annotation     •  •  
Transporters annotation    •    •  
Compartments predictioni     •  •  
Biomass reactionii       •    
Export to SBML •  •  •   •  •  
Standalone    •   •  
Interface for manual curation    •   •  
Prokaryotic models •  •  •  •  •  •  
Eukaryotic models    •   •  
[i] FAME and MEMOSys - Allow assigning compartments to reactions. merlin 2.0 and Model SEED - Predict reactions 
localisation. 
[ii] merlin 2.0, MicrobesFlux and FAME - Biomass reaction inserted manually. Model SEED - Biomass reaction 
automatically generated. 
Currently, merlin 2.0 is the only tool that provides an integrated framework for the reconstruction of 
GSMM that retrieves enzymatic, transport and compartments information from the genome. 
The first three frameworks described in Table 4.1 use previously annotated genomes, thus not 
allowing metabolic (re-)annotations, which can be important to unambiguously define the reactions 
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that will be added to the GSMM. 
Although Model SEED offers, more or less, the same features that merlin 2.0 provides, there are some 
significant differences. For one, the curation of the annotation in Model SEED is performed by expert 
curator employees. This may come as an advantage for users that just need the draft model. However, 
the submission of a genome to the Model SEED's web server turns the genome project, as well as 
the model, publicly available for other users. Contrarily, merlin 2.0 provides a semi-automatic 
annotation, with confidence scores, which is privately curated by the user, because all operations are 
carried out in the user's personal computer. 
Also, both applications also have structural differences, such as the origin of the metabolic information 
used to develop the GSMM, which is the widely used and well known KEGG19 in merlin 2.0 and an 
internally developed database in Model SEED. 
Lastly, one of the major differences between both tools is that merlin 2.0 also performs the 
reconstruction of Eukaryotic GSMM, which is currently not supported by the Model SEED. 
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4.3 IMPLEMENTATION 
4.3.1 SPECIFICATIONS AND ARCHITECTURE 
merlin 2.0 is a free open-source application implemented in Java™. Java was chosen because it is 
a widely used platform independent programming language. merlin 2.0 was built on top of the 
AIBench (http://www.aibench.org) software development framework20. 
merlin 2.0 uses several Java libraries to access various web services, namely BioJava21, NCBI Entrez 
Utilities Web Service Java Application Programming Interface (API), UniProtJAPI22, the ChEBI Java 
API, the KEGG Representational State Transfer (REST) API, and jSBML23 among many others. 
The open source MySQL® relational database is used for the local data repository. merlin 2.0 MySQL 
schemas (supplemental material) were prepared to allow the further development of the framework, 
thus including table structures unused by the current version, namely tables prepared to store 
regulatory and experimental data. 
merlin 2.0 is available for Linux and Windows. It is distributed under the GNU General Public License 
at http://www.merlin-sysbio.org. 
4.3.2 DATABASES 
Several databases are used by merlin 2.0 for the development of GSMMs. A brief description of each 
database is available in Table 4.2. 
100 RECONSTRUCTING GENOME-SCALE METABOLIC MODELS WITH MERLIN 2.0 
 
Table 4.2. Biological databases used by merlin 2.0 for the reconstruction of GSMMs. 
Database Description Reference
National Center for 
Biotechnology Information 
(NCBI) 
http://ncbi.nlm.nih.gov 
Collection of several databases providing access to biomedical and 
genomic information. merlin 2.0 uses a couple of databases from this 
collection, namely, Entrez Protein and Entrez taxonomy. 
The Entrez Protein 
(http://www.ncbi.nlm.nih.gov/sites/entrez?db=protein) is a collection 
of sequences from several sources, including GenBank CDS translations, 
RefSeq Proteins, SwissProt, PIR, PRF, and PDB. 
The Entrez Taxonomy 
(http://www.ncbi.nlm.nih.gov/sites/entrez?db=taxonomy) provides the 
species names and higher-level classification of all organisms 
represented in the Entrez sequence databases. 
These databases are remotely accessed using the Entrez Programming 
Utilities API provided by NCBI. 
24 
Kyoto Encyclopedia of Genes 
and Genomes (KEGG) 
http://kegg.jp 
Growing repository of functional information, linking genomic information 
from KEGG GENES to the metabolic information kept in KEGG PATHWAY 
and KEGG LIGAND. 
19 
Universal Protein Resource 
Knowledgebase (UniProtKB) 
http://www.uniprot.org 
Central hub for the collection of accurate, rich and consistent functional 
information on proteins. The UniProt Knowledgebase consists of two 
sections: a section containing manually-annotated records with 
information extracted from literature and computational analysis 
(referred to as "UniProtKB/Swiss-Prot"), and a section with 
computationally analyzed records waiting full manual annotation 
("UniProtKB/TrEMBL"). 
25 
Transporter Classification 
Database (TCDB) 
http://www.tcdb.org 
This repository comprehends a classification system, approved by the 
International Union of Biochemistry and Molecular Biology (IUBMB), for 
membrane transporter proteins names known as the TC system. This 
system is analogous to the EC system, except that it incorporates 
functional and phylogenetic information. 
6 
Chemical Entities of 
Biological Interest (ChEBI) 
http://www.ebi.ac.uk/chebi 
Repository of molecular entities focused on small chemical compounds. 
The molecular entities are either natural products or synthetic products. 
Genome encoded molecules (nucleic acids, proteins) are not included in 
ChEBI. 
26 
 
4.3.3 METHODS AND ALGORITHMS 
merlin 2.0 features four main independent modules: the Load internal database, the Enzymes 
annotation, the Transporters annotation and the Compartments prediction modules, as depicted in 
Figure 4.2. A brief description of each module is performed next. 
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used to build the draft GSMM by themselves or integrated with the information from other modules. 
4.3.3.2 ENZYMES ANNOTATION 
The purpose of this module is the assignment of enzymatic functions to proteins encoded in the 
genome using the Basic Local Alignment Search Tool (BLAST)27, profile Hidden Markov Models 
(HMMER)28 or both. 
NCBI provides all data, including specie's name and full lineage, that merlin 2.0 retrieves for each 
homologue gene identified in either the BLAST or the HMMER similarity searches. Also, the locus tag 
gene identifiers for genomes downloaded from the NCBI's ftp website are retrieved from this database. 
Each gene is processed individually, and for every homologue identified by the similarity alignments 
(no matter which program is used to perform the searches) the retrieved homology data is the 
following: locus identifier, expected value, score and organism. Afterwards, merlin 2.0 remotely 
retrieves and collects information from the Entrez Protein database for each of the homologue genes. 
The downloaded information is the following: taxonomy, organelle (if available), chromosome (if 
available), locus tag, product (protein name), EC number (if available) and molecular weight. Finally, 
the downloaded information is kept in merlin 2.0's MySQL relational local database, assembled 
according to Figure S4.2 of the Supplemental material. 
merlin 2.0 uses a routine to assign EC numbers and product names to each gene g. The assignments 
are performed by weighting the number of times each EC number ec (or product name pn) is found 
within the homologue gene records (frequency), and the taxonomy of the organisms to which such 
records belong to. Equation 1 describes how this process is performed. The weights of the frequency 
(Scoref) and taxonomy scores (Scoret) are controlled by α: 
ܵܿ݋ݎ݁௘௖(௣௡)௚ = 	ߙ × ܵܿ݋ݎ ௙݁ + (1 − ߙ) × ܵܿ݋ݎ݁௧ (1) 
The frequency score, on its turn, calculates the number of occurrences of an EC number ec (or product 
name pn) within all homologues of that gene. Thus, this score is obtained by counting the number 
of homologous genes encoding an EC number ec (or product name pn) and dividing by the total 
number of homologous genes (n), according to Equation 2. 
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ܵܿ݋ݎ ௙݁(௘௖(௣௡)) = 	
∑ ൫ݒ௘௖(௣௡)೔൯௡௜ୀଵ
݊  (2) 
where: 
ݒ௘௖(௣௡)௜ = 	 ൜
1, if	݁ܿ(or	݌݊)	exists	in	record	݅
0, 																																			otherwise  
The taxonomy score is used to favour homologies with records of closely related organisms. As shown 
in Equation 3, the taxonomy frequency (sum of the number of common taxa between the organism 
being studied and the ones in the first n homology records) is multiplied by a penalty factor. This 
penalty decreases the score for EC numbers (or product names) assigned by a small number of genes, 
and may be associated to annotation errors or incorrect assignments. The denominator is calculated 
by multiplying the maximum taxonomy (MaxTaxonomy) value, which is the number of taxa of the case study 
organism, by the minimum between the number of genes encoding EC number ec (or product name 
pn) and the user defined minimal number of homologies (nhomologies). This classification allows 
determining if the first n homology records of a given EC number ec (or product name pn) are closely 
related to the case study, taxonomically. The taxonomic score is calculated according to: 
ܵܿ݋ݎ݁௧(௘௖(௣௡)) = 	
∑ ൫ݐ௜ 	× ݒ௘௖(௣௡)೔൯௡௜ୀଵ × ൫1 − ݌௘௖(௣௡) × ߚ൯
ܯܽݔ்௔௫௢௡௢௠௬ × ݉݅݊ ቀ∑ ݒ௘௖(௣௡)௜௡௜ୀଵ , ݊௛௢௠௢௟௢௚௜௘௦ቁ
 (3) 
Where ti is the common taxa count for the record of hit i and β is a penalty parameter initially set to 
0.15. 
The pec(pen) , described in Equation 4, is calculated by subtracting the frequency of the genes encoding 
EC number ec (or product name pn) from the nhomologies. If positive, the pec(pen) penalty is multiplied by 
β and subtracted to 1. Otherwise the pec(pen) penalty is zero. 
݌(௘௖(௣௡)) = 	
ە
ۖ
۔
ۖ
ۓ 		 																					0, ෍ݒ௘௖(௣௡)௜
௡
௜ୀଵ
≥ ݊௛௢௠௢௟௢௚௜௘௦
݊௛௢௠௢௟௢௚௜௘௦ −෍ݒ௘௖(௣௡)௜
௡
௜ୀଵ
, otherwise
 (4) 
The α, β and the nhomologies parameters can be directly configured in merlin 2.0's 'Homology Data 
Viewer'. 
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The confidence score, with a numeric value between 0 and 1, allows easily curating the EC numbers 
(or product names) assigned to a given gene. The user can also define a minimum threshold score 
value for the automatic acceptance of annotations. Nevertheless, all annotations can be curated and 
the automatic assignments changed. The output of this tool is the annotated metabolic genome, which 
can be integrated into merlin 2.0's internal model, or exported to files in the GenBank (*.gbk) or Excel 
formats. 
4.3.3.3 TRANSPORTERS ANNOTATION AND COMPARTMENTS PREDICTION 
Transport reactions are often only included in models if there are evidences supported in experimental 
data or literature. However, this approach usually originates a very small number of transporters and 
does not allow performing Gene-Protein-Reaction (GPR) associations, as often the associated gene 
is unknown. 
Therefore, we proposed a new methodology to identify and annotate transport systems29. This 
methodology automatically annotates carriers with TC family numbers and generates transport 
reactions for all metabolites transported by these carriers. 
It is based on the identification and classification of genes that encode transmembrane proteins, as 
it is assumed that transport proteins are located in membranes30. 
Hence, the user must, beforehand, submit the genome amino acid fasta files to the TransMembrane 
Prediction using Hidden Markov Models (TMHMM)31 web server, because this process cannot be 
remotely accessed by merlin 2.0. The TMHMM tool is used to identify protein encoding genes with 
transmembrane domains. 
Afterwards, merlin 2.0 uses an internal implementation of the Smith-Waterman (SW) algorithm32 for 
comparing protein sequences with at least n transmembrane helices (being n a user defined 
parameter with a default value of 1) with all protein sequences currently available in TCDB. The SW 
algorithm is used for determining similar regions between two sequences. This algorithm performs 
local sequence alignments, comparing segments of all lengths and optimizing the similarity measure. 
Thus, this algorithm was preferred over global alignment algorithms (such as BLAST or 
Needleman-Wunsch33) because transmembrane domains are small sequences with usually about 20 
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amino acids of length, found within the protein sequences. 
The results of the SW similarity search are kept in a relational database according to the schema 
presented in the Figure S4.3 of the supplemental material. This database provides associations 
between the genome of the organism being studied and the TCDB records. These records often 
provide direct access to specific information, namely: UniProt Accession Number, organism, Protein 
Name, Length and others. However, to date, the substrates and direction of the transport are not 
directly provided, thus, these features have to be inferred from the information provided for each 
record. 
merlin 2.0 is shipped with a growing database having thousands (over 4200) of TCDB records already 
annotated with metabolites and directions. Several databases, namely TCDB, KEGG, ChEBI and the 
semanticSBML34 tool were used to assign identifiers to the metabolites transported by each carrier 
annotated in merlin 2.0. Although our database does not include all TCDB records, if similarities to 
unannotated TCDB records are found, such records can be annotated by the user and uploaded to 
merlin 2.0, using a specific operation for that purpose. 
Finally, the metabolites transported by each carrier identified in the genome uploaded to merlin 2.0 
are inferred from the annotations of the TCDB records that have similarities to such carriers. merlin 
2.0 uses an internal scorer, based in the schema provided in Figure S4.4 of the supplemental material 
and similar to the presented above for EC numbers (and product names), to classify the assignment 
of metabolites and TC family numbers. 
An article29 with the detailed description of this methodology has been recently submitted. 
The methodology for the prediction of the proteins and metabolites subcellular localization, supported 
on WoLF PSORT for Eukaryotes35 and PSORTb v3.0 for Prokaryotes36, was also described in the same 
article29. The information provided by these tools is kept in a relational database, according to the 
schema presented in Figure S4.5 of the supplemental material. The determination of the proteins 
localization in eukaryotic organisms is performed in WoLF PSORT using a simple remote Java API, 
provided by Paul Horton in a personal communication. PSORTb 3.0 is used to determine the 
localisation of proteins in prokaryotic organisms. Unfortunately, unlike WoLF PSORT, PSORTb 3 .0 
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does not provide a web API. In this case, the compartmentalization data may be retrieved in one of 
two manners. PSORTb 3.0 offers pre-computed genome results, for genomes deposited in GenBank. 
These data can be retrieved from the PSORTdb database at http://db.psort.org/browse. Otherwise, 
the target genome sequence files, in the amino acid fasta format, should be submitted to the PSORTb 
3.0 HTML interface. 
The genes are automatically assigned with the main compartment predicted by these programs. 
Moreover, if secondary compartments have scores that differ by less than a user defined percentage 
(default value of 10%) from the main compartment, the gene will also be assigned with those 
compartments. 
To annotate transport systems three criteria have to be met. The first two are that the gene sequences 
have transmembrane domains and similarities to TCDB records, respectively. The third is having a 
localisation prediction within a membrane. However, the WoLF PSORT and PSORTb 3 lump 
intracellular membranes with the intracellular organelle predictions, allowing the assignment only to 
the cytoplasmic membrane or outer membrane for prokaryotes and the plasma membrane for 
eukaryotes. Therefore, if a sequence met the first couple of requirements and WoLF PSORT predicted 
that such sequence was going to be assigned to an intracellular organelle, it is considered that such 
sequence encoded an intracellular transport system. 
On the other hand, if a regular enzyme is predicted to be assigned to a membrane, that enzyme is 
assigned to the compartments on both sides of the membrane. 
These modules allow generating compartment’s specific transport reactions, providing associations 
between genes and reactions, thus allowing the reconstruction of more robust and reliable models. 
All records provided by TCDB have cross-references to UniProt, thus this identifier is also used as an 
unambiguous identifier for such records in merlin 2.0. Moreover, taxonomic information for the TCDB 
records is retrieved for the classification of the metabolites and the TC family numbers. 
4.3.3.4 MODULES INTEGRATION AND SBML MODEL ASSEMBLING 
The integration of the output of the previous modules is easily performed by specific operations in 
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merlin 2.0, resulting in a fully compartmentalised draft model, which can be curated by the user. 
The first module (‘Load internal database’) provides data for building the internal model. Moreover, 
some reactions retrieved from KEGG are automatically integrated into the internal model, such as 
spontaneous and non-enzymatic reactions. If genomic data are retrieved from KEGG, such data is 
taken into consideration when assembling the internal model. 
The combination of the output of the enzymes annotation module, with the metabolic data of the 
internal model, generates a draft GSMM with all the reactions and respective GPR associations. That 
is, the reactions catalysed by the enzymes encoded in the organism's genome will be integrated in 
merlin 2.0’s internal model. 
Nevertheless, the identification of reactions from the genome annotation involved laying out some 
rules. According to KEGG, enzymes may belong to zero, one or several pathways. This assumption 
is also true for reactions; thus, a reaction may belong to zero, one or several pathways.  
Any given enzyme encoded in the genome of an organism, should be associated to at least one 
reaction. Thus, enzymes that catalyse a single reaction are automatically added to the model. 
Likewise, if an enzyme is not present in any KEGG pathway, reactions catalysed by this enzyme will 
be added to the internal model. However, if an enzyme catalyses several reactions, only reactions 
having at least one pathway in common with the enzymes will be added to the internal model. This 
heuristic is applied to prevent adding dozens of reactions to the internal model that do not connect 
to any other reaction. For example, the enzyme alcohol dehydrogenase (EC 1.1.1.1) catalyses 18 
reactions; however 5 of such reactions are not present in any pathway, thus not being added to the 
internal model. Nevertheless, the user can manually add/edit/remove any reaction to/from the 
model. 
Yet, the model provided by the integration of these modules only contains reactions taking place in 
the interior of the cell. 
The Transporters Annotation module provides transport reactions to the internal model, as well as 
the respective GPR associations. From all reactions generated by this module, only the transport 
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reactions in which the metabolites are already present in the network will be included in the internal 
model, so that no further entropy is added. The integration of transport reactions in the internal model 
involves creating surrogate transport proteins. Moreover, a reaction can be promoted by proteins 
encoded in several genes, and each of those genes may be associated to different TC families, 
according to the definition of TCs. Thus, the strategy for integrating the reactions in the internal model 
was to generate a surrogate transport protein for each different transport reaction being added to the 
internal model. 
After this stage, the internal model only contains reactions taking place in the interior of the cell and 
transport reaction between the outside and the inside. The integration of the compartments prediction 
allows generating a fully compartmentalised draft model, with reactions taking place in several 
organelles and cytoplasm/cytosol, as well as transport reactions between the outside and the inside 
and between the cytoplasm/cytosol and the organelles. 
The reconstructed internal model is available in merlin 2.0 Reactions View for manual curation, where 
the user can add new reactions, (e.g. the biomass reaction) or remove reactions that are not relevant 
for the model. 
Finally, the SBML37 GSMM with MIRIAM annotations38 can be exported from merlin 2.0, so it can be 
used in other applications, such as OptFlux39.  
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boxes for selection of the Product and EC number, if an EC number has been attributed. 
Nevertheless, the user can change a pre-selected item, or manually insert a new item. 
• The ‘Info’ column allows the user to access all the information provided by the homology 
searches, thus providing the user with more information to make a decision. The ‘Status’ 
column is an easy way to determine whether such gene exists (if a star is placed inside the 
button) and is annotated (if the star is golden) in UniProt, providing at the same time a direct 
link to the UniProt entry by clicking the button. Moreover, if the button is green coloured, it 
means that UniProt's annotation is in agreement with the current EC number selection in 
merlin 2.0. Light green means that merlin 2.0 assigns more EC numbers than UniProt's 
annotation, but the UniProt assignments are included in merlin's 2.0 annotation. Orange was 
selected for the cases in which UniProt's annotation includes merlin 2.0 assignments 
together with other EC numbers. Finally, a red button represents different annotations on 
merlin 2.0 and UniProt. 
• The ‘Notes’ column is useful, for instance, to track changes performed in the annotation 
during the debugging of the model. 
• The Products and EC number(s) columns present cross-links to BRENDA and UniProt when 
the mouse's right button is clicked within these columns. 
The ‘Transporters’ menu can be used to identify transport proteins and generate transport reactions 
as well as for loading new transporters annotations and integrate the transporters data into the model. 
The first operation ‘Transport Proteins Identification’ compares genes having n transmembrane 
domains to the proteins sequences remotely retrieved from TCDB. The ‘Transport Reactions 
Generation’ creates transport reactions for metabolites carried by transporters. The third operation 
can be used to load annotations for TCDB proteins not yet available in merlin 2.0. The last operation 
integrates the transporters GPR information into merlin 2.0’s internal model. 
The compartments prediction is handled differently for Eukaryotes and Prokaryotes in merlin 2.0. For 
Prokaryotes, the HTML files retrieved from the PSORTb web interface should be loaded using the 
operation available at ‘Compartments> Load PSORTb v3.0 Results’. Then the ‘Compartments> 
Perform Compartments Prediction’ should be performed. For Eukaryotes the first step is skipped 
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because the second operation retrieves the results from WoLF PSORT remotely. After the 
compartments prediction, the results should be integrated in the internal model, generating a fully 
compartmented draft model. 
Performing the enzymatic (re-)annotation of a genome allows exporting the annotation or integrating 
it into merlin 2.0’s internal model. Similarly, the generation of transport reactions, and the 
compartmentalisation of the model implies the presence of metabolic data. Therefore, merlin 2.0 has 
to be loaded with metabolic data. Retrieving metabolic data from KEGG involves just accessing the 
‘Project’ menu and clicking ’Load KEGG Data’. If KEGG has its own annotation for the case study’s 
genome, such annotation can also be retrieved. Being so, the enzymatic (re-)annotation performed 
within merlin 2.0 is integrated with KEGG’s annotation and the internal model is assembled using both 
annotations. 
Several panels were developed for the visualisation and edition of the KEGG data associated with a 
given metabolic model, namely, the Genes Viewer, the Proteins Viewer, the Metabolites Viewer, the 
Reactions Viewer and the Pathways Viewer. 
The Proteins Viewer includes a sub-View for the visualisation of information for enzymes, the Enzymes 
Viewer. 
Likewise, the Metabolites Viewer comprehends a couple of sub-Viewers the Reagent/Products Viewer 
and the Compounds/Reactions Viewer. The first sub-view is a fast and easy way to check if a 
metabolite is a reagent, a product or if it can have both roles in the network. The second sub-view is 
used to determine in which reactions a given metabolite participates. 
One of the most relevant panels in merlin 2.0 is probably the Reactions view, shown in Figure 4.5. 
This view allows the user to perform the curation of the GSMM. The panel shows reactions grouped 
per pathway (thus the repetition of reactions is not uncommon), with different automatically sorted 
colours in each via. In this view, it is possible to see all reactions in all pathways or select just a specific 
pathway. When a KEGG pathway is selected, the ‘Draw in Browser’ button becomes activated (as 
shown in Figure 4.5). This button opens the homepage of the selected KEGG Pathway map, in the 
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4.5 CONCLUSIONS 
merlin 2.0 is an user-friendly Java application that performs the reconstruction of genome-scale 
metabolic models for every organism that has its genome sequenced. 
merlin 2.0 performs several steps of the reconstruction process, including the functional genomic 
annotations of the whole genome, using BLAST and HMMER. For every gene, homologue information 
is retrieved and the results are automatically scored, allowing the user to change the automatic 
selection, and dynamically (re-)annotate the genome. 
Moreover, merlin 2.0 includes tools for the identification and annotation of transport proteins encoding 
genes, as well as the generation of transport reactions for such carriers. 
Also, merlin 2.0 includes tools for the compartmentation of the model that predict the localisation of 
the proteins encoded in the genome, and thus the localisation of the metabolites involved in the 
reactions induced by such proteins. 
Finally, merlin 2.0 expedites the transition from genome-scale data to SBML metabolic models, 
allowing the user to have a preliminary view of the biochemical network. 
Therefore, a compartmented draft model can be obtained in less than a week with merlin 2.0, which 
also provides several tools for the curation of the genome annotation and the draft model. 
merlin 2.0's is freely available at www.merlin-sysbio.org.  
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4.6 FUTURE WORK 
merlin 2.0 is currently being embedded with other tools such as ChemAxon Marvin tool a  for 
determining the correct metabolites protonation state. Also, remote access to other databases, such 
as the SABIO-RK (http://sabio.villa-bosch.de/) will be implemented. Furthermore, the next version 
of merlin will have specific operations for the prediction and annotation of protein complexes, as well 
as for the addition of electronically inferred biomass formation equations. 
  
                                                      
a http://www.chemaxon.com/products/marvin/ 
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4.8 SUPPLEMENTAL MATERIAL 
Additional file 4.1. – File with Additional figures in PDF format. 
www.merlin-sysbio.org/supplemental_material/Additional_file_4.1.pdf 
Figure S4.1 – Database schema for data retrieved from KEGG. 
Figure S4.2 - Database schema for data retrieved from remote homology alignments for the genome 
annotation. 
Figure S4.3 - Database schema for storing data on the local similarity alignments between the genome and 
TCDB. 
Figure S4.4 - Database schema for the transport reactions generation database. 
Figure S4.5 - Database schema for the compartments prediction database. 
Figure S4.6 - KEGG Pathway map with enzymes and reactions coloured by merlin 2.0. 
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5.1 ABSTRACT 
Even before having its genome sequence published in 2004, 
Kluyveromyces lactis had long been considered a model organism for 
studies in genetics and physiology. Research on Kluyveromyces lactis is 
quite advanced and this yeast species is one of the few with which it is 
possible to perform formal genetic analysis. Nevertheless, until now, no 
complete metabolic functional annotation has been performed to the 
proteins encoded in the Kluyveromyces lactis genome. In this work, a new 
metabolic genome-wide functional re-annotation of the proteins encoded 
in the Kluyveromyces lactis genome was performed, resulting in the 
annotation of 1759 genes with metabolic functions, and the development 
of a methodology supported by merlin (software developed in-house). The 
new annotation includes novelties, such as the assignment of transporter 
superfamily numbers to genes identified as transporter proteins. Thus, the 
genes annotated with metabolic functions could be exclusively enzymatic 
(1410 genes), transporter proteins encoding genes (301 genes) or have 
both metabolic activities (48 genes). The new annotation produced by this 
work largely surpassed the Kluyveromyces lactis currently available 
annotations. A comparison with KEGG’s annotation revealed a match with 
844 (~90%) of the genes annotated by KEGG, while adding 850 new gene 
annotations. Moreover, there are 32 genes with annotations different from 
KEGG. The methodology developed throughout this work can be used to 
re-annotate any yeast or, with a little tweak of the reference organism, the 
proteins encoded in any sequenced genome. The new annotation provided 
by this study offers basic knowledge which might be useful for the 
scientific community working on this model yeast, because new functions 
have been identified for the so-called metabolic genes. Furthermore, it 
served as the basis for the reconstruction of a compartmentalized, 
genome-scale metabolic model of Kluyveromyces lactis, which is currently 
being finished. 
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5.2 BACKGROUND 
The yeast Kluyveromyces lactis (K. lactis) has long been considered a model organism for studies 
in genetics and physiolog1. As pointed out by Fukuhara2 in 2006, interest in this organism began 
in academia, mainly due to its ability to metabolize the beta-glycoside lactose and other 
properties such as its GRAS (generally regarded as safe) status. Biotechnological applications 
started to be investigated later and, as depicted on the report by van Ooyen et al.3 in 2006, 
recombinant protein expression has probably been the most widely explored application with K. 
lactis. There are reports that at least two of these proteins, namely prochymosin and lactase (or 
beta-galactosidase), reached industrial production3,4. 
A common approach used by the scientific community active on K. lactis is to either literally work 
in parallel to or at least in comparison with Saccharomyces cerevisiae (S. cerevisiae). Baker’s 
yeast is not only the best described Eukaryote (it was the first Eukaryote ever to have its genome 
completely sequenced5), but it is also the most employed organism in industry, at least in terms 
of production volumes. 
Energy metabolism is the physiological aspect that mostly distinguishes both species. While the 
Crabtree-positive yeast S. cerevisiae has a strong tendency to ferment, even under aerobic 
conditions, K. lactis is considered Crabtree-negative and preferably uses respiration for energy 
generation, unless oxygen becomes limiting6,7. Another crucial difference between the two yeasts 
is that K. lactis, in contrast to S. cerevisiae, is not capable of growing under complete 
anaerobiosis8. 
Research on K. lactis (a.k.a. milk yeast) is quite advanced and includes aspects such as the 
glucose sensing and repression cascade9,10, the molecular basis for the Crabtree-negative 
characteristic of this yeast11, the improvement of secretory pathways for heterologous protein 
expression12,13, the engineering of post-translational modifications with the aim of avoiding 
hypermannosilation of heterologous proteins14, the oxidative stress response15,16, the molecular 
basis for the incapacity of growing anaerobically8,17, the description of its transcriptional 
regulators18, and an exhaustive study of its cell wall19. Remarkably, many of the physiological 
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differences between K. lactis and S. cerevisiae seem related to the whole-genome duplication 
event20, which affected S. cerevisiae, but not K. lactis. 
One of the key aspects of research on K. lactis is the fact that most of the work performed in the 
past decades has been based on a single strain, namely CBS 2359 (a.k.a. NRRL Y-1140). This 
has facilitated enormously the interpretation of results and the interaction among laboratories 
throughout the world2. Another important factor is that, in spite of all historical changes in terms 
of taxonomic methods, mainly the recent adoption of criteria purely based on gene sequences, K. 
lactis remains K. lactis, even after a recent redefinition of the Kluyveromyces and related genera 
21,22. 
K. lactis is one of the few yeast species with which it is possible to perform formal genetic 
analysis2. Additionally, due to some recent advances19,23,24, molecular tools have been 
developed, facilitating the generation of mutants1, a task which can now be considered as simple 
to perform with this yeast as it is with S. cerevisiae. Also, its full genome sequence was made 
available some years ago25, allowing for the improvement of our understanding on eukaryotic 
genome evolution by comparing the genomes of different yeast species. Within this context, a 
number of works have been published on particular aspects of yeast genomes26–33. 
5.2.1 (RE-)ANNOTATION 
There are several reasons to re-annotate a genome, such as: new genes or protein functions 
being discovered, a research group trying to determine the reproducibility of an existing 
annotation, or just because the information associated to a specific organism is known to be out-
dated. Thus, the re-annotation of a genome, especially for genes classified as hypothetical 
proteins, is very important for assuring an up-to-date gene annotation and not compromising 
future similarity alignments for newly sequenced genes. 
Functional annotation can be defined as the inference and assignment of functions to genes or 
proteins. Such information is often obtained by similarity to formerly characterized sequences, 
found in several online or local database34. Likewise, the re-annotation process can be depicted 
as the annotation of a previously annotated gene or full genome34,35. 
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Though being uncommon, there are some examples of genome wide re-annotations, such as 
Campylobacter jejuni NCTC1116835 Mycobacterium tuberculosis H37Rv36, and Arabidopsis 
thaliana37. All of the above annotations assigned new functions to genes that had been previously 
identified as “hypothetical proteins” and corrected some of the previous annotations. 
A genome-wide metabolic functional annotation is a thorough effort which has the objective of 
trying to determine and label the genes involved in the metabolism of the organism of interest, 
skipping the regulatory and other genes annotation. Therefore, only the genes that encode 
enzymes or transporter proteins will be assigned with a function and included in this re-
annotation. 
Kluyveromyces lactis genome does not have an official genome-wide functional metabolic or 
other annotation in the GenBank38 and Reference Sequences (RefSeq)39 databases 
(http://www.ncbi.nlm.nih.gov/sites/entrez?Db=genome&Cmd=ShowDetailView&TermToSearch=
17850). The annotation available in GenBank files 
(ftp://ftp.ncbi.nih.gov/genbank/genomes/Fungi/Kluyveromyces_lactis_NRRL_Y-
1140_uid12377 any *.gbk) in the GenBank database only characterizes the gene products by 
applying the same code used for the gene identification, followed by a “p” instead of a “g”; for 
instance, /locus_tag=”KLLA0A00132g” was assigned with /product = "KLLA0A00132p". On the 
other hand, RefSeq (ftp://ftp.ncbi.nih.gov/genomes/Fungi/Kluyveromyces_lactis_NRRL_Y-
1140_uid12377/ any *.gbk) database assigns all proteins as hypothetical proteins. 
Nevertheless, all genes have descriptions in the GenBank “\notes” field. For example, the 
KLLA0A08492g gene is described as encoding a "conserved hypothetical protein", the 
KLLA0A08536g gene has "some similarities with uniprot|P25587 Saccharomyces cerevisiae 
YCL005W" and the KLLA0A08624g gene is "highly similar to uniprot|Q75ET0 Ashbya gossypii 
AAL002W AAL002Wp and similar to YCL001W uniprot|P25560 Saccharomyces cerevisiae 
YCL001W RER1 Protein…”. Other genes have more explicit annotations, for instance gene 
KLLA0A00891g is described as "uniprot|P53768 Kluyveromyces lactis KLLA0A00891g HAP2 
Transcriptional activator HAP2", KLLA0F13530g is a "uniprot|P49385 Kluyveromyces lactis 
ADH4 Alcohol dehydrogenase IV, mitochondrial precursor" and KLLA0D00231g is described as 
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"uniprot|Q9Y844 Kluyveromyces lactis mal22 Maltase" (in agreement with the new annotation). 
However, these descriptions are not considered annotations, because relevant information, such 
as the gene product and, when available, the Enzyme Commission (EC) number40, is not 
provided in most cases. Furthermore, when available, such information should be delivered in 
the correct GenBank field (“/product” and “/EC number” instead of the “/notes” field) for easier 
manipulation using bioinformatics tools and user appraisal. Other databases such as KEGG 
(http://www.genome.jp/kegg/kegg2.html)41 perform metabolic annotations, with fairly 
acceptable results, though failing in some annotations and missing several genes with metabolic 
functions. (Universal Protein Resource) UniProt (http://www.ebi.ac.uk/UniProt/), on its hand, is 
composed by two databases, Swiss-Prot and TrEMBL, which are curated and non-curated, 
respectively42. The curated database provides information that was manually annotated and 
reviewed, even if it was obtained electronically. Such database contains some information about 
the microorganism studied during this work, though somewhat scarce. 
Hence, in this work we propose a genome-wide metabolic (re-)annotation of the proteins encoded 
in the Kluyveromyces lactis complete sequenced genome, identifying the genes involved in 
metabolites conversion and carriage throughout the cell, which is imperative for the 
reconstruction of a robust genome-scale metabolic model. 
5.2.2 GENOME-SCALE RECONSTRUCTED METABOLIC MODELS 
Full genome sequences have been used, among many other applications, to reconstruct 
metabolic networks of different microorganisms such as Escherichia coli 43 or Saccharomyces 
cerevisiae 44. This allows for the establishment of the so-called genome-scale metabolic models, 
which are developed bottom-up from the genome up to the reactions catalysed by the enzymes 
encoded in such set of genes. It is an iterative process that culminates in a reaction set that is 
used to simulate in silico the phenotype of the studied organism, under several environmental or 
genetic conditions45. The use of such models has resulted in insight gaining and hypothesis 
testing, such as the enhancement of sesquiterpene production in Saccharomyces cerevisiae 46, 
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the improvement of the production of succinic acid in Escherichia coli 47 or finding new targets in 
drug research48. 
For the reconstruction of a robust genome-scale model, it is mandatory to have a proper 
annotation of the genome. For a metabolic model, all genes with metabolic roles, such as 
enzymes and transporters, have to be identified. The reconstruction of a metabolic model is a 
laborious and extensive process that has been described by Thiele and Palsson in 201049 as a 
96 steps protocol, which takes a long time to be completed, depending on data availability. Such 
work also describes the first step “1| Obtain genome annotation” as a critical step, thus the 
importance of a robust annotation for the reconstruction process. 
Although the genome of K. lactis has been publicly available for some years, a complete 
functional annotation was not made available to the public yet. In 2009, Souciet et al. 33 re-
annotated the genome of K. lactis, together with the sequencing and annotation of other yeast 
genomes, with the aim of performing comparative genomics. However, such annotation did not 
propose a functional annotation for each K. lactis gene. Here we present a work which identifies 
genes with metabolic functions and assigns functions to those genes, such as EC numbers, 
Transporter Classification Superfamily (TCS) numbers and Transporter Classification (TC) 
numbers50. Whenever a complete EC number (‘class’.’subclass’.’sub-subclass’.’enzyme serial 
number’) was not available, a partial EC number was assigned to such enzymes 
(‘class’.’subclass’.’sub-subclass.-, ‘class’.’subclass’.-.- and ‘class’.-.-.-). 
The re-annotation of the proteins encoded in the K. lactis CBS 2359 metabolic genome was 
performed in a semi-automatic manner by combining the use of the software merlin 51, 
developed in-house and available for download (at http://sysbio.uminho.pt/merlin/) and manual 
inspection. The annotated genome of this organism brings some new insights on its capabilities 
and allowed the reconstruction of the Kluyveromyces lactis genome-scale metabolic model 
(currently being finalized). merlin’s dynamic annotation tool was used to perform first an 
automatic re-annotation of the complete genome followed by a manual curation of the enzymatic 
annotation. merlin’s transporter annotation tool was used to identify genes that encode 
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transporter proteins, as well as the metabolites transported by such systems. In the end, a new, 
re-annotated, GenBank file was created by merlin for each K. lactis chromosome. 
We believe that this re-annotation not only served as the basis for the assembly of a genome-
scale metabolic model for K. lactis, but also provides relevant biological information for the 
scientific community dealing with this organism and yeasts in general. 
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5.3 METHODS 
5.3.1 ONLINE DATABASES 
Several online databases were used throughout this work. A brief description of each one is 
available bellow: 
•The first Basic Local Alignment Search Tool52 (BLAST) similarity search performed with merlin 
used All non-redundant sequences (including GenBank coding sequences translations, RefSeq 
Proteins, Brookhaven Protein Data Bank (PDB), SwissProt, Protein Information Resource (PIR), 
Protein Research Foundation (PRF) databases) (nrDB) available in the National Center for 
Biotechnology Information (NCBI) databases39 to find any protein sequence similar to translated 
K. lactis genes. 
•A second BLAST search used NCBI’s yeast database35 (yeastDB), which is a single curated set 
of Saccharomyces cerevisiae protein sequences available at the NCBI's RefSeq database. 
•The Entrez Protein 39 (http://www.ncbi.nlm.nih.gov/sites/entrez?db=protein) database is a 
collection of sequences from several sources, including GenBank CDS translations, RefSeq 
Proteins, SwissProt, PIR, PRF, and PDB. Entrez Protein provided all information that merlin 
retrieved for each Kluyveromyces lactis homologue gene. 
•The UniProtKB/Swiss-Prot (http://www.UniProt.org/) database is a manually curated protein 
sequences database which provides annotations with minimal redundancy and high level of 
integration with other databases42. Thus, UniProtKB/Swiss-Prot was selected as a reference 
resource during the Kluyveromyces lactis genomic re-annotation. 
•The Saccharomyces Genome Database (SGD – http://www.yeastgenome.org/) project collects 
information and maintains a database of the molecular biology of the yeast Saccharomyces 
cerevisiae 53. This database includes a variety of genomic and biological information and is 
maintained and updated by curators. The SGD was selected as the second reference database 
for this project. 
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•The Comprehensive Enzyme Information System BRaunschweig ENzyme DAtabase (BRENDA – 
http://www.brenda-enzymes.info/) provides enzyme functional data obtained directly from 
literature by professional curators54. This database was used to confirm the information gathered 
in the previous two databases, thus being the third reference database selected for this work. 
•The Transporter Classification Database (TCDB – http://www.tcdb.org/) details a 
comprehensive classification system, approved by the International Union of Biochemistry and 
Molecular Biology (IUBMB), for membrane transporter proteins known as the Transporter 
Classification (TC) system. The TC system is analogous to the Enzyme Commission system for 
classification of enzymes, except that it incorporates both functional and phylogenetic 
information55. This database was selected to annotate transporter proteins. 
5.3.2 METABOLIC MODELS RECONSTRUCTION USING GENOME-
SCALE INFORMATION (MERLIN) 
merlin 51 is a software tool, in continuous development, created to assist on the process of 
reconstructing a genome-scale metabolic model. The reconstruction process cannot begin 
without a functionally annotated genome; thus, merlin performs automatic genome-wide 
functional (re)annotations, by comparing biological sequences from the organism being studied 
with all of the NCBI’s databases. merlin provides a numeric confidence score for each automatic 
assignment, taking into account the frequency and the taxonomy within the annotations of all 
sequences that are similar to the gene under investigation51, according to Equation 5.1: 
ݏܿ݋ݎ݁௔௡௡௢௧௔௧௜௢௡ = 	ߙ ∙ ݏܿ݋ݎ ௙݁௥௘௤௨௘௡௖௬ + ሺ1 − ߙሻ ∙ ݏܿ݋ݎ݁௧௔௫௢௡௢௠௬ (5.1)
In which the frequency score is related with the number of times a given function (EC number) 
appears in the set of homologues and the taxonomy score is related with the taxonomic proximity 
between the studied organism and those in which those functions had been identified. The user 
can choose to give more relevance to the frequency score or to the taxonomy score, just by 
altering the alpha value in merlin’s interface (see Figure S5.1 of the supplemental material). If 
the user considers the frequency more relevant than the taxonomy of the homologue genes the 
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alpha value should be set between 0.5 and 1. If taxonomy is preferred over frequency the value 
should be between 0 and 0.5. In this work, the α value was set to 0.2, so that the yeasts’ 
annotations could be given more relevance than other organisms’ annotations. 
However, in this work merlin's automatic annotation was fully reviewed to maximize the re-
annotation confidence. 
Moreover, merlin’s interface was used throughout the (re)annotation process to assign functions 
and protein names to each metabolic gene. merlin’s interface is particularly user friendly, 
providing “drop down boxes” (see Figure S5.1 of the supplemental material) for the annotation of 
each gene. merlin allows exporting the annotation as an Excel file or in the GenBank format, 
during or after the end of the annotation process. 
5.3.3 IDENTIFICATION OF GENES THAT ENCODE ENZYMES 
To retrieve enzymatic information, merlin performs remote BLAST similarity searches to the NCBI 
databases. When the purpose of performing BLAST similarity searches is to retrieve metabolic 
information for a genome re-annotation, the output of a BLAST similarity search can be too 
minimalistic and very confusing. Anyone that has tried one of the many BLAST search tools 
available in the internet (such as http://blast.ncbi.nlm.nih.gov/Blast.cgi or 
http://www.UniProt.org/blast/) knows that the output of a BLAST search is not much helpful for 
the collection of metabolic data (see Figure S5.2 of the supplemental material), because the user 
has to follow several links to retrieve the data: to retrieve metabolic data, the user has to go over 
all identified homologue genes, retrieve enzymatic information and compile such information for 
all genes of the studied genome. To avoid such massive effort, merlin was used to implement the 
remote similarity alignments between the user set of genes (or full genome as was the case) and 
the previously selected remote NCBI database, as well as retrieve and classify each homologue’s 
annotation, providing comprehensible information. 
The path from genome sequence information to enzymatic data retrieved from homology is 
described in Figure 5.1. 
 Figure
The B
homol
parsed
such a
Initial
the 
ftp://
merli
param
(Janu
encom
The p
time 
 5.1 - merlin
LAST search 
ogy data infere
 and saved in 
s EC numbers 
ly, merlin re
ftp.ncbi.nih.
n performed
eters also 
ary 2010) 
passed 629
rogram use
of the BLAST
’s path from 
(configured wit
nce (STEP A). 
STEP B. Finally
or taxonomy in
ceived the K
Ge
gov/genome
 the remot
depicted in 
the nrDB w
8 sequence
d to perform
). The e-valu
organism gen
h the parame
Specific inform
, the Entrez pr
 STEP C. 
. lactis geno
nBank 
s/Fungi/Klu
e BLAST si
the first ste
as a colle
s. 
 the remote
e is used to
ome to enzy
ters presented
ation for each 
otein web serv
me in the a
yveromyces_
milarities se
p of the fig
ction of 10
 blast searc
 create a sig
matic homolo
 above) was 
gene homolog
ices are used t
mino acid f
repos
lactis_NRR
arch, config
ure. At the 
,140,583 s
h was the b
nificance th
gy data. 
performed in t
ues, such as id
o retrieve the m
asta format, 
itory 
L_Y-1140_u
uring the a
time of the
equences a
lastp (versio
reshold for re
CHAP
he first stage 
entifiers or sc
etabolic infor
downloaded
id12377/. 
lgorithm wit
 similarity s
nd the ye
n 2.2.22+ 
turning resu
TER 5 133
 
of the 
ores, is 
mation, 
 from 
at 
Then 
h the 
earch 
astDB 
at the 
lts. A 
134 GENOME-WIDE METABOLIC (RE-) ANNOTATION OF KLUYVEROMYCES LACTIS 
 
lower e-value will result in a shorter list with more quality homologues, thus the maximum e-value 
threshold was set to 1E-30. 
The matrices referred in Figure 5.1 are parameters of the BLAST algorithm, and are used to 
evaluate the quality of a pairwise sequence alignment by assigning scores for the alignment of 
any possible pair of residues. BLOSUM 62 was used as the default matrix for the similarity 
search algorithm configuration and was changed to PAM30 for the shorter sequences that could 
not be aligned with the first matrix. merlin takes approximately 24 h to automatically assign a 
functional annotation to every protein encoded in a given genome, depending on the NCBI 
servers’ availability and the genome size. 
For each Kluyveromyces lactis gene, the top 100 most similar homologues were retrieved and 
the information displayed in Figure 5.1 – Step 2 was collected. If less than 100 homologues were 
available, only those were processed. Afterwards, merlin accessed the Entrez Protein webservice 
to download and save several data for each homologue acquired in the previous step. Such data 
is listed in Figure 5.1 – Step 3. 
Using internal heuristics51, briefly represented above in Equation 5.1, merlin automatically 
selected a candidate annotation for each protein encoding gene of the studied genome based on 
confidence scores. The similarity result (gene product, EC number) with the highest confidence 
score was selected by merlin to automatically annotate each protein encoding gene of the studied 
genome. Moreover, merlin reduced the curation efforts, as it allows the user to browse through 
all similarity search results and change the automatic annotations provided by the software. 
When the first automatic annotation results were analysed, a pattern emerged. The homologues’ 
taxonomic distribution was, as it will be shown in the Results section, biased. Indeed, whenever a 
Saccharomyces cerevisiae homologue was available, merlin would consistently select the baker’s 
yeast gene annotation to annotate the Kluyveromyces lactis gene. Thus, the baker’s yeast was 
selected as a reference organism for the EC numbers annotation because the two 
microorganisms share the phylogenetic lineage all the way to the taxonomic family level and S. 
cerevisiae is the best studied, annotated and curated Fungus. Hence, two projects were initiated 
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with merlin, allowing the software tool to use all data available in the NCBI database (nrDB) to 
annotate the Kluyveromyces lactis genome in the first project, while for the later project only data 
from the NCBI’s yeastDB were used. Each K. lactis gene assigned by merlin with enzymatic 
functions on either the first or the second similarity search was labelled as an enzyme encoding 
gene candidate (EEGC). 
The developed approach originated two parallel annotations, as depicted in Figure 5.2, which 
allowed comparing the functional assignments for each gene. From this line up, four sets of 
genes were assembled. The EEGC’s assigned with the same enzyme by both projects were 
labelled as matches. Such genes’ annotation was generally accepted (although reviewed 
according to Figure 5.3), except for partial EC numbers (which were revised on behalf of the 
existence of complete EC numbers) and deprecated EC numbers (which were updated). 
The second set encompassed those genes which were identified as EEGC’s on the first BLAST 
search (nrDB assigned) but not on the second similarity alignment. Such set presented a high 
number of genes that, although being automatically annotated with metabolic functions, were 
later discarded by the annotation pipeline depicted in Figure 5.3 (false positives). 
The third set of genes was the most troublesome. It was the group of genes assigned with 
different enzymes on each merlin project (distinct). Such collection was carefully reviewed, with 
the purpose of selecting the correct gene function without reservations. 
The last set (yeastDB assigned) encompassed milk yeast EEGC’s which were not automatically 
annotated as enzymes by merlin in the first alignment, but when the search was performed 
against NCBI’s yeastDB, at least one Saccharomyces cerevisiae metabolic homologue was 
identified for each K. lactis gene. merlin did not assign any annotation on the first similarity 
search probably because each of those K. lactis EEGC had more than 100 homologues in 
organisms other than S. cerevisiae on such alignment. 
The EEGC’s were manually verified by following several confirmation steps as depicted in the 
functional annotation pipeline (Figure 5.3). The described methodology can be recurrently 
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BLAST searches were performed to a pair of distinct databases (nrDB and yeastDB), originating two parallel 
annotations. Four sets of genes were assembled from the comparison of such annotations: the group of genes with 
the same assignments in both annotation projects (matches), the genes with different assignments in each project 
(distinct) and two groups with the genes only annotated in either the nrDB or in the yeastDB. 
5.3.4 ANNOTATION PIPELINE 
Despite using merlin, all of the Kluyveromyces lactis functional EEGC’s automatic assignments 
were reviewed according to the schema depicted in Figure 5.3, so that the minimum number of 
false positives would be included in this annotation. For that purpose, the main criteria were, in 
first priority, the existence of information in curated databases for the K. lactis genes and, in 
second priority, the existence of curated S. cerevisiae homologues. Only when none of the 
previous information was available the search was extended to curated homologues of other 
organisms. 
Initially, for each EEGC, a query was performed in UniProt, using the gene locus identifier (locus 
tag), to assess the existence of a reviewed annotated record for such gene. If UniProt had already 
identified such gene’s product on a reviewed record, or any literature was available and 
confirmed the proposed gene annotation, the assignment was accepted and the gene was 
annotated (after EC number confirmation in BRENDA – Figure 5.3-C). 
On the other hand, if UniProt had no reviewed match for such gene, then a S. cerevisiae gene 
was sought in the BLAST hits (Figure 5.3-B) kept by merlin for such gene. So, if a baker’s yeast 
homologue was available, its identifier (YXX####x) was searched in both UniProt and SGD 
databases. After the analysis of the UniProtKB/Swiss-Prot and the SGD entries two situations 
could arise (Figure 5.3-B1): the records could be either identical or distinct. When identical, the 
gene was annotated; else, the records would be thoroughly examined and the SGD entries would 
be always favoured. As explained above, both UniProtKB/Swiss-Prot and SGD are manually 
curated databases, thus both results are reliable. Nevertheless, the SGD is favoured when a 
conflict arises between both databases because it is specific for Saccharomyces cerevisiae, and 
consequently the curators of this database are specialized in the analysis of the baker’s yeast 
genome. Hence, if the similarity between the K. lactis and the S. cerevisiae gene sequences is 
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Each EEGC locus tag was firstly queried on UniProt and, if present, the assignment was accepted and the gene was 
annotated. If not, then a S. cerevisiae gene was sought in the BLAST hits kept by merlin for such gene (STEP B). If a 
baker’s yeast homologue (STEP B1) was available, its identifier (YXX####x) was searched in both UniProt and SGD 
databases. When both databases records were identical, the gene was annotated; else, the records would be 
examined and the SGD entries would be favoured. For the EEGC’s that did not have any S. cerevisiae homologue 
(STEP B2), a new specific similarity search was performed in NCBI BLAST, restraining the possible outcomes to 
Swiss-Prot reviewed records and the organism to S. cerevisiae, with the acceptable e-value decreased to e < 1E-10. If 
there was an entry that complied with those conditions, the gene was annotated; else, the BLAST similarity search 
was unrestricted, organism wise. Again, if there was an entry that complied with the previous conditions, the gene 
was annotated as homologue of the first hit, else it was discarded. The previously annotated information was revised 
in BRENDA to verify the function about to be annotated to such gene (STEP C). Finally, the information collected in 
the previous steps is assigned to the EEGC (STEP D), rendering the EEGC a metabolic gene or discarding such gene 
as metabolic. 
For the EEGC’s that did not have any S. cerevisiae homologue (Figure 5.3-B2), a specific 
similarity search was performed in the NCBI BLAST web interface, restraining the possible 
outcomes to Swiss-Prot reviewed records and the organism to the 4932 taxID (Saccharomyces 
cerevisiae). This step was performed because merlin’s scorer was configured to calculate the 
function scores using the first 100 homologues retrieved from the BLAST similarity search. 
However, the S. cerevisiae homologue could have a cardinality of more than 100. When 
performing this specific homology search, the number of hits is considerably reduced, thus the 
acceptable e-value is also decreased to e < 1E-10. If there was an entry that complied with the 
previous conditions, the gene was annotated; else, the BLAST similarity search was unrestricted, 
organism wise. Again, if there was an entry that complied with the previous conditions, the gene 
was annotated as homologue of the first hit, else it was discarded. 
Whatever was the source of the candidate enzyme assigned to a given gene, such information 
was revised in BRENDA to verify the function about to be annotated to such gene (Figure 5.3-C). 
Some of the enzymes encoded in the genome were assigned with partial EC numbers by the 
studied databases. BRENDA was also used to try to identify complete EC numbers for such 
genes, by searching for the names of those gene products in that database. 
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Finally, the information collected in the previous steps is assigned to the EEGC, as depicted in 
Figure 5.3-D, rendering the EEGC a metabolic gene or discarding such gene as metabolic. 
5.3.5 CLASSIFICATION OF MANUAL CURATION RESULTS 
When using the annotation pipeline to analyse the EEGC’s, a limited number of logical jumps 
were detected. Therefore, an alpha-numeric cross classification system was developed to log and 
identify the gene classification patterns, encompassing the origin of the entry chosen in the final 
annotation (nrDB or yeastDB) and the database(s) that provided the information that motivated 
the choice made. A detailed description of such classification is available in Additional file 5.2 of 
the supplemental material. 
5.3.6 IDENTIFICATION OF GENES THAT ENCODE TRANSPORTER 
PROTEINS 
Only four Kluyveromyces lactis’ genes are available in TCDB as transporter protein encoding 
genes (see Table S5.1 of the supplemental material). Therefore, it was necessary to implement a 
methodology to further identify transporter proteins using homology analysis. 
Although merlin uses remote BLAST similarity searches to classify gene products, the transporter 
information is obtained by performing local smith-waterman (SW) similarity alignments56 with the 
TCDB, to identify the TCS (Transporter Classification Superfamily) number of the genes that 
encode transporter proteins. This methodology was also developed in-house and will be included 
in merlin’s 2.0 version. An article with the detailed description of this methodology (Genome-wide 
semi-automated annotation of transporter systems57) has been recently submitted. 
Unlike enzymes, transporter proteins cannot be directly classified from homology. Enzymes are 
represented by EC numbers that classify the catalysed reactions and a gene can be annotated 
with several EC numbers. TC numbers are associated to proteins that transport a specific range 
of substrates and are often associated to a single gene. For example, a gene that encodes a 
carrier that is able to transport a range of substrates is assigned with a single TC number and not 
a range of TC numbers, as is the case with EC numbers. TC numbers are grouped in TC families. 
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For example, the 2.A.1.1 – The Sugar Porter (SP) Family encompasses transport proteins that 
transport sugars. Likewise, TC families are grouped in TCS. For example, the 2.A.1–The Major 
Facilitator Superfamily (MFS) includes the 2.A.1.1. The Sugar Porter (SP) Family, the 2.A.1.2 – 
The Drug:H + Antiporter Family and several other families. Therefore, for the classification of the 
genes that encode transporter proteins, the approach was somewhat different and is concisely 
described next. 
The process of performing genome-wide similarity searches using the SW algorithm, despite 
being more accurate than BLAST, can be very time–consuming, as such alignments are very 
demanding. Therefore, the number of K. lactis genes aligned against TCDB was reduced via the 
TransMembrane prediction using Hidden Markov Models (TMHMM)58 software. TMHMM is a 
prediction algorithm that identifies the number of transmembrane helices in a protein using 
hidden Markov models. 
Thus, all genes that had one or more transmembrane helices were considered transporter 
protein encoding gene candidates (TPGC) and were aligned to the TCDB. The similarity threshold, 
when performing the SW similarity searches, was of 10 %, because the transporter database was 
very small (6100 records at the time of the alignment – September 2011). Moreover, merlin 
uses internal heuristics to lower the threshold, inversely to the number of transmembrane helices 
of the gene. 
A TPGC can have similarities to different families and super-families of the same TC class that 
can nevertheless have similar functions. Thus, the TC family numbers, as well as the 
metabolites, of the TCDB genes similar to each TPGC were classified with the same algorithm 
used by merlin to classify the EC numbers of each EEGC. Such algorithm classified the TC family 
numbers and metabolites associated to each TPGC, using the taxonomy of each of the TCDB 
homologue genes and the frequency of the TC family numbers or metabolites, within all similar 
genes. In the end of this process, each gene identified as a TPGC was either discarded (not 
considered a transporter protein) or effectively annotated as a transporter protein encoding gene. 
In the latter case, a TCS number, as well as the metabolites transported by such protein, were 
assigned to each transporter protein encoding gene. Since it was considered that the transporter 
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family number could be too restrictive, it was decided to go up a level and the TCS number was 
chosen instead.  
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The annotation pipeline ruled out 241 K. lactis EEGC’s as non-metabolic genes because the 
implemented routine suggested that such EEGC’s homologues were either wrongly assigned as 
similar to K. lactis or incorrectly annotated. The other 1458 genes were confirmed and annotated 
as metabolic genes. 
As depicted in Figure 5.4, most of those 1458 genes were annotated with at least one EC 
number and 301 were annotated as exclusively transporters, being assigned with TCS or TC 
numbers. Summing up, 1759 genes were classified as metabolic genes, of which 1410 are 
exclusively enzymatic, 301 exclusively transporter proteins and 48 have both functions. The final 
annotation of each EEGC is available in Table S5.2 of the supplemental material. 
The Kluyveromyces lactis genome had been sequenced by the Génolevures consortium; however, 
the genes identified by the consortium were not assigned with EC or TC numbers. Also, despite 
holding the genome sequencing data, GenBank does not provide any functional annotation. Thus, 
the new annotation provided by this work was compared with the data available in KEGG, UniProt 
and to a lesser extent with BRENDA and TCDB. 
The new annotation produced by this work largely surpassed the Kluyveromyces lactis currently 
available annotations, as demonstrated in Table 5.1. 
Table 5.1 Comparison of the results reached in this work and previous annotations 
available. 
 KEGG 
annotation 
UniProt 
annotation
TCDB 
annotation
BRENDA EC # new 
annotation
number of genes 938 354 4 34* (38 )** 1759 
Number of K. lactis genes annotated in each database and the new annotation. *BRENDA provides the number of 
enzymes associated to K. lactis. **In brackets the total number of EC numbers, including three EC numbers 
associated to K. lactis on BRENDA. However, such EC numbers are not present in the new annotation because one 
of them was from a plasmid59 and the other two were from vectors inserted in a K. lactis strain60. 
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5.4.2 COMPARISON WITH KEGG 
The comparison between the new annotation and KEGG’s annotation is depicted in Table S5.3 of 
the supplemental material. The new annotation matched 844 (~90%) of genes annotated by 
KEGG, adding 850 new gene annotations. Moreover, there are 32 genes with annotations 
different from KEGG. 
Also, 19 genes were assigned with more enzymes on the present annotation than on the KEGG 
annotation. For instance, KEGG annotates the KLLA0B02717g gene with the EC number 
2.3.1.86. However, our new annotation assigns 6 EC numbers (2.3.1.86, 4.2.1.61, 1.3.1.9, 
2.3.1.38, 2.3.1.39, 3.1.2.14) to such gene; thus, KEGG’s annotation is not incorrect but it is a 
subset of the present study’s annotation. On the other hand, there were 9 genes that were 
assigned with more enzymes on KEGG than on the present annotation. Finally, the annotation 
pipeline ruled out 29 genes annotated as metabolic on KEGG, due to several reasons. For 
instance, KEGG assigns the EC number 2.7.7.7 to KLLA0C11341g, and the new annotation 
identified such gene as an “Accessory subunit of DNA polymerase zeta” with no catalytic activity. 
KEGG assigns the EC number 6.3.2.19 to KLLA0C08041g. However, the new annotation 
identified that gene as a general negative regulator of transcription. These two, along with 27 
other ruled out genes are described in Table S5.4 of the supplemental material. 
Table 5.2 contains all genes for which KEGG assigns more enzymes than the new annotation. 
The 1st and the 2nd genes in the table were assigned with one EC number on the new annotation 
because the S. cerevisiae homologue only encodes one EC number. The other EC number 
assigned by KEGG is for a different protein (asparaginyl-tRNA synthase), thus being excluded by 
the annotation pipeline. The 3rd to the 8th genes in Table 5.2 were also annotated with only one 
EC number given the baker’s yeast homologue annotations, verified on SGD and UniProt. Finally, 
according to KEGG, KLLA0E19625g is associated both with Glutamate synthase [NADH], and 
Glutamate synthase [NADPH], but because UniProt and SGD disagree, the annotation pipeline 
was followed and only the second EC number was chosen. 
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Table 5.2. New annotation versus KEGG annotation. 
Gene KEGG new 
annotation
S. cerevisiae 
homologue
Protein 
KLLA0A09845g 6.3.5.6, 6.3.5.7 6.3.5.7 YMR293C glutamyl-tRNA(Gln) amidotransferase
KLLA0E20659g 6.3.5.6, 6.3.5.7 6.3.5.7 YBL080C glutamyl-tRNA(Gln) amidotransferase
KLLA0B07513g 2.7.1.105, 3.1.3.46 3.1.3.46 YJL155C fructose-2,6-bisphosphatase
KLLA0E07173g 4.2.1.51, 5.4.99.5 4.2.1.51 YNL316C prephenate dehydratase 
KLLA0E10143g 3.1.3.12, 2.4.1.15 3.1.3.12 YDR074W trehalose-phosphatase 
KLLA0F20548g 2.6.1.19, 2.6.1.22 2.6.1.19 YGR019W 4-aminobutyrate aminotransferase
KLLA0E17997g 3.1.3.16, 3.1.3.48 3.1.3.48 YIR026C tyrosine-protein phosphatase
KLLA0C09966g 2.8.1.1, 2.8.1.2 2.8.1.1 YOR251C thiosulfate sulfurtransferase
KLLA0E19625g 1.4.1.14, 1.4.1.13 1.4.1.14 YDL171C glutamate synthase [NADH]
Cases in which KEGG assigns more EC numbers than the new annotation. 
The functions only provided by the new annotation, when compared to KEGG, are distributed as 
described in Table 5.3. The new annotation provides 850 genes of which 524 are enzyme 
encoding genes not available in KEGG and 326 are associated with transport reactions. 
Table 5.3. Summary of genes not available on KEGG’s annotation but annotated in this 
work. 
genes not annotated in KEGG number of genes 
complete 
EC numbers 318 
EC numbers + TC(S) numbers 23 
partial 
EC numbers 206 
EC numbers + TC(S) numbers 2 
TC + TCS 301 
Complete EC numbers are assigned when all classes are identified (e.g. 1.1.1.1). Partial EC numbers are assigned 
when at least one subclass is unknown (e.g. 1.1.-.- or 1.1.1.-). 
Since KEGG’s annotation does not provide any transporter information, whenever a gene 
encoded a protein with both EC and TC(S) numbers, the transport system was ignored in the 
assessment, which helped to raise the number of matches between both annotations. 
5.4.3 COMPARISON WITH UNIPROT 
All 354 genes annotated with enzymatic functions by UniProt were included in the present 
annotation by the annotation pipeline, as described in Table S5.5 of the supplemental material. 
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For some (48) of those genes more information was collected, either by adding more enzymatic 
functions (e.g. KLLA0E01959g was annotated with 2.5.1.9 by UniProt and with 2.5.1.9 and 
2.5.1.78 in the new annotation) or just by providing a complete EC number to a partial UniProt 
annotation (e.g. KLLA0B01265g is annotated with 3.2.2.- in UniProt and with 3.2.2.27 in the 
new annotation). 
5.4.4 COMPARISON WITH BRENDA 
BRENDA’s annotation assessment was somewhat different from the other annotations evaluation, 
as BRENDA does not provide gene information. Hence, the EC numbers provided by BRENDA 
were sought in the new annotation to confirm if there was at least one gene that encoded such 
enzyme. The new annotation included all 34 EC numbers assigned by BRENDA to K. lactis, as 
depicted in Table S5.6 of the supplemental material. However, there were 4 other EC numbers 
associated to K. lactis on BRENDA that were not found in the new annotation. One of those EC 
numbers (1.4.1.15) was associated to K. lactis because it has an annotation declaring that there 
is “no activity in Kluyveromyces lactis”. Another one of those EC numbers was from a plasmid 59 
and the other two were from vectors inserted in a K. lactis strain to test the viability of the 
organism as a recombinant protein produce60. 
5.4.5 HOMOLOGUES TAXONOMIC DISTRIBUTION 
Translated genomes of different organisms were used as reference when performing the 
homology-based genomic annotation. Thus, an analysis of the phylogenetic distribution of those 
genes was performed. The approach developed for the transport systems annotation does not 
allow this analysis to be performed because the database was small and thus the available 
organisms span was reduced, rendering such analysis too biased. 
As a Fungus, Kluyveromyces lactis is expected to have a genome similar to other fungal 
genomes. Indeed, the homology taxonomic distribution was in accordance to the expected, 
because the well annotated Saccharomyces cerevisiae yeast was favoured by the annotation 
pipeline. Hence, the analysis of the taxonomic dispersion of the final annotation determined that 
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approximately 82% of the genes identified as metabolic were S. cerevisiae homologues. As shown 
in Table 5.4, 1442 K. lactis genes were found to be homologues to a set of 1376 distinct baker’s 
yeast genes. There is clearly a no one-to-one relationship since, for instance, KLLA0C19338g and 
KLLA0D00258g were identified as homologues of the YBR093c S. cerevisiae gene, and 
annotated with the EC number 3.1.3.2. Several other S. cerevisiae genes were used as reference 
for the annotation of two or more K. lactis genes. 
Table 5.4. Percentage of K. lactis genes annotated as S. cerevisiae or other organisms 
homologues. 
unique total % 
K. lactis genes with S. cerevisiae metabolic homologues 1376 1442 81.98%
K. lactis genes with other homologue organisms 39 43 2.44%
TCS families annotation 270 270 15.35%
K. lactis TC annotation 4 4 0.23%
The TCS families’ annotation quantifies the number of genes annotated as transporter protein encoding genes. The 
four TC numbers in the last row of the table were annotated by TCDB, hence not being annotated by homology. The 
number of unique genes represents the number of distinct homologue genes. 
Kluyveromyces lactis, unlike S. cerevisiae, did not undergo whole genome duplication61; 
nevertheless, it is likely that at least part of the 66 genes with repeated metabolic functions in K. 
lactis are a result of other gene duplication events. 
The 4 genes (see Table S5.1 of the supplemental material) reported in the transporter 
classification database (TCDB) were not inferred from another organism, thus not being included 
in the other organism’s annotation. 
An example of homologues of organisms other than S. cerevisiae is the LAC4 gene 
(KLLA0B14883g), which encodes the β-galactosidase protein (see Table S5.7 of the 
supplemental material; Escherichia coli - 3.2.1.21) which affords K. lactis with the ability of 
converting lactose into galactose and glucose, hence being able to use lactose as sole carbon 
source. 
The genes annotated by homology to organisms other than S. cerevisiae constitute less than 3% 
(43 genes) of the K. lactis genome annotated with metabolic functions. Table S5.7 of the 
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supplemental material lists the 25 organisms (other than S. cerevisiae) used for the new 
annotation of those 43 K. lactis genes, as well as the distinct EC numbers encoded on such 
genes. 5 of the 25 aforementioned organisms were of the Bacteria superkingdom. Although K. 
lactis is included in the Eukaryota superkingdom, along with the remaining 20 organisms, 
previous works have demonstrated the relevance of horizontal gene transfer from prokaryotic to 
fungal genomes62,63. 
Table 5.5 contains 29 genes (out of the 43) associated with enzymes not encoded by the S. 
cerevisiae genome (according to UniProt). There were 7 other genes annotated with functions 
inferred from non-Saccharomyces cerevisiae homologue genes but whose corresponding 
enzymes are available in the S. cerevisiae genome. However, the genes that encoded such 
functions in the baker’s yeast did not have any homologue gene in the milk’s yeast genome. The 
remaining 7 non-Saccharomyces cerevisiae homologue genes were assigned with enzymes with 
partial EC numbers (e.g. KLLA0C14993g: 1.13.-.-/O74741/Schizosaccharomyces 
pombe/Eukaryota); thus, it was not possible to assess whether such functions were available on 
the baker’s yeast or not. 
As shown in Table 5.5 the Schizosaccharomyces pombe homologue genes lead the group of 
functions not available in S. cerevisae, with five enzymes. Those enzymes were D-amino-acids 
oxidase (1.4.3.3), pseudouridine kinase (2.7.1.83), membrane dipeptidase (3.4.13.19), 
hydroxyisourate hydrolase (3.5.2.17) and agmatinase (3.5.3.11) which hydrolyses agmatine to 
putrescine and urea. Also, Kluyveromyces marxianus provides the β-glucosidase (3.2.1.21) 
enzyme encoding gene homologue, which releases β-D-glucose from polysaccharides containing 
glucose. Mortierella isabellina genome has a gene that encodes the δ-12 fatty acid desaturase 
(1.14.19.6) that catalyses the desaturation of oleic acid to linoleic acid, and K. lactis has two 
homologues of such gene (KLLA0B00473g and KLLA0F07095g). Escherichia coli strains have 
two K. lactis homologue genes not present in the S. cerevisiae genome: cyclopropane fatty acid 
synthase, (2.1.1.79), and the aforementioned β-galactosidase (3.2.1.23). 
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Table 5.5. K. lactis genes which encode enzymes not available in the baker's yeast genome. 
K. lactis tag Homologue Annotation Species Superkingdom Function 
KLLA0A02475g Q9Y7N4 1.4.3.3 Schizosaccharomyces pombe Eukaryota D-amino-acid oxidase 
KLLA0A08492g Q99042 1.4.3.3 Trigonopsis variabilis Eukaryota D-amino-acid oxidase 
KLLA0A11352g P50167 1.1.1.250 Scheffersomyces stipitis Eukaryota D-arabinitol 2-dehydrogenase 
KLLA0B00473g P59668 1.14.19.6 Mortierella isabellina Eukaryota d-12-fatty-acid desaturase 
KLLA0B04004g Q9USY1 2.7.1.83, 3.2.-.- Schizosaccharomyces pombe Eukaryota pseudouridine kinase, -- 
KLLA0B14883g P06864 3.2.1.23 Escherichia coli (strain K12) Bacteria beta-galactosidase 
KLLA0C00715g P0A9H8 2.1.1.79 Escherichia coli O6 Bacteria cyclopropane-fatty-acyl-phospholipid synthase
KLLA0C09240g Q6SZS6 1.3.5.2 Kluyveromyces marxianus Eukaryota dihydroorotate dehydrogenase 
KLLA0C11803g O74492 3.5.2.17 Schizosaccharomyces pombe Eukaryota hydroxyisourate hydrolase 
KLLA0C19107g Q9P903 3.5.2.2 Saccharomyces kluyveri Eukaryota dihydropyrimidinase 
KLLA0D00330g P07337 3.2.1.21 Kluyveromyces marxianus Eukaryota beta-glucosidase 
KLLA0D00506g O59832 3.4.13.19 Schizosaccharomyces pombe Eukaryota membrane dipeptidase 
KLLA0D03520g Q96W94 3.5.1.6 Saccharomyces kluyveri Eukaryota beta-ureidopropionase 
KLLA0D07568g Q9Y7N4 1.4.3.3 Schizosaccharomyces pombe Eukaryota D-amino-acid oxidase 
KLLA0E02641g Q16739 2.4.1.80 Homo sapiens Eukaryota ceramide glucosyltransferase 
KLLA0E10737g Q54GH4 1.13.99.1 Dictyostelium discoideum Eukaryota inositol oxygenase 
KLLA0E10935g P78609 1.7.3.3 Cyberlindnera jadinii Eukaryota urate hydroxylase 
KLLA0E14631g P07337 3.2.1.21 Kluyveromyces marxianus Eukaryota beta-glucosidase 
KLLA0E14763g A7SMW7 1.1.99.2 Nematostella vectensis Eukaryota 2-hydroxyglutarate dehydrogenase 
KLLA0E15181g Q5R778 1.3.99.3 Pongo abelii Eukaryota acyl-CoA dehydrogenase 
KLLA0E18371g Q12556 1.4.3.22 Aspergillus niger Eukaryota diamine oxidase 
KLLA0E19471g F2QNN3 1.14.19.4 Pichia pastoris Eukaryota d-8-fatty-acid desaturase 
KLLA0E22397g Q75WS0 1.1.1.184, Kluyveromyces aestuarii Eukaryota carbonyl reductase (NADPH), sorbose 
KLLA0E24003g A3GF07 1.1.1.184, Scheffersomyces stipitis Eukaryota carbonyl reductase (NADPH), sorbose 
KLLA0E25081g P07337 3.2.1.21 Kluyveromyces marxianus Eukaryota beta-glucosidase 
KLLA0F03146g P51691 3.1.6.1 Pseudomonas aeruginosa Bacteria arylsulfatase 
KLLA0F04235g Q10088 3.5.3.11 Schizosaccharomyces pombe Eukaryota agmatinase 
KLLA0F07095g P59668 1.14.19.6 Mortierella isabellina Eukaryota d-12-fatty-acid desaturase 
KLLA0F27995g O42887 3.5.3.11 Schizosaccharomyces pombe Eukaryota Agmatinase 
The species name was automatically retrieved; thus, instead of the last taxonomic name, the organism name may be 
a synonym. 
5.4.6 ANNOTATION SCHEME AND MANUAL CURATION RESULTS 
merlin’s automatic scored similarity results were manually curated by the authors, using the 
annotation pipeline described on the methods section. The outcome of such classification is 
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shown in Table S5.8 of the supplemental material. It represents the results obtained using the 
cross classification developed and applied throughout this work. This table shows that most 
annotations were supported by all databases (SGD, UniProt and BRENDA), which means that the 
present annotation is robust and supported by information provided by several data sources. 
Also, almost half (calculation details on Additional file 5.2) of the incorrect merlin automated gene 
annotations were reclassified by BRENDA. Most of the reclassifications dictated by BRENDA 
corresponded to partial EC numbers for which a complete EC number was now available in 
BRENDA. 
BRENDA was also important for other reasons. For example, one of the K. lactis genes that had a 
baker’s yeast homologue was assigned with a completely different function in both genomes. The 
XYL1 (KLLA0E21627g – 1.1.1.307) K. lactis gene64 is homologue to the GRE3 (YHR104W-
1.1.1.306) S. cerevisiae gene. However, on the first case it encodes a NADPH-dependent D-
xylose reductase, but on the second organism it encodes a NADPH-dependent aldose reductase. 
This is a major difference because the baker’s yeast, despite having xylose transporters, cannot 
use xylose as the single carbon source. The XYL1 gene is identified in UniProt [Swiss-Prot: 
P49378] as a “NAD(P)H-dependent D-xylose reductase”; yet, UniProt provides a partial EC 
number (1.1.1-) and KEGG annotates such gene as an hypothetical protein [KEGG: 
kla:KLLA0E21627g]. BRENDA was used to confirm EC number assignments, by describing the 
reactions catalysed by those enzymes, allowing a more precise gene annotation. 
Another carbon source that S. cerevisiae is unable to metabolise is lactose. However, in this 
case, the gene did not have a baker’s yeast homologue (it was an Escherichia coli homologue). 
That gene was well known to be encoded in K. lactis, the previously mentioned LAC4 gene (β-
galactosidase – 3.2.1.23). 
Table S5.9 of the supplemental material lists the seven genes for which literature was considered 
through the annotation process. The curation of those genes was based on previous knowledge 
of the authors regarding specificities of Kluyveromyces lactis metabolism 
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5.4.7 ASSIGNMENT OF ENZYME COMMISSION NUMBERS 
More than 80% of the genes to which a metabolic function was assigned were classified with at 
least one EC number. Indeed, as shown in Table 5.6, 1325 (1107 + 218) genes were assigned 
with only one EC number (monofunctional genes). Nevertheless, three other gene groups were 
identified while classifying the protein encoding genes, originating 4 distinct groups: 
•monofunctional genes 
•multifunctional genes 
•multiclass genes 
•genes with EC and TC(S) numbers 
 
Table 5.6. Enzyme encoding genes classification. 
Oxidoreductases Transferases Hydrolases Lyases Isomerases Ligases Total
complete 
monofunctional 165 397 347 53 44 101 1107
multifunctional 13 28 8 5 1 4 59 
multiclass 4 4 4 3 1 2 18 
with TC(S) number 16 6 23 0 0 1 46 
subtotal 198 435 382 61 46 108 1230
partial 
monofunctional 38 63 110 0 3 4 218 
multifunctional 0 1 2 0 0 1 4 
multiclass 0 4 0 0 0 0 4 
with TC(S) number 0 2 0 0 0 0 2 
subtotal 38 70 112 0 3 5 228
 
Total 236 505 494 61 49 113 1458
Complete EC numbers are assigned when all classes are identified (e.g. 1.1.1.1). Partial EC numbers are assigned 
when at least one class is unknown (e.g. 1.1.-.- or 1.1.1.-). 
The multifunctional genes set includes enzyme encoding genes that were assigned with two or 
more EC numbers of the same class, according to the Enzyme Commission classification (e.g. 
KLLA0F20163g - 2.3.1.23, 2.3.1.51). The multiclass genes encompassed enzyme encoding 
genes assigned with EC numbers classified in more than one class. For the last subgroup, the 
approach was somewhat different. The proteins may not have various functions, but had at least 
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one EC number and one TC(S) number assigned to them. Hence, despite the distinctive 
classification, the function of the protein may well be the same in both classification systems. 
Regardless of the previous sorting, the genes were also divided in two major categories: the ones 
that encoded enzymes with complete EC numbers (e.g. 1.1.1.1) and the ones that encoded 
enzymes with partial (e.g. 1.-.-.-) EC numbers. These two categories were then subdivided in the 
four sets presented above as depicted in Table 5.6. Thus, any gene that encoded at least one 
enzyme with one partial EC number was clustered with the partial entries, even for the ones that 
were simultaneously classified with TC(S) numbers. 
Finally, the gene assignments were also cross-classified according to the EC class of the encoded 
proteins, those being Oxidoreductases, Transferases, Hydrolases, Lyases, Isomerases and 
Ligases. 
The cross-classification of enzyme encoding genes assigned to the multiclass group in the EC 
class followed a simple rule. When classifying a gene product, such gene was assigned to the 
subgroup of whatever enzyme was annotated first, because such function was assumed as the 
main function (e.g. gene KLLA0E15357g is associated with EC numbers 6.3.5.5 and 2.1.3.2; the 
gene was assigned to the Ligases multiclass group instead of the Transferases multiclass group 
because it is assumed that the ligase function is more significant). The final result of all cross-
classifications is presented in Table 5.6. 
As depicted in Table 5.6, most of the identified complete monofunctional genes encode 
Transferases. On the other hand, most of the genes that encode enzymes for which only a partial 
EC number is available are hydrolases. Table 5.6 also indicates that Oxidoreductases, 
Transferases and Hydrolases represent almost 85% of the identified enzyme encoding genes. 
Thus, Lyases, Isomerases and Ligases represent just a small quota of this organism’s genome. 
Most enzyme encoding genes were assigned with just one EC number (1325 genes), which 
means that such genes are monofunctional. Still, 218 genes encoding monofunctional enzymes 
have only partial EC numbers assigned. Thus, either the catalysed reactions are not completely 
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known (and therefore the enzymes may be either mono or multifunctional), or the catalysed 
reaction is well known but the EC number has not been assigned yet. 
The multifunctional genes encode proteins that catalyse similar reactions, though using 
substrates with small differences, such as the case of KLLA0F20163g – (2.3.1.23, 2.3.1.51), in 
which: 
i) 2.3.1.23: 
ܽܿݕ݈ − ܥ݋ܣ + 1 − ܽܿݕ݈ − ݏ݊ − ݈݃ݕܿ݁ݎ݋ − 3 − ݌ℎ݋ݏ݌ℎ݋ܿℎ݋݈݅݊݁
= ܥ݋ܣ + 	1,2 − ݀݅ܽܿݕ݈ − ݏ݊ − ݈݃ݕܿ݁ݎ݋ − 3 − ݌ℎ݋ݏ݌ℎ݋ܿℎ݋݈݅݊݁ 
ii) 2.3.1.51 
ܽܿݕ݈ − ܥ݋ܣ + 1 − ܽܿݕ݈ − ݏ݊ − ݈݃ݕܿ݁ݎ݋ − 3 − ݌ℎ݋ݏ݌ℎܽݐ݁
= ܥ݋ܣ + 	1,2 − ݀݅ܽܿݕ݈ − ݏ݊ − ݈݃ݕܿ݁ݎ݋ − 3 − ݌ℎ݋ݏ݌ℎܽݐ݁ 
These enzymes are O-acyltransferases that mediate the incorporation of unsaturated acyl chains 
into the sn-2 position of phospholipids. 
There were also 22 genes in the K. lactis genome that encoded multiclass enzymes due to their 
diversified catalytic activity. For example, as previously mentioned, the gene KLLA0E15357g - 
6.3.5.5, 2.1.3.2 encoded the homologue of the S. cerevisiae URA2 gene. Such protein catalyses 
the first two enzymatic steps in the de novo biosynthesis of pyrimidines: first L-glutamine is 
hydrolysed by the carbamoyl-phosphate synthase (6.3.5.5). Next, the aspartate 
carbamoyltransferase (2.1.3.2) uses the carbamoyl phosphate formed in the previous reaction 
and interacts with L-aspartate generating N-carbamoyl-L-aspartate with the release of one 
phosphate molecule. Hence, the gene was classified in the Ligases sub-group. 
5.4.8 ASSIGNMENT OF TRANSPORTER CLASSIFICATION NUMBERS 
Throughout this work, some enzymes encoded in the milk yeast genome were identified and 
classified with both EC and TC(S) numbers. In some cases, the protein was assigned with the 
same function by both classification systems. An example of such annotations were the functions 
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assigned to the gene KLLA0F20658g, which encodes the Sodium transport ATPase ENA1 (S. 
cerevisiae homologue). The protein was annotated by the enzyme commission with the EC 
number 3.6.3.7 (Na + exporting ATPase) and in the transporter classification database as 
belonging to the 3.A.3 P-type ATPase (P-ATPase) Superfamily 3.A.3.#.#, which includes proteins 
that promote cations, such as sodium, exchange or efflux. The transported metabolites analysis 
(to be published together with the transports classification methodology in Genome-wide semi-
automated annotation of transporter systems, Dias et al., 2012), provided by merlin, confirms 
that such gene facilitates the efflux of sodium ions, among the transport of other cations. 
In this work, 301 genes were assigned with, at least, one TC(S) number and no EC number, 
which means that such genes are exclusively associated to transport mechanisms. As depicted in 
Figure 5.5, more than 65% of the transporter proteins (without EC numbers) identified in this 
work were electrochemical potential-driven transporters. The electrochemical potential-driven 
transporters class encompasses several protein families, such as sugar and monocarboxylate 
porters, drugs and UDP-Galactose:UMP antiporters, amino acids and chloride transporters, zinc 
and iron permeases or cation and phosphate symporters, among many others50. According to 
Table S5.10 of the supplemental material, although all 199 K. lactis genes classified as 
electrochemical potential-driven transporters belong to the 2.A Porters (uniporters, symporters, 
antiporters) sub-class, such genes are classified in 63 distinct families. Nevertheless, most of the 
Porters identified within the K. lactis genome (75 genes) were carriers of the 2.A.1 – Major 
Facilitator Superfamily (MFS). According to Law et al. 65 (2008) the MFS encompasses proteins 
that transport several substrates through an energy independent carrier mediated process, 
binding the transporter to the solute and undergoing a series of conformational changes. Such 
superfamily includes the secondary active membrane transporters, which sort the transporters 
through the kinetic mechanism, used to carry the substrate, in three categories: uniporters, 
symporters and antiporters55,65. 
The classification of two thirds of the transport systems available in K. lactis in the Porters sub-
class suggests that this microorganism may be able to control the uptake and efflux of the 
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nutrients, providing the organism with the ability to be selective about the carbon source it will 
use. 
Table S5.10 of the supplemental material also demonstrates that at least 21 broad sugar porters 
encoding genes were identified, as well as several alcohols, organic acids and nitrogen sources 
and amino acid transport systems. It is accepted that non-ionized organic acids can penetrate 
cell walls by passive diffusion66. Thus, evidences of organic acids transport systems may be 
related to the transport of ionized organic acids and with the need for controlling the uptake or 
excretion of those compounds. 
 
Figure 5.5. TC(S) numbers distribution. 
 
Furthermore, Kluyveromyces lactis can use several alcohols as carbon sources, as demonstrated 
in67–72. Some of those alcohols are known as sugar alcohols (polyols) and are transported by the 
sugar porter family transport systems 2.A.1.1.# encoded in genes KLLA0E06755g and 
KLLA0E01783g. Three glycerol transport systems were also identified during the course of this 
work (KLLA0A03223g - 2.A.1.1.#, KLLA0F26246g - 2.A.1.1.#, KLLA0E19185g - 2.A.50.1.#, 
KLLA0E00617g - 1.A.8.5.#). 
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Table 5.7 demonstrates that the new annotation identified several new enzymes in global 
pathways. Global pathways are universal, and include enzymes from several pathways, which 
may or may not be available in K. lactis. Thus, Table S5.11 of the supplemental material depicts 
the pathways in which new enzymes have been identified in the new annotation, as well as the 
number of unidentified enzymes, and the enzymes identified by both the new annotation and 
KEGG. 
Table 5.7. Number of enzymes in each Global pathway. 
Global pathways 
Identified 
by KEGG 
Identified in 
new annotation
Unidentified 
in K. lactis 
Total 
01100 Metabolic pathways 383 51 869 1303
01110 Biosynthesis of secondary metabolites 167 12 349 528
01120 Microbial metabolism in diverse 93 8 351 452
 
The new annotation provides new insights on the K. lactis metabolic capabilities, as it brings new 
information to the KEGG pathways, identifying several new enzymes in 56 KEGG metabolic 
pathways. Indeed, only 45 of such pathways are recognised by KEGG as K. lactis pathways. 
Thus, the other 11 pathways should be further studied to assess if the milk yeasts uses such 
paths to metabolise compounds, offering investigators new research opportunities. 
Nevertheless, the new annotation also identified new enzymes that are not allocated to any 
pathway and proteins associated only with TC numbers. 
5.4.10 ANALYSIS OF THE ANNOTATION OF THE KLUYVEROMYCES 
LACTIS CENTRAL CARBON METABOLISM 
The central carbon metabolism is a collection of pathways mainly composed by three ‘vias’, 
namely the Embden-Meyerhof-Parnas (EMP) Pathway, the Pentose Phosphate Pathway and the 
TCA Cycle. The new annotation presented in this work was able to identify the genes involved in 
such pathways. 
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The EMP pathway converts glucose to pyruvate, generating small amounts of ATP and NADH in 
the process. The uptake of glucose is done by hexose transporters such as RAG1 – 
KLLA0D13310g, HGT1 – KLLA0A11110g, KHT1 or KHT2. In some strains RAG1 is the unique 
low-affinity glucose transporter, whereas in other strains such function is divided by two genes 
(KHT1, KHT2). The strain studied throughout this work, Kluyveromyces lactis NRRL Y-1140 (CBS 
2359), encoded the RAG1 gene. 
The EMP pathway has only one hexokinase, RAG5 (KLLA0D11352g) which was identified in the 
new annotation. Breunig and Steensma73 (2003) confirm that it is the only hexokinase encoding 
gene, unlike in the case of S. cerevisiae, which has three hexokinases. RAG5 is an essential gene 
because its absence inhibits growth on glucose, fructose and higher sugars that produce these 
isomers. Glucose-6-phosphate isomerase RAG2 (KLLA0E23519g) was also identified in the new 
annotation, and, although K. lactis has only one phosphoglucose isomerase, RAG2 mutants grow 
well in glucose. Hence, RAG2 is not an essential gene. 
The oxidative phase of the pentose phosphate pathway generates 2 NADPH molecules from the 
conversion of glucose-6-phosphate into ribulose 5-phosphate which is then delivered to the non-
oxidative phase (Figure 5.6). If either the 6 – phosphofructokinase protein complex encoding 
genes or the triosephosphate isomerase encoding gene TPI1 (KLLA0F18832g) are deleted, the 
transaldolase TAL1 (KLLA0A02607g), together with the transketolase TKL1 (KLLA0B09152g) 
can convert ribulose 5 – phosphate into fructose 6 – phosphate and D-glyceraldehyde 3-
phosphate, thus surpassing the phosphofructokinase complex deletion, as depicted in Figure 5.6. 
Several ATP and NADH molecules are formed in the second half of glycolysis, which is known as 
the pay-off phase. There are NADPH dehydrogenases not present in the baker’s yeast reported to 
exist in the milk yeast genome. Such enzymes are NDE1 (KLLA0E21891g) and NDE2 
(KLLA0A08316g), and were indeed annotated in the present work. Both genes re-oxidise NADH 
as well as NADPH. NDE1’s ability to bind NADPH was verified experimentally74. However, NDE2 
was reported to have a less important role in NADPH re-oxidation75 NDI1 (KLLA0C06336g) also 
encodes a mitochondrial internal NADH oxidoreductase, though such enzyme does not oxidise 
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regulation of the glucose uptake is not enough to explain the Crabtree negative phenotypes. Only 
when the pyruvate dehydrogenase (Pdh) complex is down regulated, or blocked, the pyruvate 
decarboxylase (Pdc) can convert pyruvate to ethanol and acetaldehyde1. The first step of the 
alcoholic fermentation, which only occurs at low oxygen concentrations, is promoted by the 
pyruvate decarboxylase PDC1 (identified in gene KLLA0E16303g). Therefore, a null mutation on 
the PDA1 (KLLA0F12001g), a gene which encodes the α subunit of the E1 component (the β 
subunit was identified in the new annotation, gene PDB1_KLULA – KLLA0F09603g, not 
identified in UniProt) of the Pdh complex, can constrain growth on glucose, as PDA1 mutants 
show high ethanol formation77. Such phenotype suggests that high Pdh activity is the reason for 
the Crabtree negative phenotype exhibited by the wild type strain. 
The lactose metabolism in Kluyveromyces lactis has been well studied, because it is a distinct 
characteristic within yeasts. The lactose uptake is performed by the specific permease LAC12 
(KLLA0B14861g) and the hydrolysis by the β–galactosidade LAC4 (KLLA0B14883g) into glucose 
and galactose. The lactose metabolism is induced by both lactose and galactose. Galactose is 
converted into galactose–1–phosphate by galactokinase GAL1 (KLLA0F08393g). Then, the GAL7 
(KLLA0F08437g) gene that encodes the enzyme UDP-glucose-hexose-1-phosphate 
uridylyltransferase takes UDP–glucose and α–D–galactose–1–phosphate to synthesize α–D-
glucose–1–phosphate and UDP–galactose. The UDP–galactose formed by this reaction will be 
again converted to UDP–glucose by the GAL10 bifunctional gene. This gene encodes two 
enzymes, the aforementioned UDP–glucose–4–epimerase and the aldose–1–epimerase, that 
converts α–D–glucose into β–D–glucose. All of the genes described earlier were annotated 
throughout this work. 
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5.4.11 ASSESSING THE AGREEMENT OF THE NEW ANNOTATION TO A 
PREVIOUS COMPARISON OF THE KLUYVEROMYCES LACTIS 
GENOME TO THE ONE OF SACCHAROMYCES CEREVISIAE 
In 1998 Ozier-Kalogeropoulos et al.78 studied the Kluyveromyces lactis unsequenced genome, 
and identified 296 K. lactis genes with homology to the baker’s yeast. The exploration of the 
genome was random, thus several types of genes were identified. 
All S. cerevisiae genes identified in that study were reviewed in UniProt (SGD does not provide an 
application programming interface to expedite the results retrieval) to identify genes with 
metabolic (enzymatic or transport) functions. As depicted in Table S5.12 of the supplemental 
material, 113 of those S. cerevisiae genes had metabolic functions. The 113 metabolic genes 
identified in that study, and the corresponding milk yeast homologues, were predicted by the new 
annotation, except for four baker’s yeast transport systems which were not identified because the 
corresponding K. lactis homologues did not have any transmembrane domain. 
Again, that work was in agreement with the results obtained with the approach undertaken 
throughout this study. 
In conclusion, these examples illustrate that the new annotation not only confirms pre-sequencing 
knowledge but also, adds new gene annotations to the information currently available in 
databases such as KEGG or UniProt. 
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5.5 CONCLUSIONS 
Since the genome sequence of K. lactis was published in 2004, the proteins encoded in the 
Kluyveromyces lactis genome had never been thoroughly reviewed and annotated; or at least this 
information was not published, to our knowledge. 
In this work, 2000 genes with potential to be assigned with metabolic functions within the 
proteins encoded in the Kluyveromyces lactis genome were studied. Most of those, specifically 
87.95% (1759 genes), were indeed classified as metabolic genes. The metabolic genes could be 
exclusively enzymatic (1410 genes), transporter proteins (301 genes) or have both metabolic 
activities (48 genes). The new annotation proposed in this work could only be accomplished as 
merlin provided semi-automatic scored results. Such results were then reviewed in other 
databases such as UniProt or BRENDA to maximize the confidence in the results. The new 
annotation includes novelties, such as the assignment of transporter superfamily numbers to 
genes identified as transporter proteins. Moreover, it was demonstrated that Oxidoreductases, 
Transferases and Hydrolases represent almost 85% of the identified enzymes. When the new 
annotation is compared to the annotations currently available in some databases, it is shown to 
be broader and reliable, as it encompasses most of the metabolic information in such databases. 
Furthermore, the new annotation of the K. lactis metabolic genome confirmed the predictions of 
pre-genome sequencing studies. One of those studies compared random sequences of the K. 
lactis genome to the S. cerevisiae sequenced genome. All metabolic genes in that study were 
identified in the new annotation. 
Also, the central carbon pathways were revised in this work to assess the robustness of the new 
annotation. The new annotation was in agreement with several publications that study 
Kluyveromyces lactis’ phenotypical behaviour. 
The new annotation provided by this study yields basic knowledge which might be useful for the 
scientific community working on this model yeast, as new functions have been identified for the 
so-called metabolic genes. 
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The methodology used throughout this work can be used by other groups to annotate other 
organisms and build a robust genome-scale model. 
Furthermore, the new annotation served as the basis for the reconstruction of a 
compartmentalized, genome-scale metabolic model of Kluyveromyces lactis, which is currently 
being finished. 
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6.1 ABSTRACT 
A genome-scale metabolic model of Kluyveromyces lactis was 
reconstructed from its genome annotation. The result was the partially 
compartmentalised (4 compartments) iOD962 metabolic model 
composed of 2038 reactions and 1561 metabolites.  
Although the number of genes in this model is similar to the number of 
genes from the available S. cerevisiae models, namely the widely used 
iMM904 (904 genes), it should be kept in mind that the baker’s yeast 
experienced whole genome duplication and many reactions in such model 
are probably connected to paralogous genes.  
Previous chemostat experiments were used to adjust both growth and 
non-growth associated energy requirements, and the model proved 
accurate when predicting the biomass, oxygen and carbon dioxide yields. 
Also, the in silico knockouts predicted accurately the in vivo phenotypes, 
when compared to published experiments. This model allowed 
determining a minimal medium for cultivating K. lactis and will surely 
bring new insights on the milk yeast metabolism, identifying engineering 
targets for the improvement of the yields of products of interest by 
performing in silico simulations. 
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6.2 INTRODUCTION 
Genome-scale metabolic models are now an established tool utilised in a wide range of 
biotechnological applications, such as metabolic engineering of microbes or drug targeting1–6. 
Although a large majority of the available models are of prokaryotes, the number of models for 
eukaryotic organisms has been increasing rapidly, as half of the models available for these 
organisms were reconstructed since 2010a. 
A genome-scale metabolic network can be defined as the set of biological reactions retrieved 
from the enzymes encoded in a genome. Although these networks allow determining some 
physiological and biochemical properties of the cells, only genome-scale metabolic models can 
be used for predicting the capabilities of the metabolic system. The information contained in 
these models includes, apart from the network data, details on reaction limits, the biomass 
composition and energetic requirements. The reconstruction of these models is supported on the 
well-known stoichiometry of biochemical reactions and can be used to predict, in silico, the 
phenotypic behaviour of microorganisms under different environmental and genetic conditions7. 
The same process may, in theory, be applied for reconstructing Eukaryotic and Prokaryotic 
metabolic models8. Nevertheless, Eukaryotic models are more demanding due to their larger 
knowledge base and genomes, as well as the various compartments within the cells. Although 
some steps have been taken to standardize this methodology, for instance the publication of a 
protocol for reconstructing genome-scale models by Thiele and Palsson8 or the development of a 
standard that determines the minimum information requested for the annotation of biochemical 
models9, the reconstruction of the metabolic network of an organism is yet a complex procedure. 
The genome-scale metabolic models reconstruction process is described in several previous 
works7,8,10, and it consists of four main steps: genome annotation, assembling of the genome-
scale metabolic network, conversion of the network to a genome-scale metabolic model and 
finally the validation of the model. The genome annotation is the assignment of metabolic 
functions, by identifying enzymes and transporters, to the genes within the genome. A fully 
                                                            
a www.optflux.org/models 
CHAPTER 6 177 
 
annotated genome allows assembling a metabolic network, where two reactions are connected if 
a metabolite is the substrate of one reaction and the product of another. The addition of a 
biomass equation, constraints around the external exchange flux values and an equation 
representing the depletion of adenosine triphosphate (ATP) used for the cellular maintenance 
processes, allows converting the metabolic network in a stoichiometric metabolic model. Finally, 
the consistency of this model can be checked by computing yields under specific conditions and 
comparing those to published characterization studies. These simulations are usually performed 
using the flux balance analysis (FBA) formulation. FBA is a mathematical method, which applies 
linear programming, for the analysis of the flow of metabolites through a metabolic model, 
maximizing or minimizing a previously specified objective function11,12. A premise usually 
assumed when performing FBA is that cells are under selective pressure and biomass precursor 
fluxes should be favoured7. 
One of the major issues when building a genome-scale metabolic model is associated to the lack 
of universal identifiers for the metabolites. Unlike enzymes, which have Enzyme Commission (EC) 
numbers13, and carrier proteins that are identified by Transporter Classification (TC) numbers14, 
metabolites do not have an international classification standard widely accepted by the scientific 
community. The classifications that most resemble standards for metabolites are provided by the 
KEGG Compound database15,16 and MetaCyc17. Yet, only KEGG provides an application 
programming interface that allows retrieving this information automatically. 
Tools like merlin 2.018,19, model SEED20, and others were developed specifically for model 
reconstruction and are becoming increasingly available. These tools are usually developed for 
assisting in the automation of some steps of the reconstruction of the model, though manual 
curation is always required. merlin 2.0 is the second generation of our tool, developed for the 
reconstruction of genome-scale metabolic models. This user-friendly application allows 
performing several steps of the reconstruction process semi-automatically19 and exporting the 
model in the Systems Biology markup language (SBML)21 format. 
The availability of complete genome sequences for numerous microorganisms has promoted the 
development of several genome-scale metabolic models22. The yeast Kluyveromyces lactis, for 
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which the complete genome sequence is available since 200423, is attracting increasing attention 
from molecular biologists and process engineers, and has even become a model organism in 
biological research. Several aspects have contributed to this development24–26, namely its ability 
to grow on lactose as a sole carbon source, its various industrial applications especially in the 
dairy industry and as a host for the production of recombinant proteins27, the availability of 
various molecular tools that make it amenable to genetic manipulation almost like 
Saccharomyces cerevisiae, its evolutionary distance to S. cerevisiae which allows performing 
comparative studies between these two species and the differences on the regulation of carbon 
and energy metabolism that contrasts with the well-studied physiology of S. cerevisiae and 
reflects its adaption to aerobic conditions. 
Like S. cerevisiae, K. lactis is an ascomycetous budding yeast that belongs to the 
endoascomycetales. However, whereas the latter is an aerobic-respiring or Crabtree-negative 
yeast, the former is an aerobic-fermenting or Crabtree-positive yeast28. The first genome-scale 
metabolic model for an yeast was for S. cerevisiae29. The budding yeast has now 6 
reconstructions29–34 and several other yeasts have also reconstructions, namely several Pichia 
strains35–37, Schizosaccharomyces pombe38 among various other Fungi. However, although being 
considered, along with S. cerevisiae, one of the prototypes for modelling two distinct types of 
yeast, K. lactis did not have a model thus far39. Therefore, the metabolic model of K. lactis is 
likely to allow comparisons that will bring relevant information on the origins of the differences 
between these industrially relevant yeasts. Moreover, Kluyveromyces lactis, can grow on a 
broader diversity of substrates and is less sensitive to glucose repression than S. cerevisiae40. Its 
distinctive petite-negative nature allows using K. lactis for studying the mitochondrial function41. 
Moreover, K. lactis is a GRAS (generally regarded as safe) organism, presenting an impressive 
secretory capacity, which is already used for the large-scale production of heterologous 
proteins27, thus being a good alternative to S. cerevisiae42,43. Also, it does not require methanol 
for inducing protein secretion or expensive explosion proof equipment, like methylotrophic yeasts 
such as Pichia pastoris44. 
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Here, we present the first genome-scale in silico metabolic reconstruction of K. lactis, the 
iOD962. This model accounts for compartmentation of reactions and transport of metabolites 
across cellular membranes and allowed determining a minimal medium for cultivating K. lactis 
and will surely allow to elucidate interesting features of the milk yeast as well as to identify 
engineering targets for enhancing the strain. The model is available, in the SBML format, in the 
supplemental material.  
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latter was selected for this step because it provides this information automatically, thus all 
metabolic information available in KEGG was retrieved to assemble the metabolic model. 
The genome metabolic annotation of a given organism can be used to build an initial draft 
network. In our case, the genome annotation was previously performed within our group46. 
Nevertheless, merlin 2.0 was used to update this annotation, by creating a new project and 
automatically re-annotating the genome using the default parameters, except the alpha value that 
was set to 0.2. This step was performed for assuring an up-to-date annotation, because 
annotations are not static and everyday new gene functions are discovered and registered in 
databases. Also, the transport proteins annotation was revised using a transporters annotation 
tool that has been developed after the re-annotation47. 
Using the updated annotation, the reactions promoted by each complete EC number were used 
to assemble the draft network. At this stage, one of the major concerns is to identify which 
reactions should be included in the model when an EC number is associated with more than one 
reaction. A conservative approach would include all reactions, but that would also originate a 
metabolic model with many gaps and dead ends. In order to overcome that, while having a 
reliable model, we used the concept of KEGG pathways. KEGG pathways are functional sets of 
reactions, enzymes, metabolites which are connected by metabolites. A fact that a reaction is 
part of a pathway does not necessarily mean that all EC numbers associated with that reaction 
are also part of the pathway. Assuming that the most relevant reactions are the ones linked to the 
EC numbers present in the associated pathway, in our approach, when an EC number was linked 
to several reactions, only those reactions present in the KEGG pathways that also included the 
mentioned EC number were included in the model, except in the case where the EC number only 
promoted a single reaction, in which case the reaction was directly included in the model. In the 
same way, all reactions classified as spontaneous or non-enzymatic were also included in the 
model. 
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6.3.2 REACTIONS REVERSIBILITY 
However, this network is still inadequate, as all KEGG reactions are set to be reversible. Thus, 
data provided in a study by Stelzer et al.48 was used to perform an automatic initial correction of 
the reactions reversibility. These authors firstly retrieved the information shown in the KEGG 
PATHWAY maps and confirmed it in BRENDA whenever possible. Still, the criteria for the 
determination of irreversible reactions described by Ma and Zeng49 was generally adopted by 
Stelzer and co-workers when elaborating their database. Each KEGG reaction identified as 
irreversible in that study was automatically set to irreversible in the model. 
6.3.3 CORRECT DELETED/TRANSFERRED EC NUMBERS 
Although the annotation was upgraded, there are no guaranties that the EC numbers available in 
the different databases are updated, even though the function assigned to each gene might be 
correct. Some EC numbers found during annotation matched KEGG records labelled as 
Transferred or Deleted. In these cases, a manual inspection was performed to try to assign all 
metabolic genes with roles in the model. 
6.3.4 TRANSPORT REACTIONS 
The draft model contained all enzymatic reactions potentially encoded in the K. lactis genome, as 
well as spontaneous and non-enzymatic reactions. Yet, this network did not include transport 
reactions. Therefore, transport reactions were generated using genomic information together with 
public databases. In brief, the procedure consists in finding genes with transmembrane domains 
using the TransMembrane prediction using Hidden Markov Models (TMHMM) tool50 on K. lactis’ 
genome. Then, the amino acid sequences for proteins predicted to have at least one 
transmembrane helix were compared, using the Smith-Waterman51 algorithm, to all sequences 
kept in the Transporters Classification Database14 (TCDB). The metabolites associated to TCDB 
records with similarities to a given K. lactis gene were associated to that gene, according to the 
following procedure: every metabolite linked to a K. lactis gene was assigned with a score, which 
took into account the frequency of such metabolite among the homologues, as well as the 
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taxonomy of the TCDB records that are associated to that metabolite and have similarities to the 
mentioned gene. The computed score, which ranged between 0 and 1, represented the likelihood 
of a particular metabolite being transported by a carrier encoded in that K. lactis gene. Hence, 
transport reactions for all metabolites with classifications above a given threshold were 
generated. The manner in which each metabolite was transported through the membrane (e.g. 
uniport, symport, antiport) was selected using the same process used for the metabolites sorting. 
For more information in this methodology please refer to “Genome-wide Semi-automated 
Annotation of Transporter Systems”47. Nevertheless, only transport reactions with metabolites 
already available in biochemical reactions were included in the model to prevent introducing gaps 
in the network. 
6.3.5 COMPARTMENTATION 
Subsequently, the model was compartmentalized. This model accounts for 4 compartments (i.e. 
extracellular milieu, cytoplasm, mitochondria and endoplasmic reticulum). The two internal 
compartments included are of utmost importance in eukaryotes since the mitochondrion has a 
major role in Eukaryotic ATP synthesis, while, among several other functions, the endoplasmic 
reticulum is responsible for promoting lipids, glycogen, and proteins biosynthesis. The prediction 
of the assignment of enzymes and carriers to compartments was performed using the WoLF 
PSORT52 tool. Other compartments were predicted to be assigned to proteins encoded in the K. 
lactis genome, namely: the nucleus, the Golgi apparatus and the peroxisome. However, the 
reactions promoted by proteins assigned to these compartments were unconnected from the 
network. Therefore such enzymes were reassigned to the cytoplasm. Moreover, reactions 
promoted by enzymes predicted to be located in the plasma membrane were assigned to both 
the cytoplasm and the extracellular milieu, so that both possibilities would be anticipated. On the 
other hand, proteins identified as carriers by the transporters annotation tool, though predicted to 
be localized in internal compartments (i.e. endoplasmic reticulum or the mitochondrion) were 
assigned with transport reactions between the cytoplasm and the organelle milieu. Transport 
reactions for carriers predicted to be localised in the cytoplasm and the extracellular environment 
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were discarded and assigned with transport reactions between the cytoplasm and the 
extracellular milieu, respectively. 
6.3.6 BIOMASS FORMATION AND MAINTENANCE ATP 
Besides the reactions from KEGG, this model includes reactions representing specific bioentities 
present inside the cell and reactions representing the biomass formation and the maintenance 
ATP requirements. The bioentities reactions represented the average fatty acid composition and 
the average protein composition in the biomass. The biomass formation was represented by an 
equation that included all components considered to be required for growth and their 
stoichiometries. The lack of specific studies for determining the composition of K. lactis was 
overcome by assuming that this yeast composition was similar to the composition of S. 
cerevisiae. Hence, the biomass equation from the iMM904 S. cerevisiae model was used in 
iOD962, except for the 1,3-beta-D-Glucan, mannan, proteins, ribonucleotide and 
deoxyribonucleotides contents. The 1,3-beta-D-Glucan and mannan contents were inferred from a 
study of the K. lactis cell wall53. The proteins, ribonucleotide and deoxyribonucleotides contents 
were compiled using the iMM904 S. cerevisiae model34 as reference and inferred from the K. 
lactis genome. Table 6.1 shows the contribution of each component to the biomass formation 
equation, including the ATP requirements for growth, which were also adopted from the same 
model. 
The growth ATP requirements (also adopted from the iMM904 S. cerevisiae model), shown in 
Equation 1, were introduced in the biomass equation, so that these energy requirements can be 
taken into account when performing simulations: 
59.276	ATP + 	59.276 HଶO → 	59.276	 ADP + 59.276 P୧ (1) 
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Table 6.1. Biomass components other than the proteins, deoxyribonucleotide and 
ribonucleotide contents. 
Metabolite Formula KEGG ID iMM904* iOD962* 
1,3-beta-D-Glucan (C6H10O5)n C00965 1.134800 1.374396 
1-Phosphatidyl-D-myo-inositol C11H17O13PR2 C01194 0.000053 0.000053 
3',5'-Cyclic AMP C10H12N5O6P C00575 0.000001 0.000001 
alpha,alpha-Trehalose C12H22O11 C01083 0.023400 0.023400 
Amylose (C6H10O5)n C00718 0.518500 0.518500 
Chitin (C8H13NO5)n C00461 0.000001 0.000001 
CoA C21H36N7O16P3S C00010 0.000001 0.000001 
Ergosterol C28H44O C01694 0.000700 0.000700 
FAD C27H33N9O15P2 C00016 0.000001 0.000001 
Glutathione C10H17N3O6S C00051 0.000001 0.000001 
Heme C34H32FeN4O4 C00032 0.000001 0.000001 
Mannan C00464 0.807900 0.570048 
NAD+ C21H28N7O14P2 C00003 0.000001 0.000001 
Orthophosphate H3PO4 C00009 0.029000 0.029000 
Phosphatidate C5H7O8PR2 C00416 0.000006 0.000006 
Phosphatidylcholine C10H18NO8PR2 C00157 0.000006 0.000006 
Phosphatidylethanolamine C7H12NO8PR2 C00350 0.000045 0.000045 
Phosphatidylserine C8H12NO10PR2 C02737 0.000017 0.000017 
Protein_Entity C2H4NO2R(C2H2NOR)n C00017 - 1 
Riboflavin C17H20N4O6 C00255 0.00099 0.000990 
Sulfate H2SO4 C00059 0.020000 0.020000 
Tetrahydrofolate C19H23N7O6 C00101 0.000001 0.000001 
Thiamin triphosphate C12H20N4O10P3S C03028 0.000001 0.000001 
Triacylglycerol C6H5O6R3 C00422 0.000066 0.000066 
Zymosterol C27H44O C05437 0.001500 0.001500 
* mol of biomass component . gram biomass-1 
The inclusion of the biomass equation and the maintenance ATP requirements allowed 
converting the genome-scale metabolic network into a working draft of the genome-scale 
metabolic model. 
The conception of the bioentities and other biomass components equations is concisely 
described next. 
6.3.6.1 FATTY ACID ENTITY 
The fatty acid entity represents the average composition of the fatty acids in the cell. Again, the 
estimations used in the iMM904 model for S. cerevisiae for the weight of each fatty acid were 
used. The final composition of the fatty acids is show in Table 6.2. This bioentity allowed creating 
lipids for the biomass equation, because the average fatty acid entity is used for producing Acyl-
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CoA (reaction R00390) and Acyl-CoA is a precursor of all lipids present in the biomass equation. 
For instance, it is directly used to generate phosphatidate (reaction R02241) and triacylglycerol 
(reaction R02251). 
Table 6.2. Average fatty acid composition. 
Metabolite Chemical Formula KEGG ID Molar* 
Fatty acid CHO2R C00162 1 
Dodecanoic acid C12H24O2 C02679 0.06 
Octadecanoic acid C18H36O2 C01530 0.05 
Hexadecanoic acid C16H32O2 C00249 0.27 
(9Z)-Hexadecenoic acid C16H30O2 C08362 0.17 
(9Z)-Octadecenoic acid C18H34O2 C00712 0.24 
Tetradecanoic acid C14H28O2 C06424 0.10 
Linoleate C18H32O2 C01595 0.09 
Decanoic acid C10H20O2 C01571 0.02 
* mol of specific fatty acid.mol average fatty acid-1 
6.3.6.2 PROTEIN ENTITY 
Likewise, the protein entity represents the average composition of the proteins in the cell and an 
essential component of the biomass composition. Although the total protein contents, retrieved 
from the iMM904, have been used to calculate the weight of the proteins in the cell, the amount 
of each amino acid in the total protein contents was estimated by calculating the percentage of 
each codon usage, from the translated genome sequence. The methodology for estimating the 
amino acid contents from the genome is detailed in a protocol by Thiele and Palsson8. The 
average protein composition is available in Table 6.3. 
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Table 6.3. Average protein composition. 
Amino Acid Chemical Formula KEGG ID iMM904* iOD962* 
Glycine C2H5NO2 C00037 7.88 5.11 
L-Alanine C3H7NO2 C00041 12.45 5.61 
L-Arginine C6H14N4O2 C00062 4.36 4.33 
L-Asparagine C4H8N2O3 C00152 2.76 5.51 
L-Aspartate C4H7NO4 C00049 8.07 6.11 
L-Cysteine C3H7NO2S C00097 0.18 1.24 
L-Glutamate C5H9NO4 C00025 8.19 6.75 
L-Glutamine C5H10N2O3 C00064 2.86 4.17 
L-Histidine C6H9N3O2 C00135 1.80 2.19 
L-Isoleucine C6H13NO2 C00407 5.23 6.35 
L-Leucine C6H13NO2 C00123 8.04 9.72 
L-Lysine C6H14N2O2 C00047 7.77 7.01 
L-Methionine C5H11NO2S C00073 1.38 2.08 
L-Phenylalanine C9H11NO2 C00079 3.63 4.39 
L-Proline C5H9NO2 C00148 4.47 4.31 
L-Serine C3H7NO3 C00065 5.03 8.84 
L-Threonine C4H9NO3 C00188 5.19 5.84 
L-Tryptophan C11H12N2O2 C00078 0.77 1.09 
L-Tyrosine C9H11NO3 C00082 2.77 3.35 
L-Valine C5H11NO2 C00183 7.18 6.01 
* mol amino acid.gram biomass-1. Values used in the iMM904 model are also shown for reference. 
The estimation of the amino acid contents allows focusing the model predictions on the 
Kluyveromyces lactis genomic requirements. 
6.3.6.3 ESTIMATION OF THE NUCLEOTIDE CONTENTS 
The estimation of the nucleoside monophosphates (NMP) i.e. nucleotides, and deoxynucleoside 
monophosphates (dNMPs) i.e. deoxynucleotides, contents in the biomass can also be inferred 
from the genome, and were determined as well using the methodology described in the protocol 
from Thiele and Palsson8. The estimation of each dNMP (i.e., dAMP, dCMP, dGMP and dTMP), 
shown in Table 6.4, was performed by calculating the frequency of each nucleobase in the whole 
genome (including mitochondrial DNA). The same percentage of DNA cellular contents utilised in 
the iMM904 biomass equation, that is 0.04 grams dNMP . gram biomass-1, was used for the 
calculations. 
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Table 6.4. Deoxynucleoside monophosphates contents in the biomass. 
dNMP Chemical Formula KEGG ID iMM904* iOD962* 
dAMP C10H14N5O6P C00360 0.0036 0.0038 
dCMP C9H14N3O7P C00239 0.0024 0.0024
dGMP C10H14N5O7P C00362 0.0024 0.0024
dTMP C10H15N2O8P C00364 0.0036 0.0038
* mol deoxynucleoside.gram biomass-1. Values used in the iMM904 model are also shown for reference. 
The determination of the nucleotides (namely, AMP, CMP, GMP and UMP), shown in Table 6.5, 
was also calculated according to the previously referred protocol with a major difference. Cells 
contain different types of RNA, which is not taken into account by Thiele and Palsson, which use 
only mRNA to perform these calculations. However, rRNA accounts for the majority of the RNA 
content in any cell, thus in this work three types of RNA were used, namely rRNA, tRNA, and 
mRNA, with the following percentages 80%, 15%, 5%, respectively54,55. The same percentage of 
overall RNA cellular contents utilised in the iMM904 biomass equation, that is 0.063 grams NMP 
. gram biomass-1, was used for the calculations. 
Table 6.5. Nucleotide contents in the biomass. 
NMP Chemical Formula KEGG ID iMM904 iOD962
AMP C10H14N5O7P C00020 0.0460 0.0536
CMP C9H14N3O8P C00055 0.0447 0.0339
GMP C10H14N5O8P C00144 0.0460 0.0454
UMP C9H13N2O9P C00105 0.0599 0.0524
* mol nucleotide.gram biomass-1. Values used in the iMM904 model are also shown for reference. 
6.3.6.4 POLYSACCHARIDES 
The contents of several polysaccharides present in the biomass equation, namely alpha,alpha-
Trehalose, amylose and chitin have been adapted from the iMM904 model. However, a study of 
the composition of the K. lactis cell wall53 was used to retrieve the relative contents of 1,3-beta-D-
glucan and mannan contents in the cell. 
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Table 6.6. Mannan and 1,3-beta-D-glucan contents in the cell. 
Metabolite Chemical Formula 
KEGG 
ID 
iMM904 iOD962 
Molar* Percentage** Molar* Percentage**
1,3-beta-D-Glucan (C6H10O5)n C00965 1.1348 18.40 1.374396 22.265
Mannan  C00464 0.06 13.10 0.570048 9.24 
* mol of polysaccharide.gram biomass-1; ** gram polysaccharide.gram biomass-1 
This information allowed converging the biomass requirements of the K. lactis in silico and in vivo 
strains. 
6.3.6.5 P/O RATIO 
The P/O ratio is the relationship between ATP synthesis and oxygen consumption. This quotient 
indicates the number of orthophosphate molecules used for ATP synthesis per atom of oxygen 
consumed during oxidative phosphorylation. In the absence of specific studies to characterize the 
phosphate to oxygen ratio in Kluyveromyces lactis, the same (i.e. 1.5) P/O ratio used in the S. 
cerevisiae iMM904 metabolic model was used. The reactions contributing to this ratio were 
automatically generated by the transporters annotation tool. However, these reactions are generic 
and were updated to provide the same P/O ratio as in the iMM904 model. The three reactions, 
generated by the transporters annotation tool, which contribute to this calculation, are listed next. 
Reaction T03074_C4: 
1.0	ܱݔݕ݃݁݊௠௜௧௢ + 4.0		ܨ݁ݎݎ݋ܿݕݐ݋ܿℎݎ݋݉݁	ܿ௠௜௧௢ + 8.0	ܪ௠௜௧௢ା ⇒ 2.0	HଶO୫୧୲୭
+ 4.0	ܨ݁ݎݎiܿݕݐ݋ܿℎݎ݋݉݁	ܿ௠௜௧௢ + 4.0	ܪ௖௬௧௢ା  
Reaction T03020_C4: 
2.0	Ubiquinol୫୧୲୭ + 4.0	Ferricytochrome	c୫୧୲୭ + 4.0	H୫୧୲୭ା ⇒ 2.0	Ubiquinone୫୧୲୭
+ 4.0	Ferrocytochrome	c୫୧୲୭ + 8.0	Hୡ୷୲୭ା  
Reaction T02959_C4: 
1.0	Orthophosphate୫୧୲୭ + 1.0	ADP୫୧୲୭ + 4.0	Hୡ୷୲୭ା ⇒ 1.0	ATP୫୧୲୭ + 1.0	HଶO୫୧୲୭ + 4.0	Hୡ୷୲୭ା  
 
The final balance of the summing of these three reactions is  
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3.0	Orthophosphate୫୧୲୭ + 1.0	Oxygen୫୧୲୭ + 3.0	ADP୫୧୲୭ + 2.0	Ubiquinool୫୧୲୭ ⇒ 3.0	ATP୫୧୲୭
+ 5.0	HଶO୫୧୲୭ + 2.0	Ubiquinone୫୧୲୭ 
This means that for each molecule of oxygen (2 atoms) three inorganic phosphate molecules are 
used to form three ATP molecules. 
6.3.7 MODEL CURATION 
Successively, the first curation of the model was performed, to check for reactions with wrong 
compartmentation information. For instance, KEGG reactions R00124 (ATP + ADP <=> ADP + 
ATP) and R07480 (N-(4-Aminobutylidene)-[eIF5A-precursor]-lysine + [eIF5A-precursor]-lysine <=> 
N-(4-Aminobutylidene)-[eIF5A-precursor]-lysine + [eIF5A-precursor]-lysine) only make sense if the 
reactants and products are in different compartments. Moreover, reactions promoted by enzymes 
assigned by WoLF PSORT to the plasma membrane were verified to determine the likelihood of 
those reactions taking place outside the cell. 
After the first curation step, the size of the model was decreased by automatically eliminating 
reactions, either biochemical or transport, with dead end metabolites from the model. That is, if 
in a given reaction a reactant was neither produced by another reaction nor transported from 
another compartment, or a product was neither being consumed by another reaction nor 
transported to other compartments, then that reaction was automatically excluded from the 
model. This step was performed recursively, because removing a reaction can render other 
metabolites as dead ends. 
Then, the model was checked for unbalanced reactions. KEGG has several reactions unbalanced 
at the stoichiometric level, namely reactions involving glycan. KEGG reactions include a field 
labelled ‘number of chains’ to balance those reactions, where adding a monomer to a metabolite 
having n chains will create an oligomer with n+1 chains. However, metabolic models only use the 
stoichiometry; thus, these reactions were simplified by setting n=0. For instance, the equation for 
KEGG’s reaction R00887 is GDP-mannose + Mannan(n) <=> GDP + Mannan(n+1). However, this 
equation is unbalanced and replacing n per zero simplifies the reaction, turning it into GDP-
mannose  <=> GDP + Mannan. 
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Also, several reactions were unbalanced at the protons level. Reactions such as R00137 or 
R02744 had more protons being produced than consumed. This step was very important, as an 
unbalanced model would not provide feasible predictions. 
The connection between reactions in distinct compartments, the duplication of various reactions 
in different compartments and the direction of irreversible reactions (onward or backward) was 
verified manually. 
The origin of each biomass precursor was also similarly verified to identify unconnected 
reactions. For that purpose the model was exported from merlin 2.0 in the SBML format, and 
imported into OptFlux, so that simulations could be performed. When a metabolic model is 
imported into OptFlux, boundaries are automatically created for each reaction. Moreover, drains 
(unbalanced reactions that allow performing simulations) are also created for all external 
metabolites. For more information on this formulation please refer to Rocha et al.56. The method 
used to perform the simulations was the Flux Balance Analysis. More information on this 
methodology is provided on Chapter 2. 
Initially, the boundaries of all uptake drains of the model were unrestricted to determine whether 
the model was able to produce biomass or not. For that end, a simulation with such broad 
environmental conditions was performed. When a given biomass precursor was not being 
produced, the connectivity from the environmental conditions to the biomass was verified. 
The next simulations with the in silico K. lactis strain were performed restricting the 
Environmental Conditions to the metabolites consumed in the previous viable simulation, plus the 
metabolites from an in silico adaptation of the well–known defined medium, namely the synthetic 
Verduyn medium57 supplemented with 5 fold the nicotinate contents58, as shown in Table 6.7. 
All boundaries of the metabolites provided by the environmental conditions described in Table 
6.7 were unrestricted, except alpha-D-Glucose that was restricted to 1 mmol.g-1.h-1 for simulating 
a glucose limited chemostat. This restriction allowed limiting the number of metabolites that the 
model had available to generate biomass in the next iteration. Moreover, special attention was 
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provided to the curation of futile cycles in internal fluxes of the model and the biomass 
precursors. 
Table 6.7. In silico adaptation of the Verduyn medium for growth of Kluyveromyces lactis. 
Metabolite KEGG ID Formula 
alpha-D-Glucose C00267 C6H12O6
thiamine C00378 C12H17N4OS
myo-Inositol C00137 C6H12O6
Fe2+ C14818 Fe
Orthophosphate C00009 H3PO4
NH3 C00014 NH3
Sulfate C00059 H2SO4
Oxygen C00007 O2
Nicotinate C00253 C6H5NO2
Pyridoxal C00250 C8H9NO3
4-Aminobenzoate C00568 C7H7NO2
Pantothenate C00864 C9H17NO5
 
After the first verification of the model, while the model did not provide feasible results, it was 
continuously curated. The curation of the model involved verifying the flux values in important 
pathways, like the Oxidative Phosphorylation, Central Carbon Metabolism, the Fatty Acids 
Biosynthesis or the Glycolipids Metabolism. When key reactions in these pathways had zero flux 
values, gaps in the network were sought, and, when found, new reactions were added to the 
model to correct them. These gaps in the network could exist due to several reasons. The 
enzymes promoting those reactions could have been, erroneously, assigned to different 
compartments. If that was the case, the reactions were either relocated to the correct 
compartment, or duplicated to the compartments of interest if the enzyme is hypothesised to be 
active in several locations. Instead, those gaps could be related with the removal, in a previous 
step, of reactions from the model, when the metabolites involved in such reactions were 
unconnected from the remaining network. However, when these reactions were found to be 
relevant, they were re-included in the model, and the dead end metabolites connections verified. 
Another set of reactions found to be missing from the network was the transport reactions 
from/to the exterior and across internal membranes for currency metabolites, like H2O, CO2, NH3 
and others. The availability of these reactions was confirmed because these metabolites are often 
CHAPTER 6 193 
 
carried by facilitated diffusion and the lack of transport reactions for these metabolites would 
impair the model. 
Contrarily, some reactions were incorrectly included in the network. Several enzymes catalyse 
reactions that accept different cofactors in different organisms, and in KEGG these reactions are 
usually replicated for each cofactor. Therefore, some of these reactions had to be removed from 
the model, and the iMM904 model was used to determine which cofactors are usually used by 
yeasts. Also, some enzymes were assigned to several compartments, although they were only 
relevant in one of them. In these cases, the reactions were removed from the model. At this step, 
the reversibility of the reactions in the network was verified once again, to be sure that the 
removal and/or inclusion of new reactions did not impair the model prediction capabilities. 
Subsequently, the model was again trimmed, yet now only for transport reactions with 
unconnected metabolites, as the removal or re-location of reactions may disconnect transport 
reactions from the network. Once the connectivity to the biomass precursors was also re-verified, 
the model was tested by simulating growth using the restricted environmental conditions 
(Verduyn medium presented in Table 6.7 + metabolites consumed in the previous iteration), in 
the case that the specific growth rate of the previous simulation was positive, or with the 
unrestricted environmental conditions (boundaries of all uptake drains of the model unrestricted) 
otherwise. 
This process was repeated several times, according to Figure 6.1, until the simulation could be 
performed with the Environmental Conditions set to the minimal medium conditions, and the in 
silico results replicate the in vivo results. 
This methodology was implemented using merlin 2.0 for the reconstruction process and OptFlux 
3.056 for the validation of the model. All predictions were performed using the IBM® CPLEX 
solver. 
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6.4 MODEL EVALUATION 
6.4.1 MODEL CHARACTERISTICS 
Initially, the previous annotation46 was verified in merlin 2.0 to determine if it was up-to-date. The 
comparison of the automatic annotation of the new BLAST search, performed with the default 
merlin 2.0 parameters, with the previous annotation, resulted in the updating of the annotation of 
45 genes and the addition of 20 new metabolic genes (supplemental material, Table S6.1). The 
majority of the updated genes (39) were already classified as metabolic, yet the remaining 6 were 
genes previously classified as non-metabolic. The new metabolic genes, not present in the 
previous annotation, included 6 genes encoding enzymes and 14 genes encoding carriers. From 
the 65 new and updated genes 49 were utilised in the model. 
From the 1759 metabolic genes provided by the previous annotation, only 936 were used in this 
model. The additional 824 genes encoding proteins that promote reactions not included in 
iOD962, though remaining available for posterior development of an extended version of the 
model in merlin 2.0, were excluded due to several reasons: 
• Approximately one quarter (200) of these genes encoded enzymes exclusively identified 
with partial EC numbers, thus not being integrated in the model; 
• 79 of previously annotated genes encoding proteins that promote reactions not included 
in the model, exclusively encoded transporters. However, the transport reactions 
generation tool, did not assign any reaction to 23 of these genes, thus not being possible 
to include them in the model. The remaining 56 genes are connected to transport 
reactions in merlin 2.0, though none of these reactions is currently required in the model 
as the associated metabolites were not present; 
• The remaining 545 genes encode proteins promoting reactions available in merlin 2.0, 
still not being included in this version of the model, either because the metabolites 
involved in them are unconnected from the main network or due to a decision taken 
throughout the manual curation of the model. 
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Nevertheless, as shown in Table 6.8 the final version of the model included 962 genes (936 from 
the previous annotation + 6 previously discarded genes + 20 new metabolic genes), which 
encode 776 enzymatic activities that promote 2029 reactions. The major shortcoming of iOD962 
is that this model’s GPR associations are all set to “OR”, that is, there are no protein complexes 
or enzymatic subunits in iOD962. As a consequence, there is no distinction between isoenzymes 
and protein complexes and, when simulating the deletion of a subunit of a protein complex, all 
subunits have to be deleted. For instance, the in silico deletion of the PFK1 subunit of the PFK 
complex (PFK1+PFK2) has to complemented by the deletion of the other subunit. 
Table 6.8. Model characteristics. 
Genes Proteins 
Enzymatic 
Reactions 
Spontaneous 
Reactions 
Transport 
Reactions 
Metabolites Compartments
962 768 1243 29 766 1561 4 
 
Although it may seem that the number of genes in this model is similar to the number of genes 
from the S. cerevisiae models, namely the widely used iMM904, it should be kept in mind that 
the baker’s yeast experienced whole genome duplication59 and many reactions in such model are 
probably connected to paralogous genes. 
6.4.2 OXYGEN AVAILABILITY 
The iMM904 S. cerevisiae model may simulate anaerobic growth, when the environmental 
conditions are supplemented with sterols (ergosterol and zymosterol) and unsaturated fatty acids 
(C10-C18), and when heme (only mandatory for the oxidative phosphorilation) is removed from 
the biomass equation, because the biosynthesis of these metabolites require oxygen. Sterols and 
unsaturated fatty acids also have to be supplemented for anaerobic in vivo growth experiments. 
However, it was expected that iOD962 could not grow in anaerobiosis, even without heme in the 
biomass formation equation and when supplemented with sterols and unsaturated fatty acids, 
which was not the case. According, to Snoek and Steensma60 one of the reasons for the absence 
of anaerobic growth in K. lactis should be the lack of genes involved in sterol uptake. However, 
the transporters annotation tool found several K. lactis genes with homologies to S. cerevisiae 
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genes known to be related to such function, as shown in Table S6.2 of the supplemental 
material. For instance the gene KLLA0D18601g was found to be homologous to the S. 
cerevisiae’s ARV1 gene, known to be required for sterol uptake and growth during anaerobiosis. 
Another reason for this behaviour proposed by the authors is the absence of transcription factors 
involved in sterol uptake, which was not corroborated in our work, because during the re-
annotation of the genome it was noticed that the KLLA0A04169g gene is a functional homologue 
of the UPC2 S. cerevisiae gene, known to be implicated in the activation of anaerobic genes 
involved in sterol uptake and regulation of the sterol biosynthesis. Therefore, the absence of 
anaerobic growth in K. lactis does not seem to be related with any metabolic impairment nor 
correlated with the regulation of sterols uptake, and must be associated to several other factors, 
namely regulatory phenomena, as also remarked by the authors. 
This model complies with several published experiments in yields and viability as it will be shown 
later. Yet, simulations performed under oxygen-limited conditions (1 mmol.gDw-1.h-1) predict the 
production of ethanol and residual amounts of formate instead of glycerol. 
It is generally accepted that under oxygen-limited conditions K. lactis starts increasing the glucose 
metabolism, accumulating ethanol and glycerol. Yet, the activity of glycerol-3-phosphate 
dehydrogenase is induced by low-oxygen conditions, which decreases the production of glycerol, 
thus providing more ATP for growth and enabling a higher growth rate61. 
However, the stoichiometric nature of iOD962 with unconstrained internal fluxes cannot account 
for regulatory and kinetic phenomena. Thus when the objective function is set for the 
maximization of the biomass, the glycerol-3-phosphate dehydrogenase will always redirect all flux 
for the biomass formation, even in restricted oxygen conditions, thus never producing glycerol. 
6.4.3 GAP FILLING 
This model includes 57 (17 enzymatic + 17 transport + 12 spontaneous + 11 non-enzymatic) 
reactions added to model without genomic evidences, either to eliminate gaps in the network or 
because the reactions can take place without the intermediation of a catalyser. Such reactions 
are available in Table S6.3 of the supplemental material. The enzymatic reactions were added to 
CHAPTER 6 197 
 
fill gaps in the model, either because the EC numbers associated to these reactions are 
incomplete or because the reaction is critical to the model. Likewise, the transport reactions in 
the same table were not predicted by the transporters annotation tool. The carriers not available 
in the model were usually for currency metabolites (i.e. metabolites with hundreds of connections 
in the model, for instance water, oxygen, ammonia) and for the transport of specific metabolites 
to uncommon compartments, like NADPH and ergosterol to the endoplasmic reticulum. The 
generation of transport reactions is very demanding because the transporter of a specific 
compound has to be associated to a specific compartment and therefore the tool has to meet 
several criteria to generate such reactions. 
6.4.4 MAINTENANCE ATP FITTING 
The depletion of ATP by processes not directly associated to growth, like futile cycles or turnover 
of molecules, was represented in the model by an equation that forces ATP consumption 
throughout a specific flux. The boundaries of this flux were inferred by fitting the in silico 
predictions of the model to experimental in vivo data from Kiers et al.58. 
The model was used to predict the growth, oxygen consumption and carbon dioxide production 
yields using the same environmental conditions utilised in that work, and limiting the carbon 
source (glucose) availability to the actual glucose uptake yield, using different maintenance ATP 
flux values (1.0 - 5.0 mmol.h-1.g-1). Table 6.9 lists the results for simulations performed in 
OptFlux. 
The models’ specific growth predictions, as well as oxygen consumption and carbon dioxide 
production, per concentration of carbon source for each maintenance ATP value were regressed 
against the in vivo data, in Microsoft Excel®. The linear regression slopes and y-intercept values 
for each maintenance ATP regression are depicted in Figure 6.2. 
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Table 6.9. Analysis of the model response to different maintenance ATP requirements. 
qS (mmol.g-1.h-1) 0.68 1.18 2.22 3.33 4.44 
μ (g.g-1.h-1) 
in vivo 0.05 0.1 0.2 0.3 0.4 
ATPM 
1 0.06 0.12 0.23 0.34 0.45 
2 0.06 0.11 0.22 0.33 0.45 
3 0.05 0.10 0.21 0.33 0.44 
4 0.05 0.10 0.21 0.32 0.43 
5 0.04 0.09 0.20 0.31 0.43 
qO2 (mmol.g-1.h-1) 
in vivo 1.95 3.5 6 8.8 11 
ATPM 
1 1.77 2.92 5.30 7.85 10.39 
2 1.98 3.13 5.51 8.31 10.60 
3 2.19 3.34 5.72 8.27 10.81 
4 2.40 3.55 5.93 8.48 11.02 
5 2.61 3.76 6.14 8.69 11.23 
qCO2 (mmol.g-1.h-1) in vivo 
in vivo 1.95 3.5 6 9.1 11 
ATPM 
1 1.82 3.01 5.47 8.11 10.74 
2 2.03 3.21 5.68 8.06 10.95 
3 2.23 3.42 5.89 8.52 11.15 
4 2.44 3.62 6.09 8.73 11.36 
5 2.64 3.83 6.30 8.93 11.57 
 
The analysis of Figure 6.2 shows that the slopes of the linear regressions, between the in vivo 
data and the predictions (biomass yield, O2 consumption and CO2 production) provided by 
simulations under the in vivo growth environmental conditions remain constant for all ATP 
maintenance values tested. However, the analysis of the linear regressions’ y-intercept values 
suggests that the ATP used for maintenance should be set to 2 mmol.gDW-1.h-1, as this value 
provides the best fitting to the in vivo data on all the predictions (biomass yield, O2 consumption 
and CO2 production). 
The analysis of Figure 6.2 shows that the slopes of the linear regressions, between the in vivo 
data and the predictions (biomass yield, O2 consumption and CO2 production) provided by 
simulations under the in vivo growth environmental conditions remain constant for all ATP 
maintenance values tested. However, the analysis of the linear regressions’ y-intercept values 
suggests that the ATP used for maintenance should be set to 2 mmol.gDW-1.h-1, as this value 
provides the best fitting to the in vivo data on all the predictions (biomass yield, O2 consumption 
and CO2 production). 
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Figure 6.2.Linear regression analysis of the alignment between the in vivo values (Kiers et 
al.58) and the prediction values from iOD962 shown in Table 6.9. 
The vertical bars on the columns represent the standard error, automatically calculated considering all glucose 
uptake rates. 
6.4.5 KNOCKOUT ANALYSIS 
Several gene deletions in vivo experiments were collected and the corresponding phenotypes 
compared to the in silico predictions of this model, to assess the model reliability. The result of 
the comparison is shown in Table 6.10 and Table 6.11. 
As shown in Table 6.10, over 90% of the model predictions are in accordance with the simulation 
results, thus confirming the accuracy of the model. 
Table 6.10. Truth table for the in silico knockout predictions. 
 
POSITIVE NEGATIVE
POSITIVE 25 2
NEGATIVE 2 14
The in vivo results are represented in the top row the in silico predictions on the first column. 
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The detailed comparison between the in silico and the in vivo knockouts is available in Table 
6.11. This table lists the genes that were inactivated and the phenotypic behaviour of the 
organism to such stress. 
Table 6.11. Comparison of the behaviour of the in silico model to the in vivo knockout 
experiments. 
in vivo 
knockout 
in silico 
knockout 
in silico phenotype in vivo phenotype strain reference 
RAG2- RAG2- growth on glucose growth on glucose 
NRRL-
Y1140* 
Tarrío et al. 
(2006)39 
Verho et al. 
(2002)62 
HK5-2B 
Jacoby et al. 
(1993)63 
RAG2- & TAL1- RAG2- & TAL1- 
no growth on glucose; 
no growth on fructose; 
no growth on glycerol 
no growth on glucose; 
no growth on fructose; 
growth on glycerol 
HK5-2B 
Jacoby et al. 
(1993)63 
PDC1- PDC1- 
growth on glucose 
(does not produce ethanol**) 
growth on glucose; 
(does not produce ethanol) 
NRRL-
Y1140* 
Bianchi et al. 
(2001) 64; 
Zeeman et 
al. (2000)65 
PFK1- PFK1- & PFK2- growth on glucose growth on glucose NRRL-Y1140* 
Tarrío et al. 
(2006)39 
TAL1- TAL1- 
growth on glucose; 
growth on glycerol 
growth on glucose; 
growth on glycerol 
HK5-2B 
Jacoby et al. 
(1993)63 
PFK1- & TAL1- PFK1- & TAL1- 
growth on glucose; 
growth on glycerol 
growth on glucose; 
growth on glycerol 
PFK2- & TAL1- PFK2- & TAL1- 
growth on glucose; 
growth on glycerol 
growth on glucose; 
growth on glycerol 
PFK1- & PFK2- 
& TAL1- 
PFK1- & PFK2- 
&  TAL1- 
no growth on glucose; 
no growth on fructose; 
growth on glycerol 
no growth on glucose; 
no growth on fructose; 
 growth on glycerol 
XYL1- XYL1- no growth on xylose no growth on xylose SD6 
Billard et al. 
(1995)66 
ICL1 - ICL1- no growth on ethanol no growth on ethanol 
-- 
Lopez et al. 
(2004)67 FBP1- FBP1- growth on ethanol 
overpassed by PPP 
no growth on non-
fermentable carbon sources 
ACS1- ACS1- growth on glucose; 
growth on ethanol 
growth on glucose; 
growth on ethanol 
NRRL-
Y1140*) 
Zeeman and 
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ACS2- ACS2- 
growth on glucose; 
growth on ethanol 
reduced growth on glucose; 
reduced growth on ethanol 
Steensma 
(2003)68 
ACS1- & ACS2- ACS1- & ACS2- 
growth on glucose; 
no growth ethanol; 
no growth on acetate 
apparently lethal 
GLR1- GLR1- growth on glucose growth on glucose 
NRRL-
Y1140* 
García-Leiro 
et al. 
(2010)69 
PDA1- PDA1- & PDB1- 
reduced growth rate when 
compared to wild type 
four-fold reduced specific 
growth rate on glucose in 
minimal medium. 
NRRL-
Y1140* 
Zeeman et 
al. (1999) 70 
INV1- INV1- 
growth on glucose; 
no growth on raffinose 
growth on glucose; 
defective growth on raffinose JA6 
Georis at al. 
(1999) 40 
ARG8- ARG8- 
no growth on glucose; 
arginine auxotrophy arginine auxotrophy 
CK213–
4C 
Janssen and 
Chen 
(1998)41 
GGS1- (TPS1-) TPS1- 
no growth on glucose; 
no growth on fructose; 
growth on trehalose (same 
as WT) 
no growth on glucose; 
no growth on fructose; 
reduced growth on trehalose 
NRRL-
Y1140* 
Luyten et al. 
(1993) 71 
LYS2- LYS2- no growth on glucose; lysine auxotrophy lysine auxotrophy 
NRRL-
Y1140* 
Alberti et al. 
(2003) 42 
LAC4- LAC4- 
growth on glucose; 
no growth lactose; 
growth on galactose 
growth on glucose; 
no growth lactose; 
growth on galactose NRRL-
Y1140* 
 
Sheetz and 
Dickson 
(1980) 72 
GAL1- GAL1- 
growth on glucose; 
growth lactose; 
no growth on galactose 
growth on glucose; 
growth lactose; 
no growth on galactose 
SDH1- 
SDH1- & SDH2- 
& SDH3- & 
SDH4- 
growth on glucose;  
(accumulation of 
succinate**); 
growth on lactate 
growth on glucose 
(accumulation of succinate); 
growth on lactate 
NRRL-
Y1140* 
Saliola et al. 
(2004)73 
TPI1- TPI1- 
growth on glucose 
(accumulates glycerol**) growth on glucose PM6-7A  
Compagno et 
al. (1999) 74 
* - also known as CBS2359 and ATCC8585; ** - when O2 is restricted to 1 mmol.g-1.h-1 
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One of the main differences between K. lactis and S. cerevisiae is its viable RAG2 mutant 
phenotype46,62. Yet, the simultaneous deletion of RAG2 and TAL1, although not impairing growth 
in non-fermentable carbon sources 63, is lethal for K. lactis in this model, because this pair is 
critical for glycolysis / gluconeogenesis. As shown in Table 6.11, the deletion of these genes 
separately is not critical, because the other gene can be used to surpass the deletion. 
Another distinction to S. cerevisiae is that in K. lactis growth on glucose does not require the 
presence of the pyruvate decarboxylase65, which was also predicted in this model, as the 
knockout of the PDC1 gene did not impair growth on glucose. Nevertheless, this mutant did not 
accumulate ethanol when under limited oxygen conditions (oxygen flux limited to 1 mmol.gDw-1.h-
1). 
Surprisingly, the in vivo deletion of each of the phosphofructokinase (PFK) subunits by itself did 
not impair K. lactis growth on fermentable carbon sources as it would be expected. The authors 
claim that “This could be caused by a residual PFK activity conferred by the remaining subunit in 
vivo that escapes detection by in vitro enzymatic determinations”63,75. Nevertheless, the non-
growth in fermentable carbon sources for the double PFK mutant in conjunction with the TAL1 
knockout is correctly predicted by the iOD962. 
As expected, the single deletion of the XYL1 gene blocked growth on xylose in the same way that 
the knockout of the LAC4 and GAL1 genes compromised growth on lactose and galactose, 
respectively, both in silico and in vivo.  
Similarly, the separate deletion of the ARG8 and LYS2 genes generated auxotrophic mutants on 
arginine and lysine, respectively. This phenotype was also observed in silico. 
The in silico deletion of the ICL1 gene produced mutants not growing on ethanol, which is in 
accordance with the in vivo data. However, the in vivo data deletion of FBP1 disagrees with the in 
silico prediction because in the same way that in Glycolysis the RAG2 gene or the 
phosphofructokinase complex deletion is surpassed by the Pentose Phosphate Pathway (PPP), so 
should the FBP1 deletion, in the Gluconeogenesis, be surpassed by the inverse route in the PPP. 
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The lack of data in the reversibility of the reactions in the PPP provides an alternative route for 
the generation of glucose from ethanol, when the fructose-1,6-bisphosphatase is deleted. 
Since iOD962 is a stoichiometric model, the predictions of the decreased growth rate when 
deleting the dominant Acetyl-coenzyme A synthetase copy (ACS1 gene) or the less reduced 
growth rate provided by the ACS2 knockout, could not be verified, although the viability of the 
model was confirmed for these single deletions. However, the double mutant lethal phenotype, 
claimed by the authors of the study, could not be verified in silico, as the model predicted growth 
on glucose, though not growing in acetate and ethanol. The results of the work of Zeeman and 
Steensma (2003)68 are inconsistent with the growth on glucose of PDC1 mutants, which 
indicates that in K. lactis, during growth in glucose, the pyruvate dehydrogenase is not essential 
for generating cytosolic acetyl-CoA, or this metabolite can be obtained from another source. In 
both cases the presence of ACS is not mandatory. Therefore, they propose that ACS may have a 
yet unknown critical function apart from its enzymatic activity, thus endorsing the model result. 
The PDA1 knockout had to be simulated in this model, with the deletion of both Pyruvate 
dehydrogenase subunits (PDA1 and PDB1). Nevertheless, the observed growth rate in glucose 
was decreased when compared to wild type, which, though not being a four-fold reduction as in 
the work of Zeeman et al.70, is in accordance with in the in vivo experiments. 
The model confirmed that GLR1 is not an essential gene, as its knockout had no observable 
phenotypical effect. 
The deletion of the only gene encoding an Invertase in K. lactis (INV1) did not impair growth on 
glucose, though being lethal for growth on raffinose. Although this is the only enzyme able to 
hydrolyse polysaccharides, the authors of the study only report defective growth on raffinose. 
The knockout of the TPS1 gene prevents K. lactis from growing in glucose and fructose, both in 
vivo and in silico. However, this mutant is viable when using alpha,alpha-trehalose as carbon 
source. Again, the stoichiometric nature of the model cannot predict the reduction of the growth 
rate in this mutant, proposed by the in vivo experiments, as this reduction may arise from a 
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decreased affinity of the alpha,alpha-trehalose uptake, or a reduced kinetic rate of conversion of  
alpha,alpha-trehalose into glucose by the alpha,alpha-trehalase. 
The knockout of a single subunit of the succinate dehydrogenase complex had to be simulated in 
the model by deleting all four subunits (SDH1, SDH2, SDH3 and SDH4). The predictions of the 
model were in accordance with the in vivo results, having growth on glucose and lactate, and 
producing succinate instead of ethanol under limited oxygen conditions (oxygen flux limited to 1 
mmol.gDw-1.h-1). 
Contrarily to S. cerevisiae, in which the deletion of TPI1 gene is lethal, the phenotype of the 
deletion of this gene in K. lactis is viable. In the latter case, this mutation increases the glycerol 
yield under limited oxygen conditions (oxygen flux limited to 1 mmol.gDw-1.h-1), which can be 
verified in silico. As stated earlier, the in silico strain cannot predict the formation of glycerol in 
the presence of such gene, because all the glycerone phosphate produced by the fructose-
bisphosphate aldolase is redirected to glycolysis by this enzyme, instead of generating glycerol. 
6.4.6 MINIMAL MEDIUM 
The minimal medium for growth of K. lactis was determined using the iOD962. The starting point 
was the Verduyn defined medium57, and the medium was developed by exclusion of metabolites 
irrelevant for growth. The result of this approach is shown in Table 6.12. 
Table 6.12. Minimal medium for in silico growth of Kluyveromyces lactis. 
Metabolite KEGG ID Formula 
alpha-D-Glucose C00267 C6H12O6
thiamine C00378 C12H17N4OS
myo-Inositol C00137 C6H12O6
Fe2+ C14818 Fe
Orthophosphate C00009 H3PO4
NH3 C00014 NH3
Sulfate C00059 H2SO4
Oxygen C00007 O2
Nicotinate C00253 C6H5NO2
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The difference between the constituents of this medium and the Verduyn medium presented in 
Table 6.7 is the absence of Pyridoxal, 4-Aminobenzoate and Pantothenate, which can be 
generated from metabolites produced in the Glycolysis. In K. lactis the first metabolite is 
synthesized from D-Glyceraldehyde 3-phosphate on the Vitamin B6 metabolism pathway. The 
second metabolite is a folate precursor, generated from chorismate produced in the 
Phenylalanine, tyrosine and tryptophan biosynthesis pathway from phosphoenylpyruvate. The 
latter metabolite is produced in the Pantothenate and CoA biosynthesis pathway from pyruvate. 
6.4.7 OTHER PROPERTIES 
As shown in the previous section folate is not an essential metabolite, yet its exclusion from the 
environmental conditions has a side effect: the mandatory production of a metabolite called 
glycoaldehyde. In the Folate Biosynthesis pathway the reaction catalysed by the dihydroneopterin 
aldolase (4.1.2.25), which is precursor of 2-Amino-4-hydroxy-6-hydroxymethyl-7,8-
dihydropteridine that is needed to produce folate generates the glycoaldehyde. However, this 
metabolite is not reused in the network, thus having to be excreted by the cell. Although this is 
also observed in S. cerevisiae’s model, to the best of our knowledge there is still not an 
experimental evaluation of this phenomena. 
The critical reactions for growth in the minimal medium were identified using OptFlux 3.0. The 
result of that analysis is available in Table S6.4 of the supplemental material. The model 
accounts for 207 critical reactions for growth in the minimal medium.  
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6.5 CONCLUSIONS 
This model was developed semi-automatically using merlin 2.0 and a previous genome-wide re-
annotation of the K. lactis genome, allowing a fast reconstruction (in a couple of months). 
Although being only partly curated, it was able to predict phenotypes from several experiments 
published over the last three decades. Moreover, it provides reasonable results for quantitative 
simulations of chemostat experiments, as shown in the previous section. 
We showed that the iOD962 metabolic model can be useful for predicting the K. lactis behaviour 
as well as its mutants. Moreover, this model allowed determining a minimal medium for 
cultivating K. lactis, which should be tested in vivo, and will surely allow elucidating insights on 
the milk yeast metabolism, as well as identifying engineering targets for the improvement of the 
production of by-products of interest by performing in silico simulations. 
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6.7 SUPPLEMENTAL MATERIAL 
Additional file 6.1 – File with model in the SBML format. 
www.merlin-sysbio.org/supplemental_material/kla_model.xml 
 
Additional file 6.2. - File with Additional tables in Excel format.  
www.merlin-sysbio.org/supplemental_material/additional_file_6.2.xlsx 
Table S6.1 - Genes that had their annotation updated.  
Table S6.2 - Genes associated to sterols uptake in S. cerevisiae and corresponding K. lactis homologues. 
Table S6.3 - Reactions not associated to genes in the model. 
Table S6.4 - Critical reactions for growth in the minimal medium. 
